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Abstract i 
  
Abstract 
The equilibrium model (EM) (Daniel et al., 2001) postulates two forms of a 
folded enzyme, one catalytically active (Eact) and the other inactive (Einact), 
which interconvert via a fast thermal equilibrium (Keq) (Figure A). This 
model for enzyme catalysis accounts for experimentally observed time 
and temperature profiles of enzyme/substrate systems more accurately 
than the classically derived, single folded-species, model (Figure B). In 
both models, the denatured species (X) is formed via the kinact process, 
which is temperature and time-dependent. 
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Figure A – The equilibrium model Figure B – The classical model 
Comparison between the equilibrium model and classical model for enzyme catalysis. 
For both, the vertical axis is catalytic rate (M s-1), the left-right axis is increasing 
temperature (K) and the back-front axis is assay duration (s). 
The physical basis for the Eact/Einact equilibrium is unknown. To study the 
equilibrium, the temperature midpoint of the Eact/Einact transition (Teq) has 
to be separated from the thermostability of the enzyme (Tm) to allow the 
Einact species to exist in measurable concentrations without exhibiting 
denaturation. 
Abstract ii 
  
Mutations were made in a well-studied and NMR-accessible ribonuclease, 
barnase, to alter the thermostability and/or the Teq of the enzyme activity. 
The stability properties of each mutant were measured and the activity 
against two substrates assayed. New models were derived and fitted 
against wild-type barnase, and an ideal data set, to give insight into 
alternative irreversible and reversible denaturation pathways. Simulations 
of these models were developed to benchmark potential dynamics work 
and explain the movements of species within each model’s framework. 
Assay data fits to the EM and alternative models show a preference for 
irreversible denaturation pathways via the Einact species. A mathematically 
simplified model was also found that accounts for data and could provide 
an alternative method for determining EM parameters. Although fits of 
barnase to the EM were statistically good, the denaturation properties 
could not be reconciled with the literature or experimentally determined 
values for stability and unfolding. Simulations illustrating how the Eact, 
Einact and denatured (X) species interact also corroborate this finding. 
Despite this discrepancy (in fitted parameters to the EM), it is 
hypothesised that the Teq and Tm of a disulphide-bridged mutant of 
barnase have been successfully decoupled. This mutant has been 15N-
labelled for future NMR dynamics measurements. New approaches to the 
EM model are proposed where the separate determination of enzyme 
thermodynamic properties (e.g., rate and free energy of denaturation) 
would allow other EM parameters to be fitted independently to each data 
set. 
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1 Introduction 
1.1 Catalysis and Kinetics 
1.1.1 General Catalysis and Kinetics 
Chemical reactions can spontaneously occur on time-scales with half-lives 
(t1/2) of millions of years, to those that are almost instantaneous (Fersht, 
1999). When another entity – be it another molecule in solution or a rare-
metal/carbon composite – speeds up a chemical reaction, but is not itself 
consumed, that entity is called a catalyst. 
To briefly illustrate how catalysts work, we can consider a simple 
chemical-reaction; the hydrolysis of an ester molecule by a water 
molecule: 
 
Figure 1.1 – Ester hydrolysis in neutral aqueous solution 
The transition state (TS) for the spontaneous uncatalysed reaction is highly 
unstable due to the formation of negative and positive partial charges on 
the ester’s carbonyl oxygen and the water’s oxygen, respectively: 
 
Figure 1.2 – Transition state for uncatalysed ester hydrolysis (Fersht, 1999) 
If, for example, an acetate ion was in solution, the negative charge on the 
acetate carboxylate group could partially stabilise the !+ on the water, 
lowering the overall free energy of the TS. In this case, the effect is known 
as general-base catalysis. It can be shown that the Gibbs free energy 
barrier from the ground state (reactant) to the TS is therefore less (by 
∆∆G‡), and due to the laws of mass action, the reaction proceeds at a faster 
rate (Fersht, 1999) (Figure 1.3). 
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Figure 1.3 – Gibbs free energy diagram for uncatalysed and catalysed reactions 
∆∆G‡ is the difference between ∆G‡ for the uncatalysed reaction (uncat.), 
and ∆G‡ for the catalysed reaction (cat.). The rate constant for the reaction 
(k) can be described in terms of ∆G‡ using transition state theory and the 
Eyring equation (Laidler & King, 1983): 
  
 
k = kB !ThP
!exp "#G
‡
R !T
$ 
% & 
' 
( ) 
 
Equation 1.1 – The relationship between rate constant and ∆G‡ 
where kB is Boltzmann’s constant, hP is Planck’s constant, R is the gas 
constant and T is the temperature in Kelvin. Linus Pauling, amongst 
others, hypothesised that enzymes might work as catalysts by similarly 
lowering the ∆G‡ of a reaction (Pauling, 1948). 
1.1.2 Enzyme Catalysis and Kinetics 
Catalysts are ubiquitous; it has been suggested that life itself has arisen 
from autocatalytic processes, where inorganic precursor molecules were 
arranged into basic building blocks of many enzymes – porphyrins 
chelating iron, for example, mediating reaction redox properties – and that 
these processes have been refined in the RNA- and DNA-based organisms 
present today (Johnson et al., 2008; Miller & Urey, 1959). Some proteins 
are the most efficient catalysts known and are called enzymes (Fersht, 
1999). 
Given that organisms produce metabolically costly enzymes, from an 
evolutionary standpoint they must gain an advantage from doing so. In an 
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extreme example, the decarboxylation of orotidine 5'-monophosphate to 
5'-uridylic acid has a t1/2 of 78 million years in neutral aqueous solution, 
but with orotidine 5'-phosphate decarboxylase present as a catalyst this 
drops to 18 milliseconds, a ~1017 rate increase (Miller & Wolfenden, 2002). 
The benefit in terms of higher (faster) rate constants is clear, as at 298 K (25 
°C), this equates to a ∆∆G‡ advantage of ~98 kJ mol-1. 
So, how do enzymes achieve such rate increases? The components that 
make up ∆G‡ itself give insight: 
  
 
!G‡ = !H‡ "T #!S‡  
Equation 1.2 – The relation between Gibbs free energy, enthalpy and entropy 
where ∆H‡ is the enthalpy change and ∆S‡ the entropy change in going 
from the substrate to the TS structure. Hence, smaller enthalpy changes 
and more positive entropy changes will result in a lower ∆G‡ overall. 
Equation 1.1 can be modified: 
  
 
k = kB !ThP
!exp "#H
‡
R !T
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% & 
' 
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!exp #S
‡
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$ 
% & 
' 
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Equation 1.3 – The relationship between rate constant, ∆H‡ and ∆S‡  (Fersht, 1999) 
Simplistically, enzymes are scaffolds made up of amino acids that 
maintain an environment (the active site) with several properties that aid 
in catalysis (Benkovic & Hammes-Schiffer, 2003). Firstly, the TS of the 
reaction is stabilized by the active site (by straining the shape of a 
substrate towards the TS conformation shape, it reduces the amount of 
activation energy, a kind of enthalpy, required to complete the reaction) 
(Pauling, 1948). Secondly, the pocket in which the substrate binds is 
complementary to the properties of the substrate, e.g. in terms of shape, 
charge, polarity and hydrophobicity. Hence, the fit of the substrate is 
induced; binding gets tighter as more favourable contacts are made (Tsou, 
1995). A major related effect involves reducing the entropy change of 
catalysis by bringing substrate(s) and the enzyme together in the correct 
orientation to react (Daniel et al., 2003; Garcia-Viloca et al., 2004). 
Lastly, enzymes can provide an alternative pathway. Reactions under 
uncatalysed “normal” conditions may have alternative pathways via 
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enzyme catalysis. These pathways can be of significantly lower ∆G‡, and 
hence have faster rate constants. The variance in enzymatic pathways is 
large (Fersht, 1999). For example, covalent catalysis involves the formation 
of temporary chemical bonds between enzyme and substrate, allowing a 
more energetically favourable series of reactions than the uncatalysed 
pathway. Alternatively, electrostatic effects that polarise bonds or stabilise 
charges on intermediates can enhance the reactivity of substrate groups 
(Warshel et al., 2006). 
1.1.3 Michaelis-Menten Kinetics 
The previous section suggests that the binding of the substrate is a major 
force in enzymatic catalysis. Leonor Michaelis and Maud Menten 
developed a general model for the binding of an enzyme to its substrate in 
1913 to explain the saturation kinetics seen experimentally with enzyme 
rate and substrate concentration (Michaelis & Menten, 1913). Such 
behaviour (Figure 1.4) is seen with all enzymes that follow the Michaelis-
Menten model (Equation 1.4) (Briggs & Haldane, 1925; Fersht, 1999). 
 E+S  
KM! "!!# !!  ES  kcat! "!  E+ P  
Equation 1.4 – Illustration of substrate binding and catalysis from the enzyme-
substrate complex 
 
Figure 1.4 – Plot of the Michaelis-Menten equation for enzyme kinetics 
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V = kcat ![E] ![S]K M + [S]
     and       
 
Vmax = kcat ![E] 
Equation 1.5 – (Left) Michaelis-Menten equation for enzyme kinetics (V) 
Equation 1.6 –(Right) The general case for maximum enzyme velocity (Vmax) 
In Equation 1.5 and Equation 1.6 V, the reaction velocity, is expressed as a 
function of [S], the concentration of substrate. KM is the concentration of 
substrate at which V=Vmax/2; kcat is the rate constant for catalysis and [E] is 
the concentration of active enzyme in the assay. Vmax is the velocity of the 
reaction if no product inhibition is observed and KM ≈ 0 (or [S] is >> KM). 
1.2 Time, Temperature and the Equilibrium Model 
1.2.1 Time and Temperature 
Michaelis-Menten kinetics are time-independent; for example, in Equation 
1.5, kcat varies with temperature (as in Equation 1.1), but not assay 
duration. This assumption holds only if the enzyme is not inhibited by 
product formation and the temperature is well below that where the 
enzyme denatures – both conditions that lead to [E] decreasing and hence, 
a reduction in the observed rate. The Michaelis-Menten equations can be 
modified to account for enzyme denaturation, a generally slow 
thermodynamic process, assuming the following scheme: 
 
Equation 1.7 – Irreversible denaturation in the classic enzyme kinetics model 
where E is the active enzyme available for catalysis, X is the denatured 
form of the enzyme and kdenat is the rate constant for the denaturation 
process. Hence, the amount of active enzyme available to catalyse the 
reaction at any point in time, [E], is given by: 
     and therefore      
Equation 1.8 and Equation 1.9 – Expressions for the amount of active enzyme present 
in assays according to classical enzyme kinetics 
where t is time and [E]0 is the amount of active enzyme added to the assay 
at t = 0. Therefore, the equation for Vmax (Equation 1.6) can be modified to 
allow for denaturation (Daniel et al., 2001): 
 E  kdenat! "!!  X
  
 
[E] = [E]0 ! [X]   
 
[E] = [E]0 !exp("kdenat !t)
Introduction – Time, Temperature and the Equilibrium Model 6 
  
 
Equation 1.10 – Maximum enzyme velocity allowing for denaturation in the classical 
kinetics 
1.2.2 The Equilibrium Model Concept 
Equation 1.10 can be analysed to understand why Figure 1.6 shows high 
rates at short assay duration and high temperature. The rate constants for 
catalysis and denaturation (kcat and kdenat respectively) are both relatively 
high (due to the high T term in Equation 1.1), but the high kdenat is 
compensated for by the small t term. Thus, the rate of catalysis according 
to Equation 1.10 is much higher than that seen experimentally (Figure 1.5) 
for these conditions (Daniel et al., 2001). This flaw was ignored until the 
last ~15 years, as most enzyme assays were performed under “ideal” 
conditions away from denaturing temperatures and over longer time 
periods (Daniel & Danson, 2001). 
The equilibrium model (EM) was conceived to reconcile experimentally 
observed enzyme rates (with respect to time and temperature) with the 
kinetics (Daniel et al., 2001). The classical Michaelis-Menten kinetics 
approach, even when corrected for non-Vmax conditions (Equation 2.5), 
fails to adequately explain the high temperature/short timescale portion 
of the profile observed (vertical axis is Vmax): 
  
  
 
Vmax = kcat ![E]0 !exp("kdenat !t)
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Figure 1.5 – (Previous Left) Smoothed 
experimental data for a model enzyme 
(collected as per Section 2.6.1) 
Figure 1.6 – (Previous Right) Simulated 
rate profile for the same enzyme using 
classical kinetics (Equation 1.10) 
Figure 1.7 – (Immediate Left) Simulated 
rate profile for the same enzyme using the 
equilibrium model kinetics (Equation 1.15) 
To account for the low experimentally-observed rates at short time scales 
and high temperatures, something other than denaturation must be 
occurring. The classical Michaelis-Menten equations only adequately 
describes experimental data when temperatures are significantly below 
the denaturation temperature of the enzyme being studied (the thermal 
midpoint of denaturation being Tm), and the assay duration is long (on the 
order of tens of seconds and greater) (Daniel et al., 2001). 
1.2.2.1 Initial Postulate 
It was proposed that, with increasing temperature, the active enzyme (E) 
was being inactivated in a reversible way that was separate from 
denaturation (Daniel et al., 2001; Thomas & Scopes, 1998). This was 
because denaturation, as shown in Section 1.2.1, is not a fast enough 
process to counteract the high rate of catalysis at higher temperatures 
(Fulton et al., 2005). Hence, the inactivation process has to be very fast (cf. 
denaturation) to account for the lower-than-expected rates of activity at 
high temperatures. This concept has existed since 1944 in various guises, 
but never explicitly as an enzymatic thermal equilibrium (Sizer, 1944). 
If two folded forms of the enzyme are allowed for, one form being 
catalytically active and one catalytically inactive (Eact and Einact 
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respectively), and they are in fast thermal equilibrium with one another, 
then we can use Equation 1.11 to describe their relationship: 
 Eact  
Keq! "!# !!  Einact  
Equation 1.11 – The Eact to Einact equilibrium 
where Keq is the equilibrium constant. The thermal interconversion can be 
explained using a modified Van ’t Hoff equation (Daniel et al., 2001; 
Fersht, 1999): 
  
 
Keq = exp
!Heq
R "
1
Teq
# 1T
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)  
Equation 1.12 – The dependence of Keq on ∆Heq and Teq for thermal equilibrium 
Here Teq is the midpoint of the transition (in Kelvin) between the two 
forms and ∆Heq is the Van ‘t Hoff enthalpy for the interconversion process. 
It then follows that instead of Vmax being in terms of E (Equation 1.5), it 
must be in terms of Eact: 
  
 
Vmax = kcat ![Eact ] 
Equation 1.13 – The rate of enzyme catalysis according to the equilibrium model 
If Equation 1.11 is expanded to include a version of Equation 1.7, the 
manner in which two folded and one denatured forms of the enzyme 
might interact is obtained: 
 Eact
Keq! "!# !!  Einact
kinact! "!!  X  
Equation 1.14  – The interconversion between forms in the equilibrium model 
kinact is the rate constant for denaturation from the Einact form. The authors 
of the EM saw that a thermal equilibrium between Eact and Einact would lead 
to Einact being the dominant folded species at high temperatures and short 
timescales (Daniel et al., 2001). This implies that it is on-path to 
denaturation, as illustrated above in Equation 1.14. 
All that remains is for the scheme in Equation 1.14 to be described 
kinetically in terms of Keq, kinact and kcat, which defines the rate profile (Vmax) 
in terms of assay time (t) and temperature (T). By expanding Equation 
1.13, the full rate equation is obtained in terms of constants describing 
Introduction – Time, Temperature and the Equilibrium Model 9 
  
rates for catalysis, denaturation and the Eact/Einact thermal equilibrium 
(Equation 1.15). For a full derivation of the EM, see Appendix B.1. 
  
 
Vmax =
kcat ![E]0
1 + Keq
!exp "kinact !Keq !t1 + Keq
# 
$ 
% 
& 
' 
(  
Equation 1.15 – The full equilibrium model rate equation for Vmax 
1.2.3 Building Evidence for the Equilibrium Model 
1.2.3.1 Work up to 2009: Proof, Validation and Key Points 
The basis of the theory for the EM has been discussed above, and was first 
published in 2001 (Daniel et al., 2001). The concept was initially tested 
against phosphoglycerate kinase from mesophilic and thermophilic 
sources, and found to qualitatively account for the lack of enzyme activity 
at temperatures lower than where significant denaturation occurs. Prior 
research on other enzymes also agreed, showing zero-time plots similar to 
the model (Arnott et al., 2000; Buchanan et al., 1999). An alternative 
strategy allowing denaturation through the Eact form in addition to Einact 
was found to have a similar fit to the original EM (Equation 1.15). Hence, 
the original model, specifying that Einact alone is on path to denaturation, 
was used exclusively in all future work (Daniel et al., 2001). 
The methodology for fitting experimental data to model equations was 
first cited in 2004, where individual experimental time/temperature/rate 
data sets were fitted to Eyring and Arrhenius plots (see Equation 1.1 & 
Equation 1.12) (Peterson et al., 2004). The data was smoothed in the time 
dimension before fitting. This allowed for the determination of ∆Heq, Teq, 
 ∆Gcat
‡  and  ∆Ginact
‡  parameters, but not an overall model fit that would 
minimise the residual error between the model and the entire 
experimental data set. Four more enzymes (acid & alkaline phosphatases, 
an aryl-acylamidase and a ß-lactamase) were trialed against the model. 
Observations were made that the model was not restricted to purely 
monomeric enzymes and that the Topt (T at t = 0 where maximum V is 
reached) for the enzymes was ~20-40 °C above the ideal growth 
temperature of the organism (Peterson et al., 2004; Thomas & Scopes, 
1998). 
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It was also observed that the Eact/Einact equilibrium process was at least two 
orders of magnitude faster than thermal denaturation (Fulton et al., 2005; 
Peterson et al., 2004). Plots extrapolated back to the assay start, at t = 0, 
showed drops in activity at high temperatures that could not be ascribed 
to denaturation. For example, in the case of aryl-acylamidase, at 5 °C 
higher than the Topt the activity was ~40% lower than maximum, yet 40% 
denaturation at that temperature was known to take ~60 seconds 
(Peterson et al., 2004). Hence, the EM accounted mathematically more 
accurately for what was seen experimentally, compared with the classical 
model (Equation 1.10). 
By 2006, 30 enzymes had been studied in detail and all adhered to the EM, 
having a distinctive “tent shape” three-dimensional rate profile (Figure 
1.7). The equilibrium process was shown to be reversible as enzymes 
could be taken past their apparent Topt (as above), but not their Tm, and 
regain lost activity once cooled (Eisenthal et al., 2006). This kind of 
reactivation is assumed to be disallowed in the classical kinetic situation, 
where denaturation is irreversible and is the only process leading to loss 
of enzyme activity (Section 1.2.1). The effects of a stabilising agent 
(betaine) and a destabilising agent (guanidinium hydrochloride) on Teq 
were also explored and found to have no effect on Teq, providing initial 
evidence that Teq is a distinct and decoupled property from Tm (Eisenthal et 
al., 2006). 
Alternative substrates were tested on enzymes, and it was found that 
different substrates gave different experimental values for ∆Heq, Teq,  ∆Gcat
‡  
and  ∆Ginact
‡ (the output parameters) (Peterson, 2005). From this, the 
molecular difference between Eact and Einact was hypothesised to be a 
change at the active site, seeing as Teq was substrate-specific. It was 
suggested that NMR would be a possible method to investigate the 
molecular basis for the Keq equilibrium change, as long as Teq was 
sufficiently below the enzyme Tm that a population of Einact could be 
maintained for NMR timescales (~24 hours). 
The extensive data gathered by 2007 (for ~40 enzymes) provided a large 
data set with not just ∆Heq, Teq,  ∆Gcat
‡  and  ∆Ginact
‡  for each enzyme, but also 
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data on enzyme size, quaternary structure, growth temperature and other 
derivations from the output parameters. Hence, a correlation analysis was 
performed to see if any significant trends could be observed (Lee et al., 
2007). Correlations between ∆Heq, HWHM (the temperature difference at t 
= 0 between Topt and the temperature at which activity is half-maximal, on 
the high-temperature side of the curve), and the difference between Teq & 
Topt were observed. As these parameters are linked mathematically, it is 
unsurprising that they are correlated (Daniel et al., 2008; Lee et al., 2007; 
Peterson et al., 2004). Growth temperature was shown to have a strong 
positive correlation with Teq however, backing up inferences made earlier 
about the relationship between Teq and optimal temperatures for enzymes 
based on their environments (Daniel et al., 2008; Peterson et al., 2004; 
Thomas & Scopes, 1998). 
Now that the model had been established, the methodology behind 
gathering experimental data was explored to ensure valid determination 
of parameters. As the rate equation described Vmax, yet most measurements 
were not made under saturated conditions (due to substrate expense, 
solubility or other considerations), most gathered V data had to be 
corrected for KM influences (see Equation 1.5 and Equation 2.5). Other 
considerations, such as product inhibition and the minimal amount of 
data points required for fitting of data to the model, were also explored 
(Daniel et al., 2007). Fitting was automated by a stand-alone MATLAB 
run-time program, which takes matrices of data and fits the model via a 
least-squares residual minimisation approach (Section 2.7.2) (Daniel et al., 
2007). The validation culminated in a full analysis of the required 
conditions for reliable determination of EM parameters (Peterson et al., 
2007). 
The fitting of enzyme assay data was further streamlined by integrating 
the rate equation for the model (Equation 1.15 and Section B.1.6) which 
enabled processing using raw product concentration data (Peterson et al., 
2007). This removed the steps of smoothing raw product data runs (in the 
time dimension) and then deriving the rate from the manipulated data. 
Although only minimal differences in output parameters were observed, 
this gave more confidence in the parameter derivations. The use of initial 
rates (called t0 runs) found linearly over the first few seconds of an assay 
Introduction – Time, Temperature and the Equilibrium Model 12 
  
also gave valid parameters, useful for non-ideal enzymes. However, this 
excluded determining the time-dependent  ∆Ginact
‡  parameter. It was also 
shown that discontinuous assays could be used for model data collection 
by reducing data sets to discontinuous points (Peterson et al., 2007). 
Lastly, circular dichroism (CD) work was performed on the !-glucosidase 
from Saccharomyces cerevisiae to probe the molecular basis for the Eact/Einact 
species equilibrium. It was found that Einact is not significantly unfolded 
and is structurally more similar to Eact than the denatured form (X) or a 
molten-globule state (Daniel et al., 2009). 
1.2.3.2 The Current State of the Model 
As of 2009, the EM had been tested against nearly 50 different 
enzyme/substrate combinations. Extremophile enzymes from the Pomeii 
worm (Alvinella pompejana) and its episymbionts have even been fitted to 
the model (Lee et al., 2008). All systems, “monomeric to hexameric, and 
including a citrate synthase where the active site is at a subunit interface” 
(Daniel et al., 2009) follow the model rate profile much more closely than 
that of the classical model, but the molecular basis for the Eact/Einact 
equilibrium is still unknown (Daniel et al., 2008; Weinberg et al., 2008). 
Value   ∆Heq ∆Seq Teq Tgrowth 
Sub-
units 
Sub- 
unit 
MW 
∑ 
MW 
Units kJ 
mol-1 
kJ 
mol-1 
kJ 
mol-1 
kJ mol-1 
K-1 
(°C) (°C) # (kDa) (kDa) 
Av. 68 96 213 638 58 40 2.0 46 91 
Std. 
Dev. 9 5 177 517 15 19 1.6 21 89 
Table 1.1 – Average values for enzyme/substrate systems fitted to the equilibrium 
model 
The range of output parameters for 28 model enzyme/substrate systems is 
shown (Table 1.1) (Daniel et al., 2009). ∆Seq is the entropy of equilibrium, 
Tgrowth is the optimum growth temperature for the source organism, sub-
units is the number of monomers in the enzyme complex and MW is the 
molecular weight of each monomer or complex (∑). There is relatively 
little variance in the free energies of catalysis and inactivation, but large 
variance in the enthalpy change of equilibrium. This reflects how ∆Heq 
 ∆Gcat
‡
 ∆Ginact
‡
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describes the broadness or sharpness of the Keq transition.  The range of Teq 
is from ~18-90 °C, with the Tgrowth ranging from ~2-75 °C, mirroring earlier 
work showing a ~20°C increase in Teq over Tgrowth (Daniel et al., 2008; 
Peterson et al., 2004; Thomas & Scopes, 1998). 
1.3 Barnase 
1.3.1 Structure and Expression 
Barnase is a small 110-residue RNase produced by Bacillus 
amyloliquefaciens that has been studied since the early 1980s (Mauguen et 
al., 1982). It has a major helix consisting of residues 6-18 (helix1), two 
smaller helices to complete the first half of the sequence, then five 
antiparallel strands making up the ß-sheet. The packing of helix1 onto the 
ß-sheet creates the first of three hydrophobic cores (Fersht, 1999). As 
barnase is such a small (Mr ≈ 12383 Da) functional enzyme, it has been the 
focus of many studies over the past ~25 years. A cartoon representation of 
wild-type (WT) barnase (Figure 1.8) with the helices in blue and sheets in 
red is taken from a 1.7 Å-resolution crystal structure deposited in the PBD 
(1BRN) (Buckle & Fersht, 1994) and ray-traced using PyMol 1.2r1 (DeLano 
Scientific LLC, USA) (DeLano, 2002). 
Barnase was first expressed, with its structure and properties also 
determined, in 1982 (Mauguen et al., 1982). In its natural operon, barnase 
is expressed with its inhibitor, barstar, which is an 89-residue protein of 
mixed !- and ß-structure – both proteins are expressed together to ensure 
non-toxicity to the expression cell (Hartley, 1988). The complex has an 
affinity (Kd) of ~ 10-14 M, one of the tightest known (Wang et al., 2004), and 
the two bind fast with a rate (kon) of 108 M-1 s-1. Both barnase and barstar 
fold alone in solution, reversibly denature, and neither has any post-
translational modifications or disulphide bonds (Paddon et al., 1989). 
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Figure 1.8 – Cartoon representation of WT barnase from PBD 1BRN 
1.3.2 Substrates and Activity 
Barnase cleaves RNA via a two-step hydrolysis; firstly, cleaving the 
phospho-ribose bond via internal 2,3’-cyclisation to the sugar 
(transesterification), then (via a much less rapid reaction using the same 
catalytic residues in reversed roles) the hydrolysis of that bond (Day et al., 
1992). Several studies have shown that the active site of barnase consists of 
subsites with strong preferences for certain nucleotides. Generally, a GpN 
motif is required for activity, with A > G > C > U in terms of activity at 
position N, where p is the phosphodiester bond. This is shown by the 
preference of barnase for GpN dinucleotides (Day et al., 1992). The pH 
profile for short (e.g. di-,tri-,tetra-nucleotide) substrates has a maximum at 
approximately pH 5-6, whereas longer substrates are favoured at higher 
pHs (~ 8-9) (Mossakowska et al., 1989). 
Figure 1.9 shows another PyMol rendering of Figure 1.8, this time with a 
DNA substrate analogue (CGAC, GAC shown) fragment co-crystallised 
into the active site. Glu-73 and His-102, the general base and acid 
respectively, are shown in yellow carbons and the substrate in white 
carbons with orange for phosphorus. Day et. al (1992) showed that 
substrates of the type Zp0Gp1Xp2Y were favoured as before, but that 
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occupation of the p2 site led to a 1000-fold increase in kcat/KM. This means 
that GpUp, with its low KM and single cleavage site is ideal for EM data 
acquisition (Section 2.6.1) (Kippen et al., 1994). 
 
Figure 1.9 – Barnase complexed with CGAC tetranucleotide (PDB 1BRN) 
1.3.3 Barnase and the Equilibrium Model 
Barnase has been used extensively as a model protein, with >800 articles 
including “barnase” in their topic since 1989 in the ISI Web of Science 
database (Thomson Reuters, USA). This means that there is a wealth of 
information available on the folding and unfolding processes for barnase, 
the effects of many different point mutations (and x-ray and/or NMR 
structures of most of these) and extensive structural and functional data. It 
was hoped that this large reference set of data could go some way towards 
explaining the molecular basis of the EM if suitable barnase mutants were 
identified. 
1.3.3.1 Protein Folding Studies 
Studies on the folding of barnase were first published in 1989, with the 
bulk of the work available in 1992. Early work (Matouschek et al., 1989) 
showed, using amino-acid point mutations and urea denaturation studies, 
that "-values (Fersht et al., 1992) could be used to approximate the 
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structure of the transition state and pathway of folding (and hence 
unfolding). The transition state ensemble for barnase was closely related 
to the folded form, with most secondary structure formed and only 
hydrogen bonds and loop docking to be completed (Serrano et al., 1992). 
The effect of temperature on the transition state has also been probed 
(Dalby et al., 1998). 
The half-life for refolding of barnase (t1/2) is about 30 ms in the most 
favourable conditions (Fersht, 1999). This is within the range (from tens of 
µs to tens of seconds) usually seen for WT proteins (Kubelka et al., 2004). 
Interactions were found to be synergistic, meaning that the sum of the ∆G 
terms for each interaction was greater than each interaction alone 
(Horovitz & Fersht, 1992). This body of evidence means that the molecular 
basis for the Eact/Einact transition can be distinguished from processes that 
are on-pathway to denaturation – for example, it is known that the 
docking of !-helix1 to the ß-sheet is preceded by secondary structure 
formation in folding (Matouschek et al., 1989; Sancho et al., 1992). 
1.3.3.2 Mutations of Barnase 
As part of the folding work, many mutations were made for "-value 
analysis and other experimental techniques. In 1991, for example, 64 
mutations were characterised for their effects on stability (Serrano et al., 
1992a). These were also characterised via x-ray structures etc. for their 
effects on hydrogen bonding, torsion angles, solvation and sidechain 
ordering in the folded protein. The following mutations were selected for 
this thesis research due to their minimal effects on active site residue 
ordering and sidechain ordering, meaning that Teq changes can be 
attributed to changes in dynamics, not physical interactions. 
The I51V mutation (replacing isoleucine 51 with valine) was found to 
delete van der Waals’ interactions with two helices and three loops 
(Serrano et al., 1992a), decreasing stability by 7.53 kJ mol-1. The mutant is 
shown superimposed on the WT (Martin et al., 1999), from PDB structure 
1BSA. I51V, on ß-strand1, has a solvent-accessible surface area of 2 Å2, 
making it almost completely buried within hydrophobic core2 (Buckle et 
al., 1993) (see Figure 1.10). 
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Figure 1.10 – Wall-eye stereo diagram of I51V (yellow) imposed on WT (green) 
I88V and L89V are mutations either side of ß-strand3, with residue 88 
pointing down into the middle of core1 and residue 89 the opposite way 
into core3 (Serrano et al., 1992a). Both are completely buried; I88V deletes 
the sidechain interaction with helix1 and L89V only causes minor 
rearrangements of close residues with very little destabilisation of the 
protein as a whole (Buckle et al., 1993). Stereo views are presented below 
for I88V and L89V from PDBs 1BSC and 1BSE respectively (as above): 
 
Figure 1.11 – Wall-eye stereo diagram of I88V (yellow) imposed on WT (green) 
Rate constants of folding/unfolding for I51V, I88V and L89V are known 
(Matouschek et al., 1992), meaning that the shape of the three-dimensional 
EM rate profiles may be reconcilable with the relative speeds of refolding. 
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Figure 1.12 – Wall-eye stereo diagram of L89V (yellow) imposed on WT (green) 
In 1993 the effect of buried hydrogen bonds on the stability of barnase was 
investigated (Chen et al., 1993). Removing the hydroxyl group of tyrosine 
via a Y78F mutation, two hydrogen bonds (to the chain CO and NH at 
G81, shown with black dashed lines) stabilising loop4 are deleted, 
destabilising the structure to a similar amount as in I88V. The side chain 
van der Waals’ interactions to nearby residues were also altered slightly as 
they moved to compensate for the cavity, which was not filled with water 
(Chen et al., 1993). Refolding constants are also known (Chen et al., 1993). 
 
Figure 1.13 – Wall-eye stereo diagram of Y78F (yellow) imposed on WT (green) 
The above mutations all destabilise barnase and, hence, would also have 
to drop Teq by a large margin compared with Tm in order to have an 
accessible Einact population (Section 1.2.3.1). In case this did not occur, a 
significantly stabilised mutant was needed that was far enough from the 
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active site as to not affect substrate binding or active site residue 
configurations. Hence, if Teq did not change, at least the Tm would be 
significantly higher. Clarke and co-workers (Clarke & Fersht, 1993; Clarke 
et al., 1995a; Clarke et al., 1995b) have made several disulphide mutants of 
barnase, probing the effects on folding and stability. In the S80C/A43C 
double mutant (DM), a disulfide bridge was made between two residues 
known to pack together only after the rate limiting step for folding. 
Therefore, the structure was stabilised against unfolding which occurs ~20 
times slower than in WT barnase (Clarke & Fersht, 1993). This was due to 
the covalent bonding between helix3 and loop4, where normally they are 
not in contact. 
 
Figure 1.14 – Wall-eye stereo diagram of S80C/A43C (yellow) imposed on WT (green) 
It was shown, however, that the disulphide linkage induces slight 
disorder and rearrangement in nearby residues, with only T79 being 
severely disordered (Clarke et al., 1995a). This means that the DM is not as 
stable as could be predicted. Note that root mean square (RMS) values for 
the main chain showed that the majority of the structure, including the 
active site, was very close in structure to the WT (Clarke et al., 1995b). 
In conclusion, one mutant is significantly stabilised (DM), one 
significantly destabilised (I51V), one similar to the WT (L89V), and two of 
equal destabilisation through different means (I88V & Y78F). These 
properties are summarised in Table 1.2. The overlaid PDB files of the 
structures above (as PyMol session files) are in Appendix C. 
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Mutation I51V I88V L89V Y78F S80C/A43C 
 ∆∆GU-F
D50%  
(kJ mol-1) 
7.53 5.61 1.26 5.65 -8.79 
Side-chain solvent 
exposure (Å) 2 0 0 12 – 
Table 1.2 – Thermodynamic and solvation properties of selected barnase mutants 
 ∆∆GU-F
D 50%  is the difference in the  ∆GU-FD 50%  from WT to mutant (e.g. negative 
values are stabilising).  ∆GU-FD 50%  is the change in free energy associated with 
unfolding the WT or mutant at 50% [denaturant]. All values are from 
Serrano et. al (1992a) except for S80C/A43C (Johnson et al., 1997). 
1.3.3.3 Reversible Denaturation 
A special property of barnase, and all mutants of barnase that fold 
spontaneously, is that they renature and do not appreciably aggregate 
(hence, do not form a kinetic “sink” for the denatured species X) (Sali et 
al., 1988). If a population of barnase is equilibrated at a temperature close 
to its Tm, there is an equilibrium between the folded and unfolded forms 
(Matouschek et al., 1992). The EM for activity was expected to either a) not 
fit the data well or b) not fit the data at all, as it cannot account for 
renaturing (the one-direction kinact implies irreversible denaturation) 
(Equation 1.14). 
1.3.3.4 NMR Accessibility of Mutants 
Barnase is small enough (~12 kDa) that it is NMR-accessible. Sizes greater 
than ~50 kDa (the EM average being 91 kDa (Table 1.1)) have been 
inaccessible or problematic with traditional NMR experiments, although 
complexes of 300 kDa and 14 subunits have now been used successfully 
(Mittermaier & Kay, 2009). Proteins in complex with GroEL (~900 kDa) 
have also been studied (Fiaux et al., 2002). NMR has been performed on 
barnase extensively: structure determination (Bycroft et al., 1991), 
denatured structure studies (Arcus et al., 1995), pKa titrations (Loewenthal 
et al., 1992; Tan et al., 1995), catalysis (Meiering et al., 1993), hydrogen-
exchange (Clarke et al., 1995b) and even real-time folding (Killick et al., 
1998). Hence, probing the dynamics change in the Eact/Einact equilibrium 
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with a suitable mutant would be viable and comparable to a large body of 
previous work. 
1.4 Research Objectives 
The overall goal of this thesis was to identify and characterise either the 
wild-type or a mutant of barnase that would allow insight into the 
structural changes occurring over the Eact/Einact equilibrium. A major 
contribution towards this goal would be decoupling the thermal stability 
of an enzyme from its thermoactivity through mutation(s) that either 
lower Teq or raise Tm. This would allow the Einact species to predominate at 
temperatures lower than the Tm if the separation of Tm and Teq was 
sufficient and the magnitude of ∆Heq for the enzyme was sufficient. The 
following objectives make up this overall goal. 
1.4.1 Experimental 
As elaborated in Section 1.2.3.2, the current EM only considers irreversible 
denaturation and the exact changes associated with Teq are currently 
unknown. Therefore, the objectives for this research were to: 
• generate mutants of barnase (Section 1.3.3.2) then express and purify 
them; 
• determine Tm values and enthalpies of unfolding (∆HVH) determined 
under the conditions used to assay the enzymes, using circular 
dichroism (CD), differential scanning calorimetry (DSC) and other 
appropriate techniques; 
• acquire data for fitting to the EM, using previously characterised 
substrates (Section 1.3.2) and moving on to others if unsuccessful; 
• assess the experimental data to see if the interesting properties of 
barnase (Section 1.3.3) fit to the model, or if barnase is an exception; 
and 
• prepare barnase for NMR dynamics measurements (e.g. 15N 
labelling, preliminary testing etc.). 
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1.4.2 Theoretical 
The theory behind the EM has been explained in introductory detail 
(Section 1.2). The mathematics, however, is not trivial and understanding 
the derivation of the full rate and product equations was important. For 
the purposes of NMR dynamics measurements, new mathematical 
derivations that describe EM species concentration changes with time and 
temperature were also required. 
It was also investigated to see if a simpler model could be derived and 
checked against the data to adequately describe the observed kinetics. In 
addition, alternative derivations of equal complexity to the EM were 
investigated to see if they too could account for the observed rate profiles, 
or shed light on the movements of species within the EM. Lastly, to 
explore the full compliment of possible scenarios, a general model that 
could account for every possible instance of renaturation was developed 
and fitted against data. 
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2 Materials and Methods 
2.1 Reagents and General Methods 
Unless otherwise stated, all chemicals were purchased from Merk KGaA 
(Germany), BDH Chemicals Ltd (UK), Sigma-Aldrich Chemicals (USA), 
Applichem (Germany), Invitrogen (USA), Bio-Rad Laboratories (USA), 
Scharlau Chemie (Spain) or Fluka Biochemica (Switzerland). All percent 
values are in weight/volume unless noted otherwise. Details of reagents 
and buffers referred to below are given in Appendix A. 
2.2 DNA, Transformation and Sequencing Methods 
2.2.1 Plasmids 
Plasmid pMT1002 was obtained from Professor C. Nick Pace (Center for 
Advanced Biomolecular Research, Texas A&M University). pMT1002 
(Addgene plasmid 8621) (Hartley et al., 1996) was synthesised by the 
Hartley group, based primarily on pMT416 (Addgene plasmid 8607) 
(Hartley, 1988). 
Both plasmids require bacterial strains with the lacIq gene (such as DH5-!, 
XL1-blue, SURE or HB107). pMT1002, which was used for all work in this 
thesis, has a temperature sensitive repressor gene (CI157) from lambda 
phage, followed by its own promoter and, in the forward direction, the PR 
promoter from # phage (Okorokov et al., 1994) for barnase (Hartley, 1988). 
Only a partial sequence of pMT1002 was available (see Section 2.2.4). 
pMT1002 was resuspended in 50 µL Tris buffer. 
2.2.2 Nucleic Acid Concentration Determinations 
The Nanodrop ND-1000 Spectrophotometer (Nanodrop Technologies, 
USA) was used to measure the concentration of DNA/RNA samples via 
extinction coefficients. 
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2.2.3 General Electroporation Methodology 
The following was used for the transformation of WT pMT1002 plasmid 
into E. coli DH5-$ cells (Appendix A.5.1) and mutant pMT1002 plasmids 
(Section 2.3) into E. coli XL1-blue cells (Appendix A.5.2 and A.5.3). 
A Bio-Rad Gene Pulser™ (Bio-Rad Laboratories, USA) with Pulse 
Controller was used, following the procedure in the manual. An aliquot of 
1 µL rehydrated plasmid DNA or mini-prep DNA (Appendix A.6) was 
added to 50 µL freshly thawed (on ice) electrocompetent cells from a 10% 
glycerol stock. The mixture was placed between the electrodes in a 0.2 cm 
electroporation cuvette (Bio-Rad Laboratories, USA) and electroporated 
with 2.5 kV at 25 µF capacitance and 200 % resistance. The electroporated 
cells were immediately pipetted into 1 mL of SOC media pre-equilibrated 
at 37°C, and shaken at that temperature for 1 hour at 200 rpm in a 1.5 mL 
tube for cell recovery. 
2.2.3.1 Agar Plating of Freshly Transformed Cells 
50 µL of recovered SOC culture (Section 2.2.3) was spread on LB-agar 
plates with ampicillin at 100 µg/mL. Plates were grown at 37 °C until 
optimal colony formation (generally overnight, 16 hours) and kept at 4 °C 
thereafter. Mutant plasmids were grown on plates containing X-gal as 
prescribed in the Stratagene QuikChange™ II-E kit manual (Stratagene, 
USA) revision B.01.  
2.2.4 Plasmid Sequencing and Transformed Cell Stocks 
DNA was prepared for sequencing using an alkaline lysis method 
(Appendix A.6) on cultures grown from single transformed colonies from 
agar plates (Section 2.2.3.1). 
2.2.4.1 Sequencing Methods 
pMT1002 was initially sequenced using outward primers based on the 
sequence of the barnase/barstar gene known from the addgene entries. 
Primers used were “Reverse start” and “Forward end”, see below. New 
primers (“Forward start” and “Reverse end”) were designed using initial 
results to give inward sequence overlap, confirming sequence for design 
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of mutagenesis primers and for confirmation of successful mutagenesis 
(Section 2.3) (see Appendix D for results). 
Name Sequence (5'–3') 
Reverse start ATAATCCGCAACCCCGTC 
Foward end GAGAGTGTGCTTCAGGTT 
Forward start GCACTGGCACTCTTACCG 
Reverse end CTCCCATTGATCGTATTAAG 
Table 2.1 – Sequencing primers for plasmid pMT1002 
12 µL plasmid DNA, prepared as in Appendix A.6, was submitted to the 
Waikato DNA Sequencing Facility (The University of Waikato) at 
concentrations of between 50-150 ng/µL with 2 µL of each required 
primer at 5 µM concentration. Results were obtained electronically as .ab1 
files. 
2.2.4.2 Alignment of Sequences 
Geneious Pro (Version 4.8) (Biomatters Ltd, NZ) was used for proofing 
electropherograms received from sequencing and alignments of the results 
were performed using a cost matrix of 65% similarity (5.0/-4.0), a gap 
open penalty and extension penalty of 12 and 3 respectively, as a global 
alignment. Once the area of interest on pMT1002 was mapped, 
mutagenesis products were aligned to the consensus sequence, confirming 
the codon changes of interest.  
2.2.4.3 10% Glycerol Stocks of Transformed Cells 
Once plasmids were sequenced and confirmed (see Section 2.2.4), 1 mL of 
the culture volume from Appendix A.6 was transferred to a 2 mL cryo-
tube and mixed in with 250 µL autoclaved 50% glycerol, to give a final 
concentration of 10% glycerol. This tube was labelled and stored at -80 °C. 
2.3 Site-Directed Mutagenesis 
Site-directed mutagenesis was performed using the protocol from the 
Stratagene QuikChange™ II-E kit (Stratagene, USA) revision B.01. All 
reagents used in this section are given in the kit manual. 
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2.3.1 DNA Preparation 
WT pMT1002 plasmid DNA used in the mutagenesis reactions (template) 
was prepared as in Appendix A.6 and sequenced before use (Section 
2.2.4.1).  For the creation of S80C/A43C (DM) mutant DNA, the first 
mutation made was S80C. This mutant plasmid was then used as the 
template for the A43C mutagenesis reaction, using the same methodology. 
All reactions used template DNA at a stock concentration of 5 ng/µL. 
2.3.2 Primer Design and Preparation 
Primers were designed as suggested in the manual, using the online 
system (http://www.stratagene.com/qcprimerdesign). Primers in 
particularly GC-rich regions (e.g. for the S80C mutation) were slightly 
longer to stay within the other requirements. All primers were diluted to a 
stock concentration of 100 µM in MQ water. See Table 2.3 for codon 
changes. 
Name Sequence (5'–3') 
A43Cfwd GGTGGCATCAAAAGGGAACCTTTGTGACGTCGCTCCG 
A43Crev CGGAGCGACGTCACAAAGGTTCCCTTTTGATGCCACC 
S80Cfwd GCGTGAAGCGGATATTAACTATACATGTGGCTTCAGAAATTCAGAC 
S80Crev GTCTGAATTTCTGAAGCCACATGTATAGTTAATATCCGCTTCACGC 
Y78Ffwd GAACATGGCGTGAAGCGGATATTAACTTCACATCAGGCTTCAG 
Y78Frev CTGAAGCCTGATGTGAAGTTAATATCCGCTTCACGCCATGTTC 
I51Vfwd CTCCGGGGAAAAGCGTCGGCGGAGACAT 
I51Vrev ATGTCTCCGCCGACGCTTTTCCCCGGAG 
I88Vfwd CTTCAGAAATTCAGACCGGGTTCTTTACTCAAGCGACTG 
I88Vrev CAGTCGCTTGAGTAAAGAACCCGGTCTGAATTTCTGAAG 
L89Vfwd GAAATTCAGACCGGATTGTTTACTCAAGCGACTGG 
L89Vrev CCAGTCGCTTGAGTAAACAATCCGGTCTGAATTTC 
Table 2.2 – Mutagenesis primers for WT barnase in pMT1002 plasmid 
2.3.3 Mutagenesis Protocol 
Each mutagenesis reaction used 5 µL 10 x reaction buffer, 5 µL template 
DNA stock, 4 µL each mutation primer stock, 1 µL dNTP mix, 1 µL 
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PfuUltra HF DNA polymerase and 30 µL RO water to give a final volume 
of 50 µL. Control reactions were as stated in the kit manual. 
Thermal cycling was performed as in the kit manual, utilising an 
Eppendorf Mastercycler Gradient PCR machine (Eppendorf, Germany), 
with the number of cycles for each mutation varying depending on the 
number of mutated bases: 
Mutagenesis S80C A43C Y78F I51V I88V L89V 
Original codon TCA GCA TAT ATC ATT CTT 
New codon TGT TGT TTC GTC GTT GTT 
No. of cycles 14 16 14 14 12 12 
Table 2.3 – Settings for mutagenesis thermal cycling and details of codon changes 
Product DNA was Dpn I digested and purified using the supplied 
StrataClean resin as per the kit manual. Mutagenesis and transformation 
controls were the same as the kit method. Transformation was performed 
as in Section 2.2.3, with all mutations sequenced, confirmed and made into 
glycerol stocks as in Section 2.2.4. 
2.4 Protein Expression and Purification 
Expression trials were carried out using overnight cultures (see Section 
2.4.2.1) and sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) analysis as described below to ensure barnase production. 
The large-scale method used for expression and purification was adapted 
from the work of others, with modifications for available equipment, 
reagents and speed (Baxa et al., 2002; Krishnaswamy et al., 2006; 
Mossakowska et al., 1989). 
2.4.1 SDS-PAGE Methodology 
Protein samples at appropriate concentrations were taken (diluted if 
necessary) and added to aliquots of 4 x SDS loading buffer (QX4) at a ratio 
of 3:1. Before running, the samples were incubated at 95 °C for 5 minutes. 
18 µL of each sample was added to the appropriate well and 18 µL 
Precision Plus Protein™ Unstained Ladder (Bio-Rad Laboratories, USA) 
was added to each of the outside wells. 
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Gels were run using Bio-Rad PowerPac™ Basic (Bio-Rad Laboratories, 
USA) electrophoresis equipment in constant current mode. Samples were 
stacked in the gel using 10 mA/gel for the first half-hour, then run at 25 
mA/gel until the dye-front had reached the bottom of the gel. 
2.4.1.1 Staining and Destaining of Gels 
Gels were removed from their casts and transferred to a pipette-tip box 
(with lid). ~75 mL coomassie stain was added and the closed box heated 
on high for 40 seconds in an 1100W microwave. The box was then 
transferred to a shaker for 30 minutes at 160 rpm. Destaining was 
performed in a similar manner using destain solution and microwaving, 
shaking overnight to fully destain. Colour scans were taken on a Canon 
LiDE100 scanner (Canon, USA) of each gel. 
2.4.2 Large-Scale Expression Cultures 
A sterile tungsten loop was heated to glowing, and dipped into the still-
frozen 10% glycerol stock (Section 2.2.4.3) of the required transformant, 
whilst on ice. The loop was streaked on LB-agar plates with ampicillin at 
100 µg/mL in a ¼-segment pattern, sterilising between each ¼. Plates were 
grown at 37 °C until optimal colony formation. 
2.4.2.1 For WT and Mutant Protein Expression 
3 mL cultures were inoculated with a colony from an agar plate and 
incubated overnight at 30 °C in LB media with 3 µL ampicillin stock, 
shaken at 200 rpm. A 1 L culture of TB media in a 2 L baffled flask was 
inoculated with 1 mL of the overnight culture, 1 mL ampicillin stock and 
the flask shaken at 200 rpm and 37 °C overnight (16-24 hours) for 
expression (plasmids were temperature-inducible). 
2.4.2.2 15N-incorporation for NMR 
10 mL cultures were incubated at 30 °C in LB media for 18 hours with 10 
µL ampicillin stock, shaken at 200 rpm. Cells were pelleted at 4000 x g and 
4 °C in 50 mL centrifuge for 5 minutes. Pellets were washed with 10 mL 
M9 media (containing 15NH4Cl label) and spun down again, then 
resuspended in 10 mL M9 media. A 1 L culture of labelled M9 media in a 5 
L baffled flask was inoculated with the 10 mL resuspension, 1 mL of 
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ampicillin stock and the flask shaken at 200 rpm and 37 °C for 36 hours or 
greater. 
2.4.3 Crude Isolation 
Following growth, the flask was immediately placed in an ice-slurry and 
55 mL glacial acetic acid added (5% of final volume), stirred, and left for 
15 minutes to lyse cells. This mixture was decanted evenly into 3 x 500 mL 
centrifuge bottles and cells pelleted at 4500 x g for 15 minutes to remove 
debris. The supernatant was decanted and then stirred into 560 g of 
(NH4)2SO4 in a 2 L beaker stirrer on a 40 °C hotplate, precipitating protein. 
After 30 minutes, 50 mL aliquots of MQ water were added until all salt 
was dissolved. This solution was decanted into 4 x 500 mL bottles and 
pelleted at 11000 x g. 
The resulting protein pellets, which were tacky and brown (from TB 
media; clear from M9 media), were collected into a 50 mL falcon tube and 
redissolved into a minimal volume of MQ water (approx. 15 mL). This 
volume was dialysed twice against 1 L of buffer A (20 mM Na Citrate, pH 
5.5) for ~8 hours initially, then overnight against fresh buffer, using 14.6 
mm diameter Spectra/Por® 6-8 kDa cut-off dialysis membrane tube 
(Spectrum Laboratories, USA). This step raises the pH and lowers the salt 
content, refolding the protein. Immediately before any column steps, the 
contents of the dialysis were transferred to 15 mL falcon tubes and 
centrifuged at 26000 x g for 30 minutes. The pH was checked to be 5.5 ± 
0.1, and if not was dialysed further still. 
2.4.4 Cation Exchange Chromatography 
The centrifuged supernatant was applied at 5 mL/minute to a HiTrap™ 
SP FF cation exchange column (GE Healthcare Life Sciences, UK) pre-
equilibrated in buffer A. If more than 10 mL of supernatant was available, 
multiple column runs were needed as the capacity of the column was 
exceeded (i.e. protein flowed through). 
The column was placed inline on an Äkta™ Basic or Prime system (GE 
Healthcare Life Sciences, Sweden). 35 mL of buffer A was washed through 
before a 50 mL gradient to 100% buffer B (200 mM NaCl, 20 mM K-
phosphate, pH 8.0) eluted barnase. 2 mL fractions were collected. A 
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further 5 mL of buffer B was washed through and the Äkta system used to 
manually re-equilibrate the column into buffer A for further runs. 
Fractions showing barnase on the UV trace (confirmed by SDS-PAGE 
analysis (Section 2.4.1)) were pooled and concentrated at 3500 x g and 4 °C 
using 20 mL Vivaspin-2 5 kDa cut-off concentrators (GE Healthcare Life 
Sciences, UK) to a final volume of approx. 3 mL. 
2.4.5 Size Exclusion Chromatography 
An additional size-exclusion step was added to the methods used 
previously (Baxa et al., 2002; Krishnaswamy et al., 2006). This was to 
ensure completely clean protein for sensitive enzyme assays. 
2.4.5.1 Small Scale S75 10/300 
Multiple 300 µL aliquots of the concentrate from cation exchange were 
injected into a 500 µL loop and applied to a Superdex™ 75 10/300 GL size 
exclusion column (GE Healthcare Life Sciences, UK). Buffer B was the pre-
equilibrated mobile phase and 1 mL fractions were collected, identifying 
barnase via the UV trace. 
2.4.5.2 Large Scale S75 16/60 
~3 mL of concentrate was applied to a Superdex™ 75 16/60 GL size 
exclusion column (GE Healthcare Life Sciences, UK) via injection into a 5 
mL loop. Buffer B was the pre-equilibrated mobile phase and 2 mL 
fractions were collected, identifying barnase via the UV trace. 
2.4.5.3 Final Dialysis 
Eluant showing as barnase on SDS-PAGE gels (Section 2.4.1) was pooled 
and dialysed twice against 1 L of MQ water (both periods overnight) in 6-
8 kDa cut-off dialysis membrane tubing. The final volume of 10-15 mL 
was stored at 4 °C in 15 mL tubes. 
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2.5 Characterisation of WT and Mutant Barnase 
2.5.1 Protein Concentration Determination 
Immediately after dialysis 1x, 5x, 10x, and 20x dilutions were made of 
each sample (WT and mutant). As in Section 2.2.2, the spectrometer was 
blanked against each final dialysis volume (diluted as above) and the A280 
recorded. The linearity of the concentration, determined using the 
extinction coefficient 26930 L mol-1 cm-1, was checked and 20x dilution 
points often discarded (due to low absorbances). An average value was 
obtained. Protein extinction coefficients were calculated using the known 
amino acid compositions and the online tool ProtParam (Gasteiger et al., 
2003). 
2.5.2 Mass Spectrometry 
General methodology for gel extraction and matrix-assisted laser 
desorption ionisation time of flight mass spectrometry (MALDI-TOF MS) 
was provided by Jonathan Puddick (University of Waikato) and Joanna 
McKenzie (McKenzie, 2006). 
2.5.2.1 Gel Extraction 
Fragments of SDS-PAGE gel bands (from Section 2.4.5.3) were cut out 
with a sterile scalpel blade and transferred to a 1.5 mL tube. Gel fragments 
were repeatedly destained with aliquots of 0.5 mL 1:1 acetonitrile:25 mM 
NH4HCO3 whilst shaken at 37 °C at 200 rpm for 1 hour until free of stain. 
Removing destain solution, 100 µL of the above destain was added and 
the tube spun down at 13000 rpm in a MiniSpin™ Plus centrifuge 
(Eppendorf, Germany) then the supernatant removed. 50 µL acetonitrile 
(ACN) was used to dehydrate the fragment for 15 minutes, then the tube 
was spun down again. 
With the supernatant removed, the tube was air-dried for 2 hours in a 
vacuum desiccator. For tryptic digests only, 1 µL Promega Trypsin Gold 
solution (aliquots stored at -80 °C) was resuspended in 199 µL of 25 mM 
NH4HCO3 to a final concentration of 0.02 µg/mL, then added and 
incubated at 4 °C for 1 hour. The excess trypsin solution was removed and 
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the fragment incubated at 37 °C for 5 hours, then at 4 °C until analysis 
(maximum of 24 hours). 15 µL of 20% ACN/0.1% trifluoro acetic acid 
(TFA) solution was added just prior to analysis for both whole protein and 
digested samples. 
2.5.2.2 Matrices, Calibrant(s) and Sample Preparation 
For tryptic-digested gel fragments, !-cyano-4-hydroxycinamic acid 
(HCCA) was used as matrix. For whole protein samples (from Section 
2.4.5.3) a 9:1 mixture of 2,5-dihydroxybenzoic acid and 2-hydroxy-5-
methoxybenzoic acid (Super-DHB) was used as matrix. Both were from 
Sigma-Aldrich (USA). A spot of peptide/whole-protein calibration 
standard II (Bruker Daltonics, USA, catalogue #206195) was used per 4 
sample spots, as relevant to the samples being analysed. 
Approximately 10 mg of the solid matrix of choice was added to a 1.5 mL 
tube with 30 µL of 2:1 ACN:0.1% TFA well-mixed in. Along with the 
sample tubes (containing gel fragments and 15 µL of 20% ACN/0.1% TFA 
solution), the matrix tube was sonicated on high for 10 minutes in a D-
78224 water-bath sonicator (Elma, Germany). Tubes were spun down at 
13000 rpm. On an AnchorChip™ MALDI-TOF peptide-target (Bruker 
Daltonics, USA) spot, 0.5 µL of the sample supernatant or calibrant 
solution was mixed with 0.5 µL matrix supernatant and left to air-dry. The 
chip was then attached to a frame. 
2.5.2.3 MALDI-TOF Setup 
An Autoflex™ II MALDI-TOF mass spectrometer (Bruker Daltonics, USA) 
was used to analyse samples. The electronic settings files summarised 
below are contained in Appendix C. 
For peptide digests, ~10 sets of 30 shots at 20-40% laser power were 
summated for each spot using pulsed ion extraction at 60 ns and 
suppressing <500 Da ions. In RP mode, the mass range selector was set to 
“low range”, detector gain to 1400 V, acceleration voltage to 19 kV, 
reflector voltage to 20 kV, and a range of 600-3500 Da was collected. 
FlexControl™ software (Bruker Daltonics, USA) was used to manually 
control all other settings. Before samples were analysed, the relevant 
peptide calibrant spots were collected using the same settings and the 
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spectrometer calibrated with an automatic polynomial correction. For I88V 
and L89V mutant proteins the same fingerprint was observed (digest 
parent ion was of the same mass) and, hence, LIFT™ mode (MS/MS) was 
used to give more information on the parent peptide composition. 
For whole-protein samples LP mode was used, incorporating the linear 
detector, with the mass range selector set to “high range”, pulsed ion 
extraction of 450 ns, gain to 2500 V, acceleration voltage to 20 kV and a 
range of 5-20 kDa collected. Laser power was often 30-60%. Calibration 
was as above, using the whole protein standard. 
2.5.2.4 Analysis of Mass Spectra 
Peptide spectra were saved and exported to FlexAnalysis™ software 
(Bruker Daltonics, USA) and peaks identified and labelled. The processed 
spectra were opened in BioTools (Bruker Daltonics, USA) and compared 
against the bacterial proteins section of the MASCOT database (Matrix 
Science, USA). Monoisotopic masses were used with a 1 missed-cleavage 
tolerance. Otherwise, settings were the software default. Results with a 
significance score of 70 or above were retrieved and the peptide 
fingerprint confirmed. For I88V and L89V the LIFT™ spectra were also 
compared. Whole-protein spectra had peaks identified to confirm full 
sequence length. 
2.5.3 Rotavirus RNA RNAse Assays 
To check for basic RNAse activity – indicating correct expression and 
clean purification of barnase – an assay using Rotavirus RNA was used. 
This assay was developed by Joanna McKenzie (University of Waikato). 
See Appendix A.7 for RNA preparation. 
2.5.3.1 General Method 
2x Formamide loading dye (FLD) was prepared. An Eppendorf 
Mastercycler Gradient PCR machine (Eppendorf, Germany) was set to 37 
°C with 100 °C lid. In 600 µL PCR tubes held at 0 °C, 1 µL Rotavirus RNA 
stock (at 4000 ng/µL), 1 µL enzyme (at 0.1 mg/mL) and 1 µL of any other 
reagents were added at 0 °C and made up to 10 µL with DEPC-treated MQ 
water. A 0 min control was taken and quenched with 10 µL FLD, with the 
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rest of the tubes added to the PCR machine, removing and quenching 
tubes at timed intervals or at the conclusion. 
5% urea denaturing gels (Appendix A.4.2) were pre-run in 1x TBE buffer 
at 50 V for 30 minutes using apparatus as in Section 2.4.1.  20 µL of each 
sample was separated at 150 V in constant voltage mode until the darkest 
band nearly ran off the gel. Gels were stained with SYBR green 
(Invitrogen, USA) (5 µL stock in 50 mL 1x TBE) and shaken at 240 rpm for 
40 minutes in a foil-wrapped box. Gels were visualised and photographed 
on an Apollo UV light box (Airpro Scientific, NZ) with a Cohu CCD 
camera (Cohu Inc., USA), averaging 32 frames with Scion Image 4.0.2 
software (Scion Corp., USA). 
2.5.3.2 Contaminant Screens 
The following samples were assayed at 37 °C with 1000 ng RNA for 15 
minutes (except for the 0 min control) and run on gels as in Section 2.5.3.1. 
10ML200 and GA13 are 1 µL of 0.1 mg/mL non-RNAse proteins from 
John Steemson and Marisa Till respectively (both University of Waikato) 
and “Inhibitor” is Protector RNAse Inhibitor at 20U concentration (Roche 
Applied Science, USA) – enough to inhibit ~20 ng of contaminating 
RNAse A. 
Gel 
Lane 
Duration 
(minutes) 
Barnase (µL 
0.1 mg/mL) 
EDTA (µL 
10 mM) Other Label 
1 0 – – – 0 min control 
2 15 1 – – WT Barnase 
3 15 1 1 – WT Barnase + EDTA 
4 15 – 1 – EDTA 
5 15 – – 10ML200 10ML200 
6 15 – – GA13 GA13 
7 15 – – Inhibitor Inhibit. 
8 15 1 – Inhibitor WT Barnase + Inhibit. 
9 15 1 1 Inhibitor WT Barnase + Inhibit. + EDTA 
10 15 – – – 15 min control 
Table 2.4 – RNAse contaminant screen conditions 
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2.5.3.3 Time-course Assays 
10 µL volumes with 1 µL of 1 mg/mL barnase and 4000 ng of RNA were 
assayed for 1, 3, 5, 10, 15, 30, 45 and 60 minutes at 37 °C, with final and 
initial controls as above. The samples were run on 5% Urea denaturing 
gels described previously. 
2.5.4 SYPRO™ Real-time Melts 
Real-time protein melts were performed using a RotorGene-6000 Real-
time PCR machine and analysed using supplied RotorGene software 
(version 1.7) (both Corbett Research, Australia). Barnase WT and mutant 
samples were diluted in triplicate with MQ water to a concentration of 280 
µg/mL in 200 µL RT-PCR tubes along with 7.5 µL of 300x SYPRO™ 
orange protein gel stain (Sigma-Aldrich, USA) stock solution, giving a 
final volume of 25 µL. MQ blanks with dye were also recorded, as shown 
in the literature method (Ericsson et al., 2006). 
Sample tubes were arranged in a 36-well rotor. After a 90 second 
equilibration at 25 °C, the machine was ramped to 99 °C in 0.2 °C 
increments with 5 second delays per increment. Samples were excited at 
470 nm and emission measured at 555 nm with a gain of 9.67. Data points 
were output from the RotorGene software to an Excel spreadsheet. An 
average of the 3 blank runs was subtracted from each trace, and then all 
traces for each protein overlaid. Congruent traces were then averaged and 
overlaid for comparison between WT and the mutants. 
The first derivative of each data set was then taken arithmetically, and 
plotted with a moving average line fitted (period 6). The Tm value was 
measured visually from the middle of the peak representing the inflection 
in the original melt slope. Fitting of data to a two-state equation (Ericsson 
et al., 2006) (e.g. Equation 2.1) was inappropriate, as the fluorescence did 
not level off linearly and fits would have been subjective. 
2.5.5 Circular Dichroism 
Circular Dichroism (CD) work was performed at The University of 
Canterbury (Christchurch, New Zealand) in the Biomolecular Interaction 
Centre. The instrument was a Jasco J-815 CD Spectrometer (ROM 1.01.13) 
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attached to a Jasco PTC-4235/15 peltier, with Spectra Manager™ (1.54.03 
build 1) software used to analyse results (all Jasco Inc., USA). 
2.5.5.1 Sample Preparation and Instrument Setup 
50 µL of 3 mg/mL barnase stocks, in MQ water, were made up to a final 
volume of 3050 µL with assay buffer and added to a clean 5 mL quartz 
cuvette (1 cm pathlength). For I51V, 125 µL of 1.2 mg/mL stock was used. 
Final (70 °C) and initial (20 °C) wavelength scans of the samples were 
performed in triplicate and averaged in software. A 200-260 nm range was 
collected with 0.5 nm data pitch, scanning continuously at 50 nm/minute, 
1-second response, 1 nm bandwidth and 100 mdeg sensitivity. 
For the sample time scans, spectra were measured at 230 nm (the point of 
largest difference between 20 and 70 °C), with 0.5 °C data pitch, 1 
°C/minute temperature gradient, 1-second response, 1 nm bandwidth, 100 
mdeg sensitivity and a 30 second delay time. 
For WT barnase only, a refolding scan was performed. The time scan, as 
above but starting at 40 °C, was delayed at 70 °C for 1 minute, then 
reversed back to 40 °C. Background scans for both wavelength and time 
measurements were made of the assay buffer for later subtraction. 
2.5.5.2 Data Fitting and Analysis 
CD mdeg time-scan data was exported to Microsoft Excel™ 2004 
(Microsoft Inc., USA) and the background scans subtracted. The 
temperature values were converted to degrees Kelivn (K) and the data sets 
exported to MATLAB R2009b (The MathWorks Inc., USA) as independent 
arrays of data. The 2D CurveFit module of MATLAB was invoked to fit a 
custom equation to the data; the equation used (Equation 2.1) corrects for 
both final and initial non-zero slopes and fits a ∆H and Tm value: 
  
 
y = f (a + bT)! f (c + gT) + c + gT  
Equation 2.1 – CD equation fitting mdeg data to temperature data 
a, b, c and g are variables, y is CD mdeg data and T is temperature in K. f is 
the fractional contribution to the signal from the unfolded form; f is 
defined by the thermal equilibrium constant, K: 
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Equation 2.2 and Equation 2.3 – Fractional proportion of folded and unfolded forms 
with changes in thermal equilibrium constant 
∆H is the enthalpy of the unfolding process, Tm is the midpoint of the 
transition between the folded and unfolded forms and R is the gas 
constant. 
In MATLAB, the fitting was a non-linear least squares approach. 
Robustness was set to LAR using a Trust-Region algorithm, with the 
minimum and maximum changes between iterations set to 1x10-8 and 0.1 
respectively and the tolerances in both directions set to 1x10-6. Maximum 
number of function evaluations was 1000, with a maximum of 400 
iterations. Values were defined as below: 
Unknown Initial Value Lower Limit Upper Limit Units 
∆H 5x105 0 1x107 kJ mol-1 
Tm 323 273 373 K 
a 0 –∞ ∞ – 
b 0 –∞ ∞ – 
c 0 –∞ ∞ – 
g 0 –∞ ∞ – 
Table 2.5 – Fitting parameters for CD data 
The output unknowns for each sample were then used to fit a line to the 
raw data in Excel, with plotting of the data and fits in Prism 5.02 
(GraphPad Software, USA). Statistics on the quality of fit and associated 
error were taken from MATLAB and files of the fits are available in 
Appendix C. 
2.5.6 Differential Scanning Calorimetry 
Differential Scanning Calorimetry (DSC) work was also performed at The 
University of Canterbury (Christchurch, New Zealand). The instrument 
was a NanoDSC with platinum 333 µL sample and reference cells running 
DSCRun software (version 3.3.0) and analysis was performed using 
NanoAnalyze (version 1.1.0) (all TA Instruments, USA). 
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2.5.6.1 Sample Preparation and Instrument Setup 
125 µL of 3 mg/mL barnase stocks, in MQ water, were made up to a final 
concentration of 0.5 mg/mL with 75 µL 10x assay buffer (1 M Na-
phosphate, pH 8.0) and 550 µL DEPC-water. For I51V, 312.5 µL of 1.2 
mg/mL stock was used. All samples were degassed in a desiccator under 
vacuum for 5 minutes before being transferred to the cell(s), which were 
washed thoroughly in buffer between samples. 
Each day before any runs were performed the instrument was conditioned 
from 40 °C to 90 °C with degassed assay buffer at 2 °C/minute, then back 
down to 40 °C. A reference run for background subtraction was 
performed using only buffer. Runs were at 1 °C/minute from 20-95 °C 
and at 3 atmospheres of pressure. Samples were left to equilibrate at 20 °C 
for 10 minutes before the gradient was started and runs were rejected and 
repeated if any obtrusive artefacts were observed in the trace. 
2.5.6.2 Data Fitting and Analysis 
Raw data had the reference run subtracted in NanoAnalyze software. The 
data was cropped to between 30 and 80°C to remove systematic artefacts 
and a baseline correction was applied using the built-in “scaled two-state 
model” which also fitted the data and gave values for ∆H and Tm, along 
with a scale factor (aw). This gave no statistics on the goodness of fit, so 
the fit was re-created in MATLAB using the same two-state equation 
(Prabhu & Sharp, 2005): 
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Equation 2.4 – DSC equation fitting Cp data to temperature data 
y is Cp data and T is temperature in K. ∆H is the enthalpy of the unfolding 
process, Tm is the midpoint of the transition between the folded and 
unfolded forms, aw is a scale factor and R is the gas constant.  
In MATLAB, the fitting used a non-linear least squares approach with 
robustness set to LAR using a Trust-Region algorithm, the minimum and 
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maximum changes between iterations set to 1x10-8 and 0.1 respectively 
and the tolerances in both dimensions set to 1x10-6. Maximum number of 
function evaluations was 1000, with a maximum of 400 iterations. Values 
were defined as below: 
Unknown Initial Value Lower Limit Upper Limit Units 
∆H 5x105 –∞ ∞ kJ mol-1 
Tm 323 273 373 K 
aw 0.2 0 10 – 
Table 2.6 – Fitting parameters for DSC data 
The output unknowns for each sample were then used to fit a line to the 
raw data in Excel, with plotting of the data and fits in Prism 5.02 
(GraphPad Software, USA). Statistics on the quality of fit and associated 
error were taken from MATLAB and files of the fits are available in 
Appendix C. 
2.6 Equilibrium Model Data Collection 
2.6.1 Initial Dinucleotide Trials 
 
Figure 2.1 – GpUp dinucleotide substrate with cleavage site shown 
GpUp (5’-guanosinephosphate-uridinephosphate-3’) was ordered from 
Invitrogen (USA) as a custom desalted RNA oligo with 3’ phosphate 
labelling. Two batches of 10 µmole synthesis scale were ordered. 
2.6.1.1 Substrate and Enzyme Preparation 
Substrate was shipped as a solution and concentration measured (Section 
2.2.2) using the 260 nm 20.6 mM-1 cm-1 extinction coefficient found 
previously (Day et al., 1992). GpUp was approximately 50 mM and was 
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diluted to an intermediate stock of 8 mM in acetate buffer. WT barnase 
was diluted to 0.02 mg/mL in 0.1 M acetate buffer as above. 
2.6.1.2 Sample Preparation and Instrument Setup 
10 µL of 8 mM GpUp stock was added to 385 µL 0.1 M acetate buffer in a 4 
mm pathlength quartz cuvette and equilibrated in a Helios & UV/vis 
spectrometer with a SPU-1x0 single-cell peltier. 200 µM GpUp was 
approximately 10 x the KM of GpUp at 25 °C (19.9 ± 2.0 µM) (Day et al., 
1992). A H1 93530 thermocouple probe (Hanna Instruments, USA) was in 
the cuvette solution. Once the temperature was steady (± 0.1 degree over 
30 seconds) and background data acquisition finished, the temperature 
probe was removed, 5 µL of 0.02 mg/mL barnase stock was added as a 
drop on a curved stirring rod. The solution was then mixed rapidly, the 
spectrometer lid shut and data collection started using Vision software 
(version 1.25) (Thermo Spectronic, UK). A data pitch of 0.25 seconds, 
bandwidth 2 nm, measuring absorbance at 257 nm (Day et al., 1992) for 5 
minutes was used.  All the conditions for valid EM measurements were 
met (Peterson et al., 2007). 
Assays were performed in triplicate or until 3 runs were in consensus at 
15, 20, 25, 30, 34, 38, 42, 46, 50 and 54 °C as set on the peltier. The 
temperature, as measured by the thermocouple, was ascribed to each run 
and corrected to the reference thermometer scale (Appendix A.8). 
2.6.1.3 KM Determinations 
Assays were performed as above at 46 °C (where appreciable denaturation 
of barnase is not seen (Section 3.2.6)) in duplicate at 7 concentrations from 
3.175-200 µM made via serial dilution of the 8 mM GpUp stock in acetate 
buffer. The data from each run was plotted (∆A257 vs time) and the slope of 
the plots at time = 0 found by hand. The slopes for each concentration (in 
duplicate) were plotted against substrate concentration in Prism 5.02 
(GraphPad Software, USA) and fitted with a non-linear least-squares 
analysis to the Michaelis-Menten equation (Section 1.1.3) to determine a 
value for KM. Further data points at 150, 300 and 400 µM GpUp 
concentration were needed for a good fit. A linear relation to temperature 
was assumed between KM data points (see Section 2.7.1.2). 
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2.6.2 Fluorogenic Substrate (FrG) 
FrG was ordered as a custom non-catalogue request from IDT (USA) at a 
10 µmole synthesis scale. 6-FAM™ is a fluorescein fluorophore attached 
via a C6N linker 5’ to the first dAMP, BHQ-1® is a fluorescence quencher 
attached 3’ to the final dGMP, and rG indicates the ribo-guanotide residue 
(see Figure 2.2). All other bases were deoxyriboses, limiting the cleavage 
to one site. 
 
Figure 2.2 – FrG fluorogenic substrate with cleavage site shown 
The products of cleavage were also ordered from IDT; they were 
designated “fluorophore” and “quench” at 1 µmole synthesis scales, see 
Table 2.7 below for supplied properties (from IDT) and sequences of 
compounds. The methods below were based from those in a paper on 
MazF, an E. coli RNase (Wang & Hergenrother, 2007). 
Compound Sequence Extinction Coeff. (260 nm) 
Yield 
(nmoles) 
FrG 5’-6-FAM-AAGTCrGACATCAG-BHQ-1-3’  164060 Lmol-1cm-1 779.3 
Fluorophore 5’-6-FAM-AAGTCG-3' 84560 Lmol-1cm-1 286.6 
Quench 5'-ACATCAG-BHQ-1-3’  81300 Lmol-1cm-1 232.3 
Table 2.7 – Properties of fluorogenic substrate and products 
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2.6.2.1 Substrate Stock and Preparation 
FrG substrate was shipped as a lyophilised pellet and made up in DEPC 
water to ~1 mM using the provided synthesis yield as a guide. Dilutions 
for assays etc. were made up to 80% of required volume in 0.1 M assay 
buffer, concentrations determined spectroscopically (Section 2.2.2), then 
dilutions made to obtain the correct concentration. This was due to the 
viscous nature of the 1 mM stock causing pipetting issues. 
2.6.2.2 Product Stocks and Preparation 
Product halves were shipped as lyophilised powders and made up to ~2 
mM in DEPC water using the provided synthesis yields as guides. 2 mM 
was so that equal mixed volumes would give a 1:1 ratio of product to 
substrate using similar dilutions to FrG. Dilutions were made as above to 
avoid concentration errors. 
2.6.2.3 Substrate Stability (Real-time Melts) 
Modifying the procedure from Section 2.5.4 by setting excitation to 470 nm 
and emission to 510 nm, the fluorescence of 25 µL 10 µM FrG in assay 
buffer was measured from 25 °C to 99°C and back to 25 °C. No dye was 
used and a blank of 25 µL buffer was recorded and subtracted. 
2.6.2.4 Fluorometer Setup 
A Hitachi F-7000 fluorescence spectrophotometer (Hitach High 
Technologies Corp., Japan) was fitted with a Hitachi thermostatted cell 
holder accessory; water being fed from a Julabo 13 water bath and MP 
pump (Julabo, Germany) at 5.8 L/min. 5 mm path-length thick-walled 
quartz cuvettes from Hitachi were used for all assays and tests. All work 
used a sample volume of 300 µL and experiments were controlled using 
FL Solutions software (Hitach High Technologies Corp., Japan). All time-
scans used a 0.5 second data pitch and were recorded for 3 minutes with 
PMT set to 450 V, excitation (ex.) 485 nm, emission (em.) 518 nm, 5 nm 
slits, and 2 millisecond response time. 
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2.6.2.5 Substrate/Product Optimisation 
Three-dimensional (3D) scans of the substrate with ex. 445-495 nm and 
em. 505-555 nm were performed to determine the optimum ex. and em. 
wavelengths for 10 µM FrG. PMT was at 450 V, data pitch of 1 nm in each 
dimension, a speed of 240 nm/s and response of 2 milliseconds. 
A series of standards from 100% substrate to 100% product were made 
(substrate:product in µM): 10:0, 8.75:1.25, 7.5:2.5, 6.25:3.75, 5:5, 3.75:6.25, 
2.5:7.5, 1.25:8.75, 0:10. Product concentration was 10 µM equivalents of 
each half, simulating time points of a barnase digest. The solutions were 
wave-scanned from 510-560 nm (em.) to determine if the emission peak 
moved with concentration or temperature; 25 and 50 °C were used. PMT 
was at 450 V, ex. 485 nm, 5 nm slit, 240 nm/s and 2 millisecond response 
time. Results were analysed for linearity at each wavelength. 
2.6.2.6 Assay Method 
Assays were based on the MazF method (Wang & Hergenrother, 2007) 
but, due to the relative speed of barnase and requirements of the EM 
(accurate temperature, mixing etc.), a plate reader was untenable. 
Substrate was prepared at 10 µM (Section 2.6.2.1) in assay buffer with 
enough 300 µL aliquots (4 aliquots per 1.5 mL storage tube) to do 36 runs 
for each assay. Barnase was prepared at ~0.002 mg/mL (162 nM, varies 
between mutants, see results Section 3.3.3) in assay buffer and stored in a 
1.5 mL tube. 
300 µL of FrG substrate was equilibrated in the fluorometer with a H1 
93530 thermocouple probe (Hanna Instruments, USA) in the cuvette 
solution. 10 µM FrG was only approximately 2 x the KM of any barnase 
variant at 25 °C and, hence, was corrected for in data processing (Section 
2.7.1.1). Once the temperature was steady (± 0.1 degree over 30 seconds), 2 
µL of ~0.002 mg/mL barnase stock was added as a drop on a 1 µL soft 
plastic sterile loop (TSC Ltd., UK), the solution rapidly mixed, the 
fluorometer lid shut and time-scan data collection started (Section 2.6.2.4) 
for 2 minutes. All the conditions for valid EM measurements were met 
(Peterson et al., 2007). 
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Assays were performed in duplicate or until 2 runs were in consensus at 
26, 31, 35.5, 40.5, 45, 50, 55 and 60 °C as set on the water bath. The 
temperature measured by the thermocouple was ascribed to each run, and 
was corrected to the reference thermometer scale (Section A.8). Additional 
temperature points were added for some assays (Section 3.3). 
2.6.2.7 KM Determinations 
Generally, assays were performed as above at 26 °C and 50 °C in duplicate 
or triplicate at 9 concentrations from 1-30 µM prepared via dilution of the 
1 mM FrG stock in assay buffer. The data from each run was plotted 
(Fluorescence (Fl.518) vs time) and the slope of the plots at time = 0 found 
by hand. Otherwise, assays were performed as in Section 2.6.1.3. 
2.7 Equilibrium Model Data Processing 
2.7.1.1 General Data Workup 
Data from absorbance (Section 2.6.1.2) or fluorescence (Section 2.6.2.6) 
assays were imported into Microsoft Excel 2004 and compiled into 
matrices with time down the left-hand side (seconds), temperature across 
the top (°C) and the absorbance or fluorescence values for each run filling 
the matrix points. From here, similar matrices of blanks could be made 
and backgrounds subtracted, KM values corrected for and absorbance 
/fluorescence readings converted to product concentration, as explained 
below. 
2.7.1.2 Absorbance Data Workup 
Data was exported from Vision software as ∆A257, the change in 
absorbance over the assay duration. Data was converted to product 
concentration (molar) using the extinction coefficient for GpUp (Day et al., 
1992) and corrected for KM effects using the results from Section 2.6.1.3 and 
the equation below (itself derived from Equation 1.5) (Fersht, 1999): 
  
 
[P]xcorr. = [P]x !
K M + [S]0 " [P]x
[S]0 " [P]x
 Equation 2.5 – Correction for working away from Vmax via KM values 
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where   
 
[P]xcorr.  is the corrected substrate concentration at time x, [P]x is the 
substrate concentration at time x and [S]0 is the initial substrate 
concentration. This equation effectively corrects the observed assay 
velocity, V, to Vmax. 
Corrected temperatures (Appendix A.8) for each run were converted to 
degrees K and 0.01 K added cumulatively to temperatures that had 
otherwise equivalent values. This stops fitting.exe (Section 2.7.2) from 
averaging runs and decreasing the number of data points fitted to the 
model. 
2.7.1.3 Fluorescence Data Workup 
Data was exported from FL Solutions software as raw fluorescence. 
Backgrounds for each individual run were subtracted (Section 2.7.1.1) in 
Excel and data converted to product concentration (M) using the upper 
(100% product, 10 µM) bound for each temperature (Sections 2.6.2.3 & 
2.6.2.5) and the lowest value (generally at time = 0) as 0% product. KM was 
corrected for using the results from Section 2.6.2.7 and Equation 2.5. Data 
was then “∆’d” to bring absolute product concentration at time = 0 to zero 
by subtracting the lowest concentration point in each assay. Temperatures 
were corrected and adjusted as above. 
2.7.2 Using MATBLAB fitting.exe 
Fitting.exe is a stand-alone MATLAB run-time program written by 
previous contributors to the EM project (Daniel et al., 2007). It takes clean 
Excel .xls files containing matrices of [time (seconds) x temperature (K) x 
product concentration (M)] as described above (Section 2.7.1.1) and fits the 
data to the original EM (Section 1.2.2.1) using a least-squares approach 
initially, and a bootstrapping approach (Davison & Hinkley, 2006) if a 
“high-resolution” run is enabled in the graphical interface (GUI). As part 
of the input .xls file, starting values for ∆Gcat, ∆Ginact, ∆Heq and Teq were 
provided along with [E0], the concentration of enzyme in the assay. 
Fitting was performed using various computers running Microsoft 
Windows XP SP3 (Microsoft, USA). High-resolution fitting with fitting.exe 
took on average 3-4 hours for a 3 minute, 10 temperature data set when 
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run on a Pentium 4 3.0 GHz with 2 GB RAM and was not multi-threaded. 
Multiple fitting runs were performed using the output values from the 
previous fit, until the output parameters were steady and did not vary 
outside of their 95% confidence intervals. 
The following starting parameters were used for each initial fit, with the 
[E0] being slightly different for each mutant enzyme (see Table 3.10): 
 Initial Value 
Output Parameter GpUp fits FrG fits 
Units 
[E0] 20x10-9 varies M 
 ∆Gcat
‡  90000 80000 kJ mol-1 
 ∆Ginact
‡  100000 95000 kJ mol-1 
∆Heq 120000 100000 kJ mol-1 
Teq 320 320 K 
Table 2.8 – Starting parameters for fitting.exe fitting runs 
2.7.3 Using Alternative MATLAB Equations 
For alternative EM equations (Section 4.1) it was deemed prohibitive to 
modify and check the fitting.exe MATLAB run-time program for each 
permutation in the equation. Hence, the SurfaceFitting tool in MATLAB 
R2009b (The MathWorks Inc., USA) was employed to fit data processed as 
above (Section 2.7.1). The original model was also fitted in this manner to 
compare with results from fitting.exe (see Section 2.7.2). 
The tool required 1-by-x arrays of data for time (seconds), temperature (K) 
and product concentration (M). Matrix data (Section 2.7.1.1) was compiled 
into 3-value cells using the CONCATENATE function in Excel, in the 
format “time,temperature,product concentration”. The data points were 
sorted using VisualBasic macros in Excel into a single column. The “text to 
columns“ function was used to separate the concatenated data into three 
columns, one for each variable. These columns were then imported into a 
MATLAB workbook. 
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2.7.3.1 Fitting Settings and Methodology 
The relevant custom equation was fitted using a least-squares approach. 
Equations in electronic format are in Appendix C. Robustness was set to 
LAR using a Trust-Region algorithm, with the minimum and maximum 
changes between iterations set to 1x10-8 and 0.1 respectively and the 
tolerances in both directions set to 1x10-6. Maximum number of function 
evaluations was 1000, with a maximum of 1x107 iterations. Values were 
defined as below, with E0 being input directly into the custom equation. 
Fitting was performed using various computers running Microsoft 
Windows XP SP3 (Microsoft, USA) and Apple Mac OS X 10.6.2 (Apple 
Inc., USA). High-resolution fitting took on average ten seconds for a 3 
minute, 10 temperature data set when run on a 2.66 GHz Core2 Duo 
processor with 4 GB RAM and was not multi-threaded. Multiple fitting 
runs were performed using the output values from the previous fit, until 
the output parameters were steady and did not vary outside of their 95% 
confidence intervals. 
Output 
Parameter 
Initial 
Value 
(Models N, 
R & Q) 
Initial 
Value 
(All other 
models) 
Lower 
Limit 
Upper 
Limit Units 
 ∆Gcat
‡  67000 80000 0 200000 kJ mol-1 
 ∆Ginact
‡
 ∆Gi
‡( )  93000 95000 0 200000 kJ mol-1 
 ∆Gdeact
‡
 ∆Ga
‡( )  88000 95000 0 200000 kJ mol-1 
 ∆Greact
‡
 ∆G! i
‡( )  93000 95000 0 200000 kJ mol-1 
 ∆G! a
‡( )  88000 95000 0 200000 kJ mol-1 
∆Heq 150000 100000 0 500000 kJ mol-1 
Teq 315 320 273 373 K 
Table 2.9 – Fitting parameters for custom equilibrium model equations 
Note that the parameters in brackets apply to model Q only (Section 
4.1.1.3).  
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3 Experimental Results and Discussion 
In order to collect enzyme data for equilibrium model (EM) assays, 
sufficient protein had to be expressed and purified (Section 3.1) from wild-
type (WT) and mutant barnase genes (see Section 2.3). Protein mass 
(indicating correct expression) was established using mass spectrometric 
(MS) means and activity confirmed through RNAse assays, then the 
variants were characterised for Tm and other thermostability parameters 
using DSC and CD techniques (Section 3.2). The collection of EM data 
against two substrates is then detailed, along with the fits and analyses of 
that data to the original EM (Section 3.3). 
3.1 Protein Purification 
WT and mutant barnase were purified as in Section 2.4. After the crude 
isolation steps (Section 2.4.3), the centrifuged dialysate was applied to a 
cation exchange column (CEC) and eluted with a gradient of buffer A to 
buffer B (Section 2.4.4). An example trace is shown below: 
 
Figure 3.1 – Traces from L89V CEC protein purification 
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The column load was exhaustively dialysed against buffer A, as otherwise 
the low pH and high salt concentration of the resuspended pellet lessened 
the affinity of the column for barnase, weakening binding. This was 
exhibited through SDS-PAGE analyses (not shown) of column flow-
through. SDS-PAGE analysis was performed at every step of purification. 
Figure 3.2 shows an example I51V CEC run, with A4 being the shoulder at 
10 mL, A14 the start of the gradient, B5-B10 as indicated in Figure 3.1 (the 
peak) and the crude purification as loaded on to the column in the last 
lane. The collected fractions (usually 42-54 mL fractions, as indicated with 
black arrow on trace above) were then concentrated and applied to a size 
exclusion column (SEC) (Section 2.4.5). 
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Figure 3.2 – SDS-PAGE gel of I51V CEC protein purification 
The above gel shows small proteinaceous fragments in the CEC eluant. 
Hence, to ensure correct concentration measurements and ensure purity, a 
SEC step was included to further purify barnase. 
Figure 3.3 shows the trace for a large-scale S75 16/60 purification. The 
resulting fractions (usually 80-88 mL fractions, as indicated with black 
arrow below peak in Figure 3.3) were then dialysed and/or concentrated 
as needed and concentrations measured (Section 2.5.1). 
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Figure 3.3 – Traces from Y78F SEC protein purification 
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Figure 3.4 – SDS-PAGE gel of I88V SEC protein purification 
Above, F18 is the slight bump at 68 mL, and F22-29 cover 76-92 mL from 
the large-scale S75 16/60 purification. This is indicative of the pattern seen 
on all size-exclusion eluant gels; mature barnase predominates at ~12.5 
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kDa and there is a small band at ~25 kDa that decreases in intensity 
through the main peak (see Section 3.2.1.4). 
Final yields (in mg/L of culture) are tabulated below. The variation in 
yield was mainly due to the length of incubation of the expression culture, 
the cell density of the overnight culture used for inoculation and the 
experience of the operator increasing with time. 
Preparation WT S80C/A43C Y78F I51V I88V L89V 
Yield 
(mg/L) 12 75 12 0.9 124 103 
Table 3.1 – Final yields of WT and mutant barnase 
3.2 Characterisation of WT and Mutants 
3.2.1 Mass Spectrometry (MS) 
3.2.1.1 Full Protein Results 
Whole WT and whole S80C/A43C (DM) barnase solutions were analysed 
as in Section 2.5.2. The following ions (M+ and M2+ for singly and doubly-
charged ions) were observed, compared with the theoretical mass (M): 
Sample M (Da)  MH+ (Da) M+-M (Da) MH22+ (Da) 2MH2
2+ 
(Da) 
WT 12382.7 12375.9 -6.8 6183.2 12366.4 
S80C/A43C 12430.8 12419.0 -11.8 6205.6 12411.2 
Table 3.2 – Whole-protein MALDI-TOF MS results for WT and DM barnase 
These results, coupled with those to follow, show complete sequence 
expression and purification of WT barnase, as the MH+ ion is within 0.05% 
of the theoretical mass for both samples. Additionally, the doubly-charged 
MH22+ ions still show a protein mass within 0.2% of that expected. 
3.2.1.2 Peptide Digest Results 
Identity of barnase variants was confirmed via gel extraction, tryptic 
digestion and MS (Section 2.5.2). Results are tabulated below, giving the 
degree of fragment coverage for each mutant and the reference for the top 
hit. It should be noted that fragments unambiguously showing I88V and 
Experimental Results and Discussion – Characterisation of WT and Mutants 52 
  
L89V mutations were not matched and hence LIFT™ analysis was 
performed (see below). Full results are in Appendix C. 
Sample Intensity Coverage (%) 
Sequence 
Coverage (%) 
MASCOT 
Score 
Sequence 
Reference 
WT 74.8 89.1 119.0 (Buckle et al., 1993) 
S80C/A43C 62.7 92.7 152.0 (Clarke & Fersht, 1993) 
Y78F 93.4 86.4 150.0 (Chen et al., 1993) 
I51V 83.4 89.1 140.0 (Buckle et al., 1993) 
I88V 78.0 95.5 207.0 (Buckle et al., 1993) 
L89V 90.6 77.3 143.0 (Buckle et al., 1993) 
Table 3.3 – WT and mutant tryptic digest mass spectrometry results 
3.2.1.3 LIFT™ Results for I88V and L89V 
LIFT™ MS/MS analysis was performed on the 1387.6 Da MH+ parent ions 
for residues 88-98 of both I88V and L89V. The L89V MS/MS 
fragmentation pattern was unambiguously matched to the full barnase 
mutant  (Buckle et al., 1993) with a MASCOT score of 38.0, but I88V also 
falsely matched to the L89V fragmentation pattern. When an in silico 
fragmentation of the I88V parent ion (BioTools, Bruker Daltonics, USA) 
was compared with the experimental fragmentation pattern, it was found 
to be an unambiguous match incorporating the fragmentation of a valine 
residue at the N-terminus. 
3.2.1.4 Unknown ~25 kDa SDS-PAGE Band Analysis 
A ~25 kDa band was excised from an SDS-PAGE gel of I88V (lane F23 
from Figure 3.4) and analysed as in Section 2.5.2. The tryptic digest 
fragmentation showed an intensity and sequence coverage of 30.9% and 
56.4% respectively and a MASCOT score of 66.7 for I88V barnase  (Buckle 
et al., 1993). The band seen might be a dimer of barnase, as the SDS-PAGE 
weight is approximately 2 x 12382.7 Da. It also purifies before the main 
monomeric barnase peak in size exclusion (see Figure 3.4), although the 
band is not seen on the cation exchange trace or gel (Figure 3.1 & Figure 
3.2). Barnase is not known to form dimers in solution and, as the SDS gel 
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band intensity and UV absorption in traces is low, the effect of this species 
on concentration measurements and assays is thought to be negligible. 
3.2.2 Rotavirus RNA RNAse Assays 
The RNAse activity of barnase was checked using rotavirus RNA as per 
Section 2.5.3.2. Figure 3.5 is a 5% urea denaturing gel comparing WT 
barnase with two non-RNase protiens (10ML200 and GA13), as well as 
with RNAse inhibitor. 
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Figure 3.5 – RNAse assay screen of WT barnase 
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Figure 3.6 – RNAse assay time-course of WT barnase activity 
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Figure 3.6 shows a time-course of WT barnase acting upon rotavirus RNA 
as per section 2.5.3.3. The two assays show that barnase cleaves rotavirus 
RNA at 37 °C, yet is not affected by RNAse inhibitor or EDTA (therefore is 
not metal-ion dependent). Hence, RNAse inhibitor was used in 
preparations in this thesis to exclude alternative RNAse contamination 
(RNase A, T1 etc.). It is also shown that barnase is not highly sequence 
specific, as all rotavirus RNA bands are digested in the time-course assay 
and in the +ve lanes for Figure 3.5. The preference for GpN sequences still 
holds, however (see Section 1.3.2). 
3.2.3 SYPRO™ Real-time Melts 
Protein melts of WT and mutant barnase were performed as in Section 
2.5.4. However, I51V was at 78.4 µg/mL (c.f. 280 µg/mL) due to low 
expression yield. From average traces with backgrounds subtracted, Tm 
values are determined from the steepest part of the face of the curve 
(Figure 3.7). ∆Tm is the difference from the WT (Table 3.4). Uncertainties 
are estimates based on experimental error and visual inspection accuracy. 
 
Figure 3.7 – Average SYPRO™ real-time melts for WT and mutant barnase 
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The bumps on each trace in Figure 3.7 at ~49.5 °C are present across all 
mutants. It is unlikely that they reflect an actual property of barnsae, as 
the pathway of folding is well-known and the mutations made (e.g. I88V) 
(Buckle et al., 1993) should change the temperature of any related peaks. It 
is likely just an artefact of the dye or method (RT-PCR machine etc.). I51V 
results are unreliable, due to the low fluorescence observed. 
Variant WT S80C/A43C Y78F I51V I88V L89V 
Tm (°C) 52.5 ± 0.5 57.0 ± 0.5 47.0 ± 0.5 53.0 ± 0.5 48.0 ± 0.5 52.5 ± 0.5 
∆Tm (°C) – 4.5 ± 1.0 -5.5 ± 1.0 0.5 ± 1.0 -4.5 ± 1.0 0.0 ± 1.0 
Table 3.4 – Tm values for WT and mutant barnase from differential SYPRO™ melts 
3.2.4 Circular Dichroism 
Circular dichroism work was performed as in Section 2.5.5. The CD signal 
of WT and mutant barnase was followed from 20-70 °C at 230 nm (Figure 
3.8), with full wavelength (200-260 nm) scans performed at the extremes 
(Figure 3.9). In Table 3.5, uncertainties are the largest (+ve or –ve) 95% 
confidence interval from fitting, and for Tm are greater than the 
experimental error in temperature (0.1 °C). ∆HVH is the enthalpy of 
unfolding. Values should be more precise than stated, as fitting errors are 
mainly due to data noise (Prabhu & Sharp, 2005; Vuilleumier et al., 1993). 
General data noise (see Figure 3.8) is due to the high concentration (0.1 M) 
of assay buffer causing CD voltage to increase, compensating for signal 
loss. The high buffer concentration was to ensure thermostability 
measurements were made under the same conditions as the EM assays.  
Variant WT S80C/A43C Y78F I51V I88V L89V 
Tm (°C) 54.5 ± 0.4 59.4 ± 0.9 50.7 ± 0.7 50.0 ± 0.3 50.9 ± 0.4 53.8 ± 0.4 
∆Tm (°C) – 4.9 ± 1.3 -3.8 ± 1.5 -4.5 ± 1.0 -3.6 ± 0.7 -0.7 ± 0.8 
∆HVH 
(kJ mol-1) 
572.0 
± 95.3 
503.7 
± 131.8 
427.7 
±106.0 
561.2 
±85.4 
573.4 
±98.1 
507.1 
±72.5 
R2 of fit 0.9895 0.9797 0.9728 0.9912 0.9876 0.9921 
Table 3.5 – Tm values for WT and mutant barnase from circular dichroism unfolding 
Data in Figure 3.8 were corrected for background signal and fitted to a 
two-state model for unfolding (Section 2.5.5.2). Figure 3.9 was also 
background corrected and illustrates the peak followed at 230 nm, due to 
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residue W94 (Sancho & Fersht, 1992). The data is very noisy below 210 nm 
as the voltage had to increase, amplifying noise, to compensate for the 
high buffer background signal. All data for CD is in Appendix C. 
 
Figure 3.8 – Fitted circular dichroism signal data for WT and mutant barnase unfolding 
 
Figure 3.9 – 20 (folded) and 70 °C (unfolded) circular dichroism wave scans of WT 
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3.2.4.1 Refolding Scans of WT Barnase 
Similar to scans as in Figure 3.8, WT barnase was refolded via scanning 
from 40-70 °C and back to 40 °C again, after a 1 minute delay at 70 °C 
(Figure 3.10). 
 
Figure 3.10 – Circular dichroism refolding scan of WT barnase between 40-70 °C 
 
Figure 3.11 – 20 °C circular dichroism wave scans of WT barnase before and after 
refolding 
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an ~2 °C delay in the signal, meaning both traces may overlap in reality. In 
addition, although barnase is stable in assay buffer, it may not have the 
optimal conditions for refolding. Figure 3.11 shows the same sample 
before and after the 40-70-40 °C refolding measurements at 20 °C (the first 
20-40 °C was quickly scanned for Figure 3.10 due to time constraints). It 
should be noted that the CD voltage does not linearly change with 
wavelength or between runs, and hence the two runs are only 
qualitatively comparable. This work shows how barnase can renature in 
solution without chaperones, making it a possible exception to the original 
EM, which only allows for irreversible denaturation (see Section 1.3.3.3). 
3.2.5 Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) was performed as in Section 2.5.6. 
The heat capacity (Cp) of WT and mutant barnase was recorded over the 
range 20-95 °C and data was fitted to a two-state model for unfolding 
(Section 2.5.6.2) for the 30-80 °C range due to artefacts occurring at low 
and high temperatures. Data files are in Appendix C; baselined and 
normalised raw data (for comparison of mutants) is shown in Figure 3.12. 
 
Figure 3.12 – Differential scanning calorimetry scans of WT and mutant barnase 
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Variant WT S80C/A43C Y78F I51V I88V L89V 
Tm (°C) 52.9 ± 0.1 58.1 ± 0.1 49.0 ± 0.1 48.3 ± 0.1 49.2 ± 0.1 52.1 ± 0.1 
∆Tm (°C) – 5.2 ± 0.1 -3.9 ± 0.1 -4.6 ± 0.1 -3.7 ± 0.1 -0.8 ± 0.1 
∆HVH 
(kJ mol-1) 
562.2 
± 0.3 
557.8 
± 0.2 
523.6 
± 0.3 
525.8 
± 0.3 
546.7 
± 0.2 
546.7 
± 0.2 
R2 of fit 0.9999 0.9999 0.9999 0.9999 0.9999 0.9999 
Table 3.6 – Tm values for WT and mutant barnase from DSC 
In Table 3.6, uncertainties are the largest (+ve or –ve) 95% confidence 
interval from fitting. For DSC this is over-estimated to be ± 0.1 °C for Tm to 
allow for experimental errors, as the fitting error was ± 0.01 °C on average. 
∆HVH is the Van ‘t Hoff enthalpy change. Raw data, not fitted data, was 
plotted in Figure 3.12 due to the high degree of accuracy in the fitting, as 
shown by the R2 values of 0.9999 for all the variants. 
3.2.6 Summary of Thermostability Results 
Due to the suspected lag in CD signal behind temperature (Section 3.2.4.1), 
it should be noted that the relative Tm compared with the WT (∆Tm) is most 
important, not the absolute Tm. For the absolute value, the accuracy of DSC 
(Table 3.6) is considered most applicable (Martinez et al., 1994). 
 ∆Tm from WT (°C) 
Variant S80C/A43C Y78F I51V I88V L89V 
SYPRO™ 4.5 ± 1.0 -5.5 ± 1.0 0.5 ± 1.0 -4.5 ± 1.0 0.0 ± 1.0 
CD 4.9 ± 1.3 -3.8 ± 1.5 -4.5 ± 1.0 -3.6 ± 0.7 -0.7 ± 0.8 
DSC 5.2 ± 0.1 -3.9 ± 0.1 -4.6 ± 0.1 -3.7 ± 0.1 -0.8 ± 0.1 
Table 3.7 – Summary of ∆Tm from WT for barnase mutants between three methods 
Figure 3.13 shows the concordance of CD and DSC measurements 
compared with the values obtained via the differential SYPRO™ method. 
It should be noted that Figure 3.7 shows how low the I51V fluorescence 
was, which is likely the cause of the non-concordant SYPRO™ value in 
Figure 3.13. The relatively large error in CD measurements has been 
considered elsewhere (Section 3.2.4), and is probably erroneous. The 
agreement between determined Tm values and the urea denaturation free 
energy differences (the same trends are seen) (see Section 1.3.3.2) lends 
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support to the validity of Tm results. As expected, the Tm of the DM is 
raised significantly, which may aid in decoupling activity from stability if 
the Teq of barnase variants is not affected by the mutations (see Section 
3.3.4 and Section 4.3). Also, if the L89V mutation lowers Teq, a similar 
decoupling may be seen as the Tm of L89V is very similar to the WT. 
 
Figure 3.13 – Comparison of ∆Tm from WT for barnase mutants between three methods 
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Table 3.8 – Summary of ∆HVH from WT for barnase mutants from DSC measurements 
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3.3 Original Equilibrium Model Assays 
3.3.1 Initial Dinucleotide Trials 
3.3.1.1 Experimental 
To gather WT barnase data for fitting to the original equilibrium model, 
the enzymatic hydrolysis of GpUp was measured according to Section 
2.6.1. The change in absorbance (∆A257) for the GpUp substrate was 
minimal – a change of +0.04 absorbance units was seen for full hydrolysis 
of 200 µM GpUp. Hence, assay runs had to be highly accurate and 
baseline corrections were important. The option of following cleavage at 
higher wavelengths (as in Day et al., 1992) was excluded as protein 
(barnase) could possibly interfere and the ∆A would still be approximately 
the same. In any case, linearity of absorbance with concentration was 
suspect at high concentrations (> ~400 µM) as A257 became greater than 1. 
The literature KM for GpUp in 0.1 M acetate buffer (pH 5.8) was previously 
measured at 25 °C and found to be 19.9 ± 2.0 µM (Day et al., 1992). A KM 
determination at 46 °C (approximately the temperature optimum of 
barnase with GpUp) was performed, as in Section 2.6.1.3. 
 
Figure 3.14 – KM determination at 46 °C for GpUp and WT barnase 
!"#$%&'(
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Concentrations of substrate > 400 µM were insoluble, but the fit (although 
not conclusive as Vmax was not approached) gave a KM of 725.6 ± 337.1 µM. 
The uncertainty in KM is the standard error, as 95% confidence intervals 
were not determined. Hence, assays for GpUp were at < 10 x KM (200 µM) 
for a significant portion of the temperature range (see Section 2.7.1.1). 
3.3.1.2 MATLAB fitting.exe Results 
Data points were acquired (Section 2.6.1.2), processed (Section 2.7.1.2) and 
used for fitting to the original EM as in Section 2.7.2. The best-fit output 
parameters are given below for WT barnase. The full data set was 
acquired over 5 minutes, with truncated data sets being fitted using the 
same methodology for 60 s, 30 s and t0 lengths (Section 1.2.3.1). 
Length of Data Full 60 s 30 s t0 
 ∆Gcat
‡  
(kJ mol-1) 
62.62 
± 0.15 
63.67 
± 0.10 
63.84 
± 0.16 64.10 
 ∆Ginact
‡  
(kJ mol-1) 
93.33 
± 0.27 
90.03 
± 0.43 
88.96 
± 0.86 – 
∆Heq 
(kJ mol-1) 
71.76 
± 0.04 
106.3 
± 3.3 
121.9 
± 6.5 155.6 
Teq (K) 295.8 ± 1.0 
313.2 
± 0.8 
314.9 
± 1.0 315.6 
SSE 1.35x10-4 4.09x10-6 5.75x10-7 1.47x10-11 
R2 of fit 0.9457 0.9724 0.9699 0.9664 
Table 3.9 – Output parameters for WT barnase and GpUp substrate for the original EM 
Uncertainties are the largest (+ve or –ve) 95% confidence interval from 
fitting; there are no statistics available from t0 runs. SSE is the total sum of 
squares for the fitting. The full data set did not fit well to the model. At 
long times (> ~120 seconds) the data showed lower rates than expected, 
most likely due to substrate depletion or product inhibition. The shorter 
times did not account for ∆Heq or  ∆Ginact
‡  as precisely because there were 
less data points available. The 60-second data outputs from the fitting.exe 
program are in Figure 3.15, and full statistical analyses for each parameter 
(histograms) output from fitting.exe are in Appendix C. 
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As an example of fitting.exe output, Figure 3.15 shows the data (blue lines) 
against the fitted EM product profile curve on the left; the residuals 
(difference between the fitted curve and the data) in the middle; and the 
simulated rate curve (the derivative of the product curve) on the right. 0-
60 axis is time (s), 280-340 axis is temperature (K) and vertical axes are [P] 
(left-hand and middle plots) and rate (Vmax) (right-hand plot). 
 
Figure 3.15 – Fitting.exe output figures for WT barnase with GpUp (60 s data set) 
It was decided that, with the KM at 46 °C for the WT being more than 30 x 
that at 25 °C, testing mutants against the substrate would likely lead to 
similarly high KM values or worse. Corrections with Equation 2.5 for KM 
are still not ideal as they introduce another processing step and associated 
errors, and in some instances the measured V would be several orders of 
magnitude below Vmax, magnifying errors. Issues with substrate solubility 
and maximum absorbances compounded the problems, and led to the 
investigation of an alternative substrate. 
3.3.2 Fluorogenic Substrate Characterisation 
An alternative substrate has previously been used for the analysis of MazF 
(Wang & Hergenrother, 2007), with the CrGAC motif at the cleavage site 
(see Section 1.3.2). The authors found that fluorescence increases 
proportionately to [P]. The ex./em. maxima for FrG were found to be 
485/518 nm respectively via 3D scans of excitation and emission (Section 
2.6.2.5). This also holds for the product halves (Fluorophore & Quench). 
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3.3.2.1 Real-time Melts 
Melts of the FrG product halves were performed as in Section 2.6.2.3. 
Figure 3.16 shows the heating and cooling of the fluorophore and the 
quench halves at 10 µM (maximum product concentrations/initial 
substrate concentrations in the EM assays) in assay buffer. Temperatures 
were scanned from 25-99 °C and back to 25 °C with a 1 minute pause at 
99 °C. 
 
Figure 3.16 – Real-time melts of FrG substrate 25-90-25 °C in assay buffer 
Fluorescence is plotted on an arbitrary scale. This plot demonstrates that 
the FrG substrate is not susceptible to a significant degree of temperature-
induced cleavage or photobleaching, as the cooling plot is only slightly 
higher in fluorescence than that for heating. However, the amount of 
fluorescence is not linear with temperature and must be corrected for 
when converting fluorescence to product concentration, [P], for MATLAB 
fitting procedures (see Section 2.7.1.3). 
3.3.2.2 Linearity of Fluorescence with Concentration 
Standards ranging from 10 µM FrG substrate to 10 µM products were 
wave-scanned as in Section 2.6.2.5 at 25 °C and 50 °C (Figure 3.17 & Figure 
0!
10!
20!
30!
40!
50!
60!
70!
80!
90!
100!
25!28!31!34!37!40!43!46!49!52!55!58!61!64!67!70!73!76!79!82!85!88!91!94!97!
Fl
. 51
0!
Temperature (°C)!
Cooling! Heating!
Experimental Results and Discussion – Original Equilibrium Model Assays 65 
  
3.18). Legend is ratio substrate:product in µM. The maximal values at 518 
nm were plotted against concentration of the product (not shown) and 
found to be linear with increasing [P] (R2 = 0.9985 for 25 °C and 0.9973 for 
50 °C. Hence, fluorescence at 518 nm (Fl.518) can be used as a proxy 
measure of [P] over a wide temperature range. 
 
Figure 3.17 – Wave scan of increasing FrG product concentration at 26 °C 
 
Figure 3.18 – Wave scan of increasing FrG product concentration at 50 °C 
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It should be noted that there was FrG substrate present in diminishing 
amounts to simulate “real” time points along the course of an enzyme 
assay. This is a deviation from the literature method (Wang & 
Hergenrother, 2007), where only the product halves were used. 
3.3.3 Fluorogenic Substrate Assays (WT, DM and L89V) 
3.3.3.1 Data Gathering and KM Determinations 
Assays were performed as in Section 2.6.2.6 for EM data collection, with 
approximately 1 nM of each barnase variant acting upon 10 µM of FrG 
over 2 minutes and a temperature range of 26-60 °C (see Table 3.10). KM 
values were obtained using the methods in Section 2.6.2.7 and 
temperature-dependent changes were accounted for as part of data 
processing (Section 2.7.1.3) before data fitting. KM plots for WT, DM and 
L89V barnase are on the following pages and the results are tabulated 
below. Due to time constraints, other barnase mutants were not assayed.  
WT KM determinations are given in Figure 3.19 and Figure 3.20. Data was 
very hard to acquire (hence the large ranges in values, see error bars) as 
the methodology for mixing enzyme was not yet perfected. For the DM KM 
determinations, 10 x the concentration of enzyme was used, leading to 
much higher rates and substrate depletion. Hence, at higher [S], product 
inhibition was seen (Figure 3.21 and Figure 3.22) and those points were 
not fitted. For L89V KM determinations a slight drop in KM with 
temperature was seen just outside of error bounds. This is not usually 
observed (Thomas & Scopes, 1998) and potentially shows that the error in 
fitting the KM curves does not represent the real, experimental 
inaccuracies. Changes in KM were nonetheless accounted for in the data 
processing (Section 2.7.1.3) before data fitting. For both the DM and L89V 
variants, [S] is in M. 
 
Variant [E0] (nM) KM (25-26 °C) (µM) KM (50 °C) (µM) 
WT 1.07 2.9 ± 1.2 5.3 ± 1.7 
DM 1.04 5.1 ± 1.3 7.8 ± 0.8 
L89V 1.07 3.5 ± 0.5 2.4 ± 0.4 
Table 3.10 – KM (at 25-26 & 50 °C) and [E0] values for WT, Dm and L89V EM assays 
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Figure 3.19 – KM determination at 26 °C for FrG and WT barnase 
 
 
Figure 3.20 – KM determination at 50 °C for FrG and WT barnase 
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Figure 3.21 – KM determination at 26.5 °C for FrG and DM barnase 
 
 
Figure 3.22 – KM determination at 50 °C for FrG and DM barnase 
!"#$%&'
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Figure 3.23 – KM determination at 25 °C for FrG and L89V barnase 
 
 
Figure 3.24 – KM determination at 50 °C for FrG and L89V barnase 
!"#$%&'
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3.3.3.2  Fitting Results to the Original EM 
Data were acquired for WT, DM and L89V barnase variants (see Section 
3.3.3.1), processed as in Section 2.7.1.3 and then fitted to the original 
equilibrium model using fitting.exe. Using the MATLAB SurfaceFitting 
tool, the same data was fitted to the original EM (Section 2.7.3) for 
comparison and validation of the technique. 
For the WT enzyme, four rounds of each fitting procedure was required to 
maintain parameters within their 95% confidence values. For all 
parameters below, uncertainties are the largest (+ve or –ve) 95% 
confidence interval from fitting and column headings have been described 
previously (Section 3.3.1.2). 
Table 3.11 – Output parameters for WT barnase and FrG substrate for the original EM 
For the DM enzyme, four rounds were required to maintain parameters 
within their 95% confidence values for fitting.exe and for the 
SurfaceFitting tool three rounds were necessary. 
Table 3.12 – Output parameters for DM barnase and FrG substrate for the original EM 
With L89V, five rounds of fitting.exe were required to maintain 
parameters within their 95% confidence values and for SurfaceFitting tool 
eight rounds were necessary. This shows how the number of fitting 
rounds is not a reflection on how well the data finally fits the model (see 
R2 values) but is more an indication of how the different parameters 
Fitting 
Procedure  
∆Gcat‡  
 (kJ mol-1)  
∆Ginact‡  
 (kJ mol-1) 
∆Heq 
(kJ mol-1) 
Teq 
(K) SSE R
2 of fit 
fitting.exe 67.00 ± 0.05 
92.06 
± 0.43 
170.1 
± 4.7 
315.7 
± 0.3 3.69x10
-9 0.9791 
Surface 
Tool 
67.09 
± < 0.01 
92.51 
± 0.04 
190.6 
± 0.3 
315.8 
± < 0.1 4.76x10
-10 0.9995 
Fitting 
Procedure  
∆Gcat‡  
 (kJ mol-1)  
∆Ginact‡  
 (kJ mol-1) 
∆Heq 
(kJ mol-1) 
Teq 
(K) SSE R
2 of fit 
fitting.exe 65.84 ± 0.05 
93.14 
± 0.59 
142.7 
± 3.5 
314.9 
± 0.3 7.74x10
-9 0.9910 
Surface 
Tool 
65.78 
± < 0.01 
94.88 
± 0.03 
146.7 
± 0.2 
314.6 
± < 0.1 2.63x10
-10 0.9998 
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compensate for one another and can “mask” the effects of each other, 
making fitting troublesome. There is an element of user input into the 
fitting process, mainly in the choice of starting parameters and the quality-
assurance in deciding wether data is accurate with regards to KM, product 
inhibition and other experimental sources of error (see Section 2.7). 
Table 3.13 – Output parameters for L89V barnase and FrG substrate for original EM 
The tables above show how both fitting procedures give good statistical 
fits to the data, with R2 values between 0.9787 and 0.9998. There is more 
certainty in the parameters output using the SurfaceFitting tool procedure 
(as reflected in the smaller errors, sum of squared errors (SSE) and larger 
R2 values), but, once experimental errors are considered, this becomes 
negligible (see Section 3.3.4). Except for ∆Heq, there is good agreement in 
all the other parameters between fitting processes; this exception is also 
considered later. 
Figure 3.25, Figure 3.26 & Figure 3.27 (next page) show the output plots 
for the fitting.exe method for WT, DM & L89V barnase and the FrG 
substrate respectively, as in Figure 3.15. Data points (blue lines) are shown 
against the fitted EM product profile curve on the left; the residuals 
(difference between the fitted curve and the data) are in the middle; and 
the simulated rate curve (the derivative of the product curve) is on the 
right. 0-150 axes are time (s), 290-340 axes are temperature (K) and vertical 
axes are [P] (left-hand and middle plots) and rate (Vmax) (right-hand plot). 
All statistical analyses of output parameters are given in Appendix C. 
The key figure of these is the residual plot. An ideal fit would give 
random traces of minimal amplitude either side of the zero-rate plane. In 
the case of the variants (next page), there is clearly a systematic tendency 
to have positively curving residuals from data points at 320-330 K and 
negatively curving ones above 330 K. This is considered in Section 4.1. 
Fitting 
Procedure  
∆Gcat‡  
 (kJ mol-1) 
 ∆Ginact
‡  
 (kJ mol-1) 
∆Heq 
(kJ mol-1) 
Teq 
(K) SSE R
2 of fit 
fitting.exe 66.09 ± 0.07 
91.44 
± 0.43 
174.2 
± 5.5 
317.2 
± 0.4 9.89x10
-9 0.9787 
Surface 
Tool 
65.96 
± 0.01 
90.18 
± 0.03 
160.0 
± 0.4 
316.7 
± 0.1 1.04x10
-9 0.9996 
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Figure 3.25 – Fitting.exe output figures for WT barnase with FrG 
 
Figure 3.26 – Fitting.exe output figures for DM barnase with FrG 
 
Figure 3.27 – Fitting.exe output figures for L89V barnase with FrG 
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Data points at temperatures below 320 K show more straight deviations 
from the fitted product curve – these indicate random error as the 
amplitude is small (especially compared with data points above 320 K) 
and they deviate in a linear fashion. This could be caused by inaccuracies 
in the amount of enzyme added in individual runs, as opposed to an 
actual deviation from the EM kinetics. Aside from showing that the 
original EM does not fit well at high temperatures, this could point to the 
reversible denaturation properties of barnase conflicting with the 
irreversibility implied in the EM kinetics (see Section 4.1). 
3.3.4 Discussion of Output Parameters for WT, DM and L89V Barnase 
The results from Section 3.3.3 are amalgamated below for comparison, this 
time with experimental errors in addition to fitting errors (the last section 
only included errors derived from the fitting procedures). Experimental 
error has been dealt with in detail previously (Peterson et al., 2007), 
finding a maximum of 0.5% deviation in  ∆Gcat
‡ ,  ∆Ginact
‡  & Teq and 6% in ∆Heq 
experimentally. This thesis follows those guidelines. Values that are 
significantly different between the WT and a mutant (do not overlap 
within stated error) are in italics. 
Table 3.14 – Summary of output parameters for WT and mutant barnase 
Compared with the WT, both mutants have marginally significant drops 
in  ∆Gcat
‡ . At 42 °C (~315 K, approximately the Teq of all variants) however, 
Variant Fitting Procedure  ∆Gcat
‡  
 (kJ mol-1)  
∆Ginact‡  
 (kJ mol-1) 
∆Heq 
(kJ mol-1) 
Teq 
(K) 
fitting.exe 67.00 ± 0.39 
92.06 
± 0.89 
170 
± 15 
315.7 
± 1.9 
W
ild
-ty
pe
 
Surface 
Tool 
67.09 
± 0.35 
92.51 
± 0.50 
191 
± 12 
315.8 
± 1.7 
fitting.exe 65.84 ± 0.38 
93.1 
± 1.1 
143 
± 12 
314.9 
± 1.9 
S8
0C
/A
43
C 
(D
M
) 
Surface 
Tool 
65.78 
± 0.34 
94.88 
± 0.50 
146.7 
± 9.0 
314.6 
± 1.7 
fitting.exe 66.09 ± 0.40 
91.44 
± 0.89 
174 
± 16 
317.2 
± 2.0 
L8
9V
 
Surface 
Tool 
65.96 
± 0.34 
90.18 
± 0.48 
160 
± 10 
316.7 
± 1.7 
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where no variant is more than 1% denatured (see Section 3.2.6), the change 
in  ∆Gcat
‡  amounts to a 41-65% increase in kcat (due to the exponential terms 
in Equation 1.1). Increases in catalytic rate due to non-active site mutations 
are common (for example, Schanstra et al., 1997). This finding is apparent 
when the simulated EM rate plots are overlaid (using output parameters 
from fitting.exe) as the mutants have “taller” rate profiles at their maximal 
values (Figure 3.28). 
 
Figure 3.28 – (Left) Simulated rate profiles of WT (blue) and DM (green) barnase & 
(Right) Simulated rate profiles of WT (blue) and L89V (orange) barnase 
Table 3.14 also highlights the variability in ∆Heq values. Although Teq never 
differs by more than 0.5 K between the fitting procedures, ∆Heq can vary 
between procedures relatively more so (although the values all match 
within stated errors). This reflects the difficulty in fitting ∆Heq in that a 
large change in ∆Heq can be partially compensated for by very small 
changes in the  ∆Gcat
‡  and  ∆Ginact
‡  parameters. 
It should be noted (and particularly with the SurfaceFitting tool 
derivations) that, compared with the WT enzyme, the value of  ∆Ginact
‡  
decreases for L89V and increases for the DM. These relative changes are 
expected, but the magnitude of each change does not match the literature 
or experimental values (see Table 1.2 and Section 3.2.6 respectively). As 
discussed in Section 4.3, this implies that the model has not taken the true 
denaturation properties of each enzyme into account. Hence, the other 
parameters (which are all connected in Equation 1.15) might have 
compensated for this incorrect value and, therefore, are possibly incorrect. 
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4 Theory and Modelling of the Equilibrium Model 
To help understand how the kinetic description of the EM fits to the assay 
data sets (Section 3.3), several different models were derived to cover the 
most likely kinetic situations for denaturation from the Eact/Einact 
equilibrium species (Section 4.1). These models were fitted to an ideal data 
set and the WT barnase data set (from Section 3.3.3) to compare an 
irreversibly and reversibly denaturing enzyme, respectively (Section 4.2). 
To benchmark dynamics measurements of assayed enzymes and validate 
the mathematics behind the model derivations, equations to simulate the 
concentrations of species with time and temperature were derived and 
analysed using model output parameters (Section 4.3). 
4.1 Derivation of Alternative Models 
The equilibrium model (EM) fits well with experimental data analysed to 
date (Section 1.2.3.2). Barnase, despite hypotheses to the contrary (Section 
1.3.3), also fits the model kinetics satisfactorily, although not so well at 
high temperatures above Teq (Section 3.3.3.2). However, the physical basis 
for the Eact/Einact equilibrium is not known and, although the EM more 
accurately describes experimental data compared with the classical 
kinetics approach (Section 1.1.3), there is no evidence for what is implied 
by the mathematics. As stated before (Section 1.4.2), if a model is given 
enough degrees of freedom to fit a data set, then that model will fit the 
data even if the mathematics behind the kinetics do not accurately 
describe what is physically happening. 
As covered in Section 1.2.2.1, the original EM assumes denaturation from 
the Einact species only (Daniel et al., 2001) (see Table 4.1). This implies that 
the Einact species is on-path to denaturation, and could be thought of as an 
intermediate state that is populated in a temperature-dependent manner. 
Hence, if other models were developed with alternate species schemes, it 
was hoped that the experimental data would fit best to those that most 
accurately represent the changes that are physically happening. 
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4.1.1 Species Schemes and Rate Equations for Alternate Models 
Model names are arbitrary, as the letters M-R were available as variables 
in the program Grapher (see Appendix B) that was used for comparison 
and simulation of the product and rate curves for each model. 
M
od
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Table 4.1 – Comparison of original EM to newly derived alternative models 
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For full derivations of all the models, including the original EM, see 
Appendix B. New rate constants are introduced in some variants, and are 
defined in the appendix also. The equations given in Table 4.1 can be 
extensively expanded, as explained in Appendix B, to include all the ∆G‡, 
∆Heq and Teq terms as required for fitting. 
4.1.1.1 Models “O” and “P” 
Models O and P were derived to probe whether the assumption that Einact 
is on-path to denaturation is valid. By reversing the situation compared to 
the original EM, model O implies denaturation through the Eact species 
(through a new rate constant kdeact). If it fits data better than the original 
EM, then the assumption of denaturation from Einact made to date must be 
questioned. As Eact is more prominent at low temperatures due to the Keq 
equilibrium (where the denaturation rate is known to be lower), the 
likelihood of denaturation purely occurring via this species is low. Model 
P allows for both routes to the denatured species (X), and hence fits for 
both kinact and kdeact rates. It should fit well, as it allows for the equilibrium 
model as it stands, but ideally one of the two denaturation rates will be 
favoured. This may shed light on which species, if either, is on-path to 
denaturation. If neither rate is favoured over the other (kinact ≈ kdeact), then 
the model simplifies to the next case, model M. 
4.1.1.2 Model “M” 
Model M differs from those mentioned so far in that it treats the Eact/Einact 
equilibrium pair as an ensemble, allowing denaturation from either 
species. The treatment implies that neither species is more on-path to 
denaturation than the other and, by corollary, implies that both the Eact & 
Einact species are overall natively folded. In comparison, the original EM 
scheme (see Table 4.1) only absolutely implies this for the Eact species. As 
the Eact/Einact equilibrium is no longer important for denaturation, 
compared with the original EM, the mathematics is simplified in the rate 
equation (compare with Equation 1.15). This removes two Keq terms from 
the exponential, and hence makes fitting ∆Heq and Teq parameters much 
more direct. If model M fits data better than the original EM, it suggests 
either of two scenarios: a) that the speed of the Eact/Einact equilibrium is so 
fast that assay data is insufficient to show if either species is on-path to 
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denaturation or b) that both species denature with equal rate constants 
and, hence, the original EM is unnecessarily complex. 
4.1.1.3 Models “N, “R” and “Q” 
No enzymes assayed prior to this thesis have exhibited reversible thermal 
denaturation. That is to say, the assumption of the original EM that X is a 
kinetic “trap” for denatured enzyme (as precipitate/aggregate or non-
functional unfolded enzyme) holds true for the vast majority of enzymes 
(Stempfer et al., 1996). Barnase does renature (see Section 1.3.3.3), which 
could hypothetically repopulate the Eact/Einact equilibrium and cause 
deviation from the original EM, O, P & M model kinetics. Model N allows 
for the re-population of an Eact/Einact ensemble, yet is otherwise as in model 
M. It is theorised that the renaturation rate (kreact) will be substantially 
greater for reversibly denaturing enzymes such as barnase, yet essentially 
zero (have a large ∆G‡ value) for irreversibly denaturing enzymes. Hence, 
model N is expected to be applicable to all enzymes, as the model should 
fit itself to data depending on the tendency to renature of the 
enzyme/substrate system being measured. 
Model R is a compromise; on one hand the mathematics is more 
complicated, as the Eact/Einact equilibrium has to be accounted for with 
regard to denaturation (compared with model N); but on the other hand, 
it means only one species is denaturing (Einact), therefore maintaining the 
assumption that Einact is on-path to denaturation. By definition, this should 
mean that the denaturation process is modelled to occur at a higher 
temperature. Hence, if the original EM holds true over model M for 
general enzymes, model R is the alternative model for renaturing enzymes 
such as barnase. 
Model Q expands on models N and R by allowing for all possible routes to 
and from the denatured state. For clarity, kinact, kreact and kdeact are replaced by 
ki, k–i and ka respectively, with the renaturation rate constant of the ka 
process being k–a. Sub-script characters a and i are short for “active” and 
“inactive” respectively, the species they relate to. This model, whilst 
theoretically capable of fitting insignificant rates (very high ∆G‡ values) to 
irrelevant processes, also has the potential to fit a data set incorrectly, due 
to the large number of degrees of freedom it contains (see Section 1.4.2). 
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The fitting of data sets to the model illustrates this possibility. In any case, 
it is expected that all the other models would be suitably limited cases that 
can encompass any enzyme/substrate data set when chosen correctly. 
4.2 Comparison of Alternative Models 
For both data sets fitted below, plots of the fits (curve+data and residuals) 
are available on the included CD-ROM, as listed in Appendix C. 
4.2.1 Ideal Data Set 
Model data for a ß-glucosidase from Caldicellulosiruptor thermosaccharo-
lyticus (substrate para-nitrophenol-ß-D-glucopyranoside) was provided by 
Colin Monk (University of Waikato). This data set had no corrections for 
KM or substrate stability and represents as close to raw data as possible. 
The data set was used as a fair test for comparing EM, O, P and M models, 
as well as to see if the reversible denaturation models would fit 
denaturing data sets, perhaps through fitting near-zero rate constants for 
irrelevant processes. Note that errors in the output parameters tabulated 
below are purely 95% confidence interval fitting uncertainties, as the data 
fits are most important when comparing the different models. 
4.2.1.1 Original Model Fitting 
This fitting was performed as in Section 2.7.2 & Section 2.7.3 for fitting.exe 
and SurfaceFitting tool processes respectively. E0 was 5.86x10-7 M. 
Table 4.2 – Output parameters for the ideal data set for the original EM 
The output parameters from the fitting procedures were very close to one 
another, with  ∆Gcat
‡ ,  ∆Ginact
‡  & ∆Heq being close enough to make no 
difference in a visual fit. Teq, whilst matching within experimental errors, is 
different enough to cause a slight shift in the fitted product concentration 
Fitting 
Procedure  
∆Gcat‡  
 (kJ mol-1)  
∆Ginact‡  
 (kJ mol-1) 
∆Heq 
(kJ mol-1) 
Teq 
(K) SSE R
2 of fit 
fitting.exe 78.50 ± 0.05 
104.3 
± 0.2 
131.1 
± 1.8 
349.2 
± 0.4 8.42x10
-4 0.9918 
Surface 
Tool 
78.19 
± < 0.01 
104.6 
± < 0.1 
116.9 
± 0.1 
346.9 
± < 0.1 1.16x10
-7 0.9998 
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peak. The parameters showed more concordance than those for the 
barnase variants in Section 3.3.3.2. 
4.2.1.2 Custom MATLAB Fitting of Alternative Models 
As in Section 2.7.3, the ideal data set was fitted to the alternative models 
using the SurfaceFitting tool method. Data from Section 4.2.1.1 is included. 
For an explanation of the relevant ∆G‡ terms, see Table 4.1 and Appendix 
B. Note that some parameters are only required for certain models and the 
bracketed terms are only relevant for model Q (see Section 4.1.1.3).  
Table 4.3 – Output parameters for the ideal data set for original and alternative models 
Output 
Parameter 
Orig. 
EM O P M N R Q 
 ∆Gcat
‡  
 (kJ mol-1) 
78.19 
± < 0.01 
78.40 
± 0.01 
78.20 
± 0.01 
78.28 
± < 0.01 
78.31 
± 0.45 
78.46 
± 0.01 
78.44 
± 0.41 
 ∆Ginact
‡
 ∆Gi
‡( )  
 (kJ mol-1) 
104.6 
± < 0.1 – 
104.6 
± < 0.1 
105.4 
± < 0.1 
94.69 
± 5.35 
110.2 
± 2.3 
93.67 
± 52.34 
 ∆Gdeact
‡
 ∆Ga
‡( )  
(kJ mol-1) 
– 101.9 ± < 0.1 
159.2 
± large – – – 
96.56 
± 8.86 
 ∆Greact
‡
 ∆G!i
‡( )  
(kJ mol-1) 
– – – – 89.39 ± 2.12 
100.2 
± 10.5 
91.49 
± large 
 ∆G!a
‡( )  
(kJ mol-1) 
– – – – – – 91.49 ± large 
∆Heq 
(kJ mol-1) 
116.9 
± 0.1 
173.3 
± 0.2 
117.3 
± 0.1 
127.7 
± 0.1 
165.1 
± 0.9 
153.7 
± 0.3 
167.8 
± 4.3 
Teq 
(K) 
346.9 
± < 0.1 
350.1 
± < 0.1 
346.9 
± < 0.1 
348.0 
± 0.1 
348.9 
± 0.2 
347.8 
± 0.1 
349.6 
± 20.3 
SSE 1.16 x10-7 
2.12 
x10-7 
9.92 
x10-8 
8.27 
x10-8 
2.41 
x10-5 
1.26 
 x10-6 
2.36 
 x10-5 
R2 0.9998 0.9997 0.9999 0.9999 0.9665 0.9983 0.9672 
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All of the models show excellent agreement in  ∆Gcat
‡ . This is the main 
parameter that influences the shape of the product curve at low 
temperatures, as the denaturation rate constants have larger ∆G‡ terms 
and, hence, require higher temperatures to be of significance. Teq is also 
well correlated between all models – the observed range of 3.2 K is 
considered within experimental error (see Section 3.3.4). Other parameters 
are discussed in following sections as appropriate to each group of 
models. Uncertainties labelled “large” mean that the 95% confidence 
bounds were greater than the magnitude of the value fitted (e.g., lower 
confidence bounds were giving negative values for the parameter). 
The overall fits of the irreversibly denaturing models were markedly 
better than the reversibly denaturing ones, as measured by R2 & SSE 
values, and this is discussed in Section 4.2.1.4 as well. Generally, this 
discrepancy is attributable to the N, R and Q fitting procedures having too 
many degrees of freedom. It should be noted that all of the models show a 
good surface fit to the data sets and even residuals are remarkably similar 
(see Appendix C). It is only in the individual output parameters for each 
model that a lack of confidence is observed, if at all, this being the purpose 
of the fitting experiments. 
4.2.1.3 Analysis of Irreversibly Denaturing Models (EM, O, P and M) 
Within these models, the  ∆Ginact
‡  and  ∆Gdeact
‡  values are all very similar, 
with the exception of  ∆Gdeact
‡  for model P. Because model P allows for 
denaturation via both Eact and Einact, it was expected that one rate might be 
favoured – as  ∆Gdeact
‡  is ~55 kJ mol-1 greater than  ∆Ginact
‡ , this leads to a ~108-
fold difference in denaturation rate constant (at 350 K, ≈ Teq) in favour of 
the kinact process. This is expected as, at lower temperatures, the rate of 
denaturation is inevitably slower and, hence, the higher-temperature Einact 
species is a more likely source for denaturable enzyme. Model P has 
parameters so close to EM, and excludes the kdeact process so well, that it 
gives exactly the same fit as the original EM, within error. 
Model O does not allow for the kinact process, instead defining the Eact 
species as the sole source of denaturable enzyme. The  ∆Gdeact
‡  parameter 
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fits well to the model (95% CI < 0.01 kJ mol-1), however, and the overall 
quality of fit is comparable to both models EM and P. Seeing as model P 
so clearly disfavours this route for denaturation, other processes had to be 
compensating to allow for the good mathematical fitting of the data to 
model O. ∆Heq for the EM and P models is a very closely matched 
parameter, almost within fitting error. With model O the ∆Heq value is ~55 
kJ mol-1 greater, meaning that the Eact/Einact transition is more pronounced 
(Keq changes from small to large over a shorter temperature range). It is 
postulated that this allows more Eact to be present at temperatures 
approaching Teq and, hence, more susceptible to denaturation (e.g. in 
model O the Einact is an off-path refuge from denaturation). Teq itself is also 
marginally higher and  ∆Gdeact
‡  marginally lower than  ∆Ginact
‡  from models 
EM and P, both factors aiding in lower-temperature denaturation of Eact. It 
must be remembered that the Eact/Einact equilibrium still accounts for the 
majority of the inactivation observed at low temperature, and that this 
process is still resolved in the model. 
Thus far, the case can be made that the mathematics favours denaturation 
almost exclusively through the Einact species. Although the kdeact pathway 
can be fitted to data sets, other parameters are varied to compensate, and 
the evidence from model P refutes kdeact as a favoured process. One 
objective of this thesis was to attempt to simplify the kinetics used in the 
fitting of parameters to the equilibrium model, and whilst models O and P 
help to clarify which species are involved in which processes, they have 
equally or more complicated derivations than the original EM. Model M, 
in comparison, simplifies the kinetics by assuming both Eact and Einact are so 
closely related (and quickly inter-converting) that the denaturation 
pathway is mathematically independent of the exact Eact/Einact species. The 
 ∆Ginact
‡  value for model M is almost exactly the same as for models EM and 
P, which use or favour denaturation via Einact. A slight increase of ~10 kJ 
mol-1 is seen in ∆Heq, making the Eact/Einact transition more prominent (see 
previous model O discussion), but it still matches models EM and P 
within standard experimental error, along with Teq. 
Model M fits the ideal data set the best of all models, as evidenced by R2 
and SSE values, closely followed by model P. Within experimental error 
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(see Peterson et al., 2007), the output parameters for this data set are the 
same as those fitted to the original EM, for the time and temperature range 
of the data fitted. This, coupled with the lack of evidence to date about the 
nature of the Eact/Einact transition (see Section 1.2.3.2), means that there is 
no reason to favour the more mathematically complicated original EM 
over the simplified model M for modelling this data set. 
4.2.1.4 Analysis of Reversibly Denaturing Models (N, R and Q) 
Models N, R and Q all fitted data with less certainty than the irreversibly 
denaturing models. With model Q this was expected as it allowed for two 
pathways to and from X from the Eact/Einact ensemble and hence had a 
large degree of freedom to vary parameters during the fitting process. 
There can be no conclusions drawn from the non-catalytic ∆G‡ output 
parameters, as they have such large confidence intervals and, although 
 ∆Gcat
‡
 and Teq are in agreement with all the other models, the fit as a whole 
is not sound. This model is too mathematically complicated, with too 
many variables for the data it has to fit and, therefore, it does not give 
useful information about any processes occurring within the ideal data set. 
Model N was derived to be the reversibly denaturing version of model M. 
As model M fitted the ideal data set well, it was thought that model N 
would show a near-zero rate constant for the kreact process and then fit 
similarly in all other parameters, as it then degrades to the Model M 
mathematics. However, the fitting process uses the new degree of freedom 
to compensate for the higher ∆Heq parameter – a higher ∆Heq means that 
the transition from Eact to Einact populations is more pronounced and, hence, 
inactivation due to Keq is more dramatic with temperature. The flexibility 
of models with increasingly complex or altered mathematics is discussed 
in Section 5.2.2 as well. If denaturation is modelled as a partially reversible 
process, then a loss of activity via Keq can be compensated for by an overall 
slower loss of Eact and/or Einact to X, increasing the relative concentration of 
Eact and restoring activity. The confidence in  ∆Ginact
‡  and  ∆Greact
‡  is lower 
than in the irreversible models discussed so far, but model N still gives a 
reliable fit for Teq and  ∆Gcat
‡ . 
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Model R has an improved fit over model N for all output parameters 
except  ∆Greact
‡ . As model R is the reversible counterpart to the original EM 
model, the fit provides evidence that the original EM implication that Einact 
is on-path to denaturation is correct.  For model R,  ∆Greact
‡ is very similar to 
 ∆Ginact
‡  (they match within error) and as such the kinact/kreact processes might 
represent a reversible equilibrium, suggesting that the ideal data set is 
from a reversibly denaturing enzyme (this is not known). The forward and 
reverse rates vary with temperature and time (compare with Keq), as they 
are themselves dependent on species that are time-dependent. It is 
interesting that both models N and R do not purely reject the kreact process 
(by fitting near-zero rate constants); instead, they compensate for the 
availability of the new parameter by increasing ∆Heq (as explained 
previously). Teq and  ∆Gcat
‡  for model R both match the values output for all 
other models. As illustrated in the R2 and SSE statistics, model R fits the 
ideal data set better than the other reversibly denaturing models. This may 
be due to simplified kinetics over model Q, but could also imply that the 
pathway to the denatured species goes via Einact. 
4.2.2 WT Barnase Data Set 
The fitting of the original EM to the FrG substrate has been analysed 
previously using SurfaceFitting tool (see Section 3.3.3.2). The results 
tabulated below are from those fitting runs in addition to the new results 
for alternate models (as performed in Section 2.7.3). Errors in the output 
parameters tabulated below are purely fitting errors, as above. Only WT 
barnase is included in this thesis for several reasons: brevity; to compare 
two wild-type enzymes, excluding the effects of mutations on fits; and due 
to the similarity of the conclusions that can be drawn from the fits of all 
barnase variants (data not shown). 
All of the models show excellent agreement in  ∆Gcat
‡  and Teq, as they did 
for the ideal data set. The overall fits of the irreversibly denaturing models 
were only slightly better than the reversibly denaturing ones, as measured 
by R2 & SSE values (compare with Section 4.2.1.2 onwards). Again, all the 
models show a good visual surface fit to the data sets and residuals are 
remarkably similar between models.  
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Table 4.4 – Output parameters for WT barnase and FrG for original and alternative 
models 
4.2.2.1 Analysis of Irreversibly Denaturing Models (EM, O, P and M) 
Compared with the ideal data set, most of the conclusions with respect to 
the original EM and model M fits are the same (see Section 4.2.1.3). The 
output parameters for Model P, however, do not distinguish between 
denaturation from either Eact or Einact. In this case, the model simplifies to 
model M as kinact ≈ kdeact (note the similarity of other output parameters). 
This provides further evidence that model M is a good representation of 
simplified equilibrium model kinetics, with the best statistical fit to data 
Output 
Parameter 
Orig. 
EM O P M N R Q 
 ∆Gcat
‡  
 (kJ mol-1) 
67.09 
± < 0.01 
66.99 
± < 0.01 
67.01 
± 0.01 
67.03 
± < 0.01 
65.52 
± 7.01 
67.14 
± 0.01 
66.16 
± 8.33 
 ∆Ginact
‡
 ∆Gi
‡( )  
 (kJ mol-1) 
92.51 
± 0.04 – 
93.06 
± 0.06 
93.15 
± 0.03 
76.49 
± 18.34 
87.21 
± large 
84.17 
± large 
 ∆Gdeact
‡
 ∆Ga
‡( )  
(kJ mol-1) 
– 90.97 ± 0.03 
92.19 
± 0.08 – – – 
77.37 
± 35.23 
 ∆Greact
‡
 ∆G!i
‡( )  
(kJ mol-1) 
– – – – 76.22 ± 5.23 
78.80 
± large 
77.62 
± 23.38 
 ∆G!a
‡( )  
(kJ mol-1) 
– – – – – – 76.89 ± 11.98 
∆Heq 
(kJ mol-1) 
190.6 
± 0.3 
219.8 
± 0.3 
198.3 
± 0.6 
199.7 
± 0.2 
212.0 
± 0.8 
211.8 
± 19.5 
212.2 
± 27.9 
Teq 
(K) 
315.8 
± < 0.1 
315.9 
± < 0.1 
316.1 
± < 0.1 
315.9 
± < 0.1 
315.6 
± 0.1 
315.6 
± 13.6 
314.2 
± 31.8 
SSE 4.76 x10-10 
4.35 
x10-10 
4.98 
x10-10 
2.92 
x10-10 
6.81 
 x10-9 
3.91 
 x10-9 
3.09 
 x10-9 
R2 0.9995 0.9996 0.9995 0.9997 0.9935 0.9963 0.9970 
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for the time and temperature ranges assayed. The other parameters output 
from the original EM fitting are identical to those from models M and P, 
within experimental error. 
4.2.2.2 Analysis of Reversibly Denaturing Models (N, R and Q) 
The fit of barnase to irreversibly denaturing models, in particular the 
original EM (Section 3.3.3.2), has been discussed before. It was hoped that 
the reversible versions of each model would account for barnase data 
more thoroughly and give a better fit at higher temperatures, reflecting 
renaturation. Models N, R or Q fit better to the WT barnase data than to 
the ideal data set but still have large fitting errors, in particular for model 
R. Model Q has the best fit of the reversible models, but also large 
uncertainties for ∆G‡ parameters, meaning no conclusions could be drawn 
from their values. Rises in ∆Heq for models N, R and Q are statistically 
significant in comparison to the irreversible models but, when 
experimental error is considered, they become insignificant. 
Model N is the only reversible model fitted to WT barnase data with 
output parameters of numerical uncertainties (the uncertainties are not 
labelled “large”). The similarity of  ∆Ginact
‡  and  ∆Greact
‡  rates resembles the 
situation with models N and R for the ideal data set, in that a reversible 
equilibrium might exist (although this observation is not explainable for 
the ideal data set). The observed drop in  ∆Ginact
‡  (and its resulting faster 
denaturation) is compensated for by, activity-wise, a marginal decrease in 
 ∆Gcat
‡  (increasing the activity of Eact). Despite these conclusions, the 
confidence in parameters from model N (as measured by the given 
uncertainties) is far below those derived using models EM, M & P, 
meaning that it has limited use in comparing enzymes (and mutants of the 
same enzyme) to each model. 
4.3 Species Concentration Simulations 
For the purposes of NMR dynamics experiments (see Section 1.3.3.4 and 
Section 1.4.1) an enzyme (native or mutant) needed to be identified with 
two main properties. Firstly, due to the long nature of NMR dynamics 
experiments (on the scale of days), there must not be a “sink” of denatured 
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and aggregated protein over temperature ranges where the Eact/Einact 
equilibrium would be observable; hence, reversibly denaturing enzymes 
such as barnase or other RNAses are ideal. Secondly, for the transition 
between Eact and Einact to be observable, ideally the Teq will be at least ~5 °C 
lower than the Tm, so that the major species present at higher temperatures 
(past Teq) is Einact, and not denatured enzyme (X). As any dynamics 
experiments would be benchmarked against the EM, species simulations 
based on fits to the EM needed to be derived. For example, the relative 
amounts of species present at specific times and temperatures (Eact, Einact 
and X) need to be quantified to explain any changes observed in dynamics 
experiments. Hence particular dynamic states could then be ascribed to 
different species and reflect the physical basis for the Eact/Einact transition. 
Equations for all models are derived in full in Appendix B.1.7. Only those 
for the original EM are given below as the exponential term is the only 
element that changes between models (see Table 4.1). 
Species Concentration Equation 
Eact 
 
[Eact] =
[E0]
1+ Keq
!exp
"kinact !Keq ! t
1+ Keq
#
$
%
&
'
(  
Einact 
 
[Einact] =
[E0]
1+1 Keq
!exp
"kinact !Keq ! t
1+ Keq
#
$
%
&
'
(  
X 
 
[X] = [E0] ! 1" exp
"kinact !Keq ! t
1+ Keq
#
$
%
&
'
(
#
$
%%
&
'
((
 
Table 4.5 – Species concentration equations for the original EM 
4.3.1 Simulations of Different Data Sets and Models 
The output parameters from the original EM (from fitting.exe) for the 
ideal data set (Section 4.2.1.1) and WT & DM barnase (Section 3.3.3.2) were 
used to simulate species concentrations for the original EM over suitable 
ranges of temperature for 120 minutes using the equations from Table 4.5 
(long enough to demonstrate the full interplay between species, essentially 
to t ≈ ∞). Three-dimensional interactive models (for the program Grapher, 
Apple Inc., USA) are available in Appendix C. 
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Figure 4.1 – Species simulations for the ideal data set in the original EM. (Left) View 
showing Eact (green), Einact (blue) and X (red) and (Right) View with Eact removed. 
Figure 4.1 (Left) shows clearly how the three species in the original EM 
relate. As temperature increases, the Eact/Einact equilibrium is apparent with 
increasing amounts of Eact being converted to Einact, most obviously at 
shorter assay times (in the first ~10 minutes) (Figure 4.1 (Right)). The 
denatured species (X) shows a curve that is prominent at short time-scales 
& high temperatures and at long time-scales & lower temperatures, 
reflecting the time dependency of the denaturation process. At long assay 
times (> ~10 minutes) and temperatures approximating the Einact peak, the 
irreversible denaturation process in the original EM causes the majority of 
E0 to be either in the Eact or X forms, essentially making X an immediate 
“sink” for any Einact species formed. This illustrates why previous attempts 
to determine the structural changes involved in the Eact/Einact transition 
have proven difficult (see Section 1.2.3.1); any enzyme present in the Einact 
form only accounts for ~10% of the total enzyme concentration, with ~45% 
in both Eact and X forms. 
With regard to measuring the dynamics of the Eact/Einact transition via 
NMR or any other means (see the beginning of Section 4.3), it is important 
that Eact and Einact are the primary species present at long time scales and 
over the temperature range of the equilibrium. Diagrammatically, the 
species simulations for the applicable model need to show the blue Einact 
curve at > 80% of E0 concentration at long time scales. This is because 
NMR will measure resonances over the whole population of enzyme (E0), 
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and therefore the Einact species must be in excess over the X and Eact species 
so its dynamics can be determined. With the original EM derivation this 
only occurs at short (< ~1 minute) time scales (e.g. Figure 4.1 (Right) and 
Figure 4.4). Ideally, the red X curve would rise in concentration at 
temperatures higher than the Einact peak, so that at long time scales, the 
Einact form would dominate and be protected against denaturation. 
Species simulations from WT and DM barnase fits to the original EM are 
shown in Figure 4.2 and Figure 4.3. It is known from DSC measurements 
(see Section 3.2.6) that WT barnase does not start to denature appreciably 
until ~315 K (with a Tm of ~326 K). Because the original EM does not take 
into account reversible denaturation, the loss of activity at temperatures 
well below the Tm is ascribed to X formation by the fitting process, not the 
Eact/Einact equilibrium. Therefore, the red X curve should be ~10 K higher 
than that fitted by the EM mathematics. This deviation is seen even more 
drastically with the DM barnase data set (using output parameters from 
Section 3.3.3.2). From DSC measurements, the DM does not start to 
denature until ~321 K (with a Tm of ~331 K). This is not reflected in the 
position of the X curve in Figure 4.3, which should (at long time points) 
show a midpoint approximating Tm. At 2 minutes time in Figure 4.4 ~80% 
of DM barnase is in the denatured (X) species at 330 K. Yet we know that 
only ~50% of the enzyme population should be denatured at this 
temperature, as the Tm is ~331 K. 
  
Figure 4.2 – Species simulations for WT barnase and FrG in the original EM. (Left) 
View showing Eact (green), Einact (blue) and X (red) and (Right) View with Eact removed. 
Theory and Modelling of the Equilibrium Model – Species Concentration Simulations 90 
  
  
Figure 4.3 – Species simulations for DM barnase and FrG in the original EM. (Left) 
View showing Eact (green), Einact (blue) and X (red) and (Right) View with Eact removed. 
These findings are easier to see in two dimensions if temperature is 
plotted against time for the first 10 minutes of a DM barnase assay (Figure 
4.4). Using the original EM output parameters and plotting the regions in 
which each species makes up 80% or more of the E0 population, we can see 
that a sufficient population of Einact (blue) for dynamics measurements is 
only fleetingly present. The populations of both Eact (green) and X (red) 
are, however, dominant over wide time and temperature ranges. 
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Figure 4.4 – 2D temperature/time plot of EM species at > 80% E0 for DM barnase 
The stabilising effect of substrate on enzyme Tm values is well known 
(Lejeune et al., 2001). Hence, the situation described, where the original 
EM model does not reflect the DSC thermostability results, could be worse 
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if the FrG substrate used for barnase assays stabilises barnase 
significantly. This would mean that, although the model fits parameters 
suggesting a small Einact population, in reality that population is much 
more dominant. 
4.3.2 Modelling an Ideal Enzyme 
If the original EM parameters for DM barnase are adjusted to separate Eact 
and X populations, simulations show that it is possible to have a large 
proportion of the Einact species present for long time periods, if 
denaturation occurs at sufficiently higher temperatures. By setting the 
values as in Table 4.6 (modified from the DM barnase EM output 
parameters), Figure 4.5 shows a peak for Einact that is well separated from 
the denaturation peak, allowing long time-scale dynamics measurements 
to be made of Einact. The value of  ∆Ginact
‡  is realistic, but high, as the DM is 
~9 kJ mol-1 stabilised relative to the WT (Table 1.2). 
Simulated Parameter Value 
[E0] 1.04x10-9 M 
 107000 kJ mol
-1 
∆Heq 200000 kJ mol-1 
Teq 315 K 
Table 4.6 – Simulation parameters of an ideal enzyme for the original EM 
  
Figure 4.5 – Species simulations for an ideal enzyme in the original EM. (Left) View 
showing Eact (green), Einact (blue) and X (red) and (Right) View with Eact removed. 
 ∆Ginact
‡
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This is a drastic example, used for effect, and lower  ∆Ginact
‡  values can still 
have a marked effect of the size and position of the Einact peak. The major 
change is due to a high enough  ∆Ginact
‡  and a low enough Teq that lead to 
separation of the X curve from the Einact curve. The denaturation process 
needs higher temperatures to obtain a significant rate constant and hence 
the Einact population is protected from the kinact process. Figure 4.5 shows a 
mid-point for the denaturation curve (X) at about 335 K, ~5 K higher than 
the Tm of the DM (Section 3.2.6). A lower  ∆Ginact
‡  value, closer to that 
suggested by the literature (see Table 1.2), would potentially remedy this. 
The Teq, however, remains the same and ∆Heq is also similar. 
The parameters in Table 4.6 could describe a highly-stabilised barnase 
mutant that fits to the original EM kinetics. The idea of super-stabilising 
an enzyme, to reveal a prominent Einact population, is discussed further in 
Section 5.3.1. The above findings are presented in Figure 4.6 for 
comparison to Figure 4.4; note the same profile for Eact and the clean 
transition to Einact, which is now protected from denaturation for the time 
scale of hours, not seconds. 
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Figure 4.6 – 2D temperature/time plot of EM species at > 80% E0 for an ideal enzyme 
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5 Discussion and Conclusions 
The overall goal of this thesis was to identify a mutant of barnase that 
would allow direct observation of the structural changes which occur over 
the Eact/Einact equilibrium. This could be achieved through decoupling the 
thermal stability of the enzyme from its activity through mutation(s) that 
either lower Teq and/or raise Tm. If successful, this would allow the 
dynamics of the Eact/Einact equilibrium to be measured via NMR. The 
experimental results, summarising the acquisition and fitting of EM data 
(Section 5.1.1) and thermostabilities of WT, DM & L89V barnase variants 
(Section 5.1.2), respectively, are discussed in this chapter. 
In addition, to understand and potentially improve the mathematics 
behind the EM, new model derivations were fitted to an ideal data set and 
to the WT barnase data set. A review of findings from the fitting 
experiments is given in Section 5.2.1. To benchmark the potential 
dynamics measurements of any enzyme, equations to simulate the 
concentrations of species with time and temperature were derived and 
analysed (Section 5.2.2). Finally, future work that might result from the 
findings in this thesis is summarised in Section 5.3.1 and Section 5.3.2, 
dealing with potential new experimental and theoretical approaches, 
respectively. 
5.1 Experimental 
5.1.1 Assays and Fitting Results to the Original EM 
The WT barnase assays performed using the GpUp dinucleotide substrate 
were not extended to the five barnase mutants. Declining rates with time 
that could not be attributed to either formation of the Einact species or 
denaturation were observed, and these led to poor fits between the data 
set and the original EM. These declining profiles may be due to product 
inhibition or the secondary hydrolysis step of the substrate becoming 
prevalent in assays (see Section 1.3.2). The KM values at high temperatures 
were also large which limited assays, due to substrate solubility and cost. 
The absorbance change upon hydrolysis of GpUp is very small and has 
large experimental errors so, although output parameters from fits to the 
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original EM were reasonable, the experimental difficulties made this 
substrate poor and unreliable for collection of EM data. 
The FrG substrate also had several experimental difficulties. The 
temperature dependence of the substrate (and product) fluorescence (see 
Section 3.3.2.1) meant that corrections had to be made in data processing 
(Section 2.7.1.3) to ensure linearity between fluorescence and product 
concentration. Mixing of enzyme was often a problem and a refined 
protocol was developed. KM values were much more stable with 
temperature for the FrG fluorescent substrate (see Section 3.3.3.1). This 
meant that corrections for KM, even though applied to all the data sets 
used in this thesis, were much less important than for the GpUp substrate. 
The low background and large change in fluorescence upon cleavage of 
FrG led to higher sensitivity and reliability than in the GpUp-based 
assays; hence, data was collected for WT, S80C/A43C (DM) and L89V 
barnase (Section 3.3.3). Three remaining mutant barnase enzymes studied 
(Y78F, I51V and I88V barnase) are yet to be assayed with FrG. 
The results from fitting the WT, DM and L89V assay data to the original 
EM (using fitting.exe) are detailed in Section 3.3.4. The important 
parameter with regard to dynamics measurements, Teq, did not change 
outside of experimental error between the WT and the DM or L89V 
mutants. Relative to the WT enzyme,  ∆Ginact
‡  has not changed outside of 
error for fitting.exe results, although it has for the SurfaceTool method. 
Both fitting procedures show the correct direction of change in  ∆Ginact
‡  for 
each mutant, but do not reflect the absolute values or differences 
suggested in the literature values (Table 1.2) or thermostability 
experiments (see Section 5.1.2 and Section 3.3.4). Therefore, as described 
by the EM model fits, the Einact species is not more significantly present 
than in the WT enzyme. 
5.1.2 Thermostability and Decoupling Tm from Teq 
The Tm values for WT and mutant barnase were measured under assay 
conditions (but excluding substrate) using CD and DSC methods (see 
Section 3.2). As the two mutants assayed so far show no significant 
changes in Teq from the WT, an increase in Tm could protect the Einact species 
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from denaturation and make it available for dynamics experiments at 
temperatures where it is mainly denatured in the WT assays. 
DM barnase has a Tm 5.2 ± 0.1 °C higher than the WT enzyme (Section 
3.2.6). Because Teq has not changed for the DM over the WT, this is an 
example of successfully decoupling thermal activity from denaturation. If 
the Tm values are correct, and fitted  ∆Ginact
‡  values are incorrect (see Section 
5.1.1), the Einact species in the DM enzyme might be more accessible in a 
significant concentration at temperatures between Teq and Tm than fits to 
the original EM suggest (see Section 5.3.1). The ∆Tm of L89V barnase is -0.8 
± 0.1 °C, which suggests a decoupling in the opposite direction; the 
enzyme is marginally destabilised, yet Teq has not significantly changed. 
5.2 Theory and Modelling 
5.2.1 Fitting Results for all Models 
WT, DM and L89V barnase all fit to the original EM with good R2 and SEE 
statistics and individual output parameters are well defined (Section 
3.3.3.2). However, all barnase data sets show systematic deviations from 
the fits at high temperatures in the residual plots. These deviations were 
thought to be due to poor fitting at high temperatures, as the denaturation 
of barnase is reversible but not allowed for in the original EM (see 
discussion below). 
The results in Section 4.2.1.1 illustrate how the original EM fits ideal data 
accurately with much less systematic deviation in the residuals (see 
Appendix C for all fitting plots). Denaturation from the Einact species can be 
fitted well using model O but, if the model includes a choice (as in model 
P), the preferred and best-fitting pathway is via Einact using the original EM 
derivation (see Section 4.2.1.3). This corroborates the original assumption 
of the EM, that Einact is on-path to denaturation (Daniel et al., 2001). A 
simplification of the derivation kinetics to model M results in concordant 
output parameters compared with the original EM without making the 
distinction between Eact or Einact denaturation. Model M also fits statistically 
better than any other model to the two data sets compared to date, for the 
ranges of data acquired. However, data sets with longer time periods may 
not fit as well to model M, as denaturation will be more pronounced at 
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lower temperatures, due to the lack of a reservoir of Eact (which is present 
in the original EM). This is a failing in model M, as it inherently needs a 
larger  ∆Ginact
‡  value to compensate for both Eact and Einact denaturing. In 
conclusion, the EM as it stands is the best model for the current data. 
Reversibly denaturing models (Section 4.2.1.4) have too many degrees of 
freedom to fit to data sets unaided. A potential solution to this is given in 
Section 5.3.2. Fits performed in this thesis do show reasonable, yet 
uncertain, values for parameters and, hence, could be improved by a 
better understanding of how the different rates interact with one another. 
More sensible starting values and less freedom to move (narrower search 
spaces for each parameter) might aid in this, but require extensive 
optimisation to define starting values that still allow for unbiased fitting to 
all data sets. Model N was the only reversibly denaturing model to fit 
reliably to the WT barnase data (see Section 4.2.2.2). However, it is not a 
fair comparison to the original EM model analysed in Section 4.2.2.1 
because it allows for an Eact/Einact ensemble to denature, not just Einact. This 
means that, although it fits the data well at short time scales, model N 
overestimates the amount of denaturation present in an assay, leading to 
poor fits at long time scales (like its irreversible counterpart, model M). 
Finally, it must be kept in mind that fitted output parameters are all 
inferred from rate data (and variables in exponentials of exponentials 
fitted to it). That is, the Einact and X species are removed from the Eact 
species (the activity of which is measured directly via assays) by at least 
one process (Keq, kinact et al., or both). Hence, there is potential for a model 
to ascribe rate losses to a denaturation process when it would be more 
correctly defined via a Keq equilibrium process, and vice versa (see Section 
5.2.2). This hazard has potential for remediation (see Section 5.3.2). All of 
the models have the same rate profile at zero-time (see Table 4.1) and, 
hence, the longer the assay data is, whilst remaining valid, the more 
chance the fitting procedure has to fit the correct parameters to each 
model. This is a good reason to not shorten data sets unnecessarily (see 
Section 3.3.1.2). A better statistical fit may obscure true parameter values 
through poor fitting, especially with the inactivation parameters such as 
 ∆Ginact
‡  that require time to reveal their effect on the data set. 
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5.2.2 Species Simulations 
The species simulations provide useful insight into the movement of 
species within the assay data sets. It is interesting to note that the 
concentrations of species are vastly different from what was assumed until 
recently. For example, with the ideal data set, the concentration of Einact is 
much lower at time points greater than a few minutes, making the nature 
of Einact hard to observe. This could explain why researchers have not 
found physical evidence for the Einact species to date (Daniel et al., 2009). 
Due to time constraints, the analyses of derived models other than the 
original EM have not been completed. The simulations show promise as a 
tool for understanding how the different models work and for validating 
their fits to experimental data for future dynamics experiments. 
The simulations for WT and DM barnase for the original EM do not reflect 
their denaturation properties (see Section 4.3.1). The curves simulated for 
[X] have midpoints (50% of E0) at approximately 10 and 15 K less than 
where DSC and CD measurements place the WT and DM Tm values (see 
Section 5.1.2). This means that the absolute value of  ∆Ginact
‡  is incorrect and 
much lower than it should be. The flow-on effects from misrepresenting 
the concentration of X in this way are important because the concentration 
of Einact could be, in reality, much higher at a given temperature, as 
denaturation is not really occurring at the temperatures indicated by the 
simulation. As the output parameters from the fits to the original EM are 
used to simulate the X curve, either the fitted  ∆Ginact
‡  value is incorrect (see 
Section 5.1.1) or the EM itself does not represent what is really occurring 
in the barnase assays. 
The simulation of an ideal enzyme for dynamics measurements shows 
that the separation of Einact from X is possible using the original EM 
kinetics (Section 4.3.2). Hence, the kinetics of the model do allow for a 
situation where Einact is the major species. Barnase dynamics measurements 
may be possible if the variants’  ∆Ginact
‡  values were incorrectly fitted to the 
model (see Section 5.1.1). It is postulated that a highly-stable enzyme 
might be engineered that could approach the same kind of Einact/X 
separation seen in the ideal enzyme simulations (see Section 5.3.1). 
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5.3 Future Research 
Numerous interesting details remain hidden within the available data. 
Many of the theoretical conclusions are recent developments (early 2010), 
therefore, many opportunities for better understanding and development 
of the EM are available. The following are suggestions for promising areas 
of future research based on the aforementioned conclusions. 
5.3.1 Experimental 
There are three mutant barnase enzymes (Y78F, I51V and I88V barnase) 
that have not been assayed for equilibrium model data collection. As they 
all show lower thermostability (lower Tm values), compared with the WT 
and L89V, they will need to possess significantly lowered Teq values to 
provide a good source for measuring Einact dynamics. It would be 
interesting, however, to see if they possess altered output parameters due 
to their lower stabilities, but this is not expected based on WT, L89V and 
DM trends (where Teq and  ∆Ginact
‡  did not change markedly) (see Section 
5.1.1). 
The stabilising effect of substrate on enzymes has not been tested in any 
previous work on the EM, but it is well known that substrates may 
enhance protein stability with regard to thermal denaturation (Lejeune et 
al., 2001). It would be useful to see if DSC and CD stability values are 
altered by the presence of substrate, compared to those in this thesis, 
which were measured in the absence of substrate. Due to the length of 
time required for these measurements, a non-hydrolysable FrG analogue 
(exactly the same, but with no ribose-guanoside residue) could be 
employed to enable stabilisation of the enzyme to be studied without 
substrate degradation. A related experiment is explained in Section 5.3.2. 
The DM barnase enzyme has shown a good fit to the original EM and a Teq 
that is similar to WT barnase. Although the species simulations (see 
Section 5.2.2) do not show a large Einact population present for dynamics 
measurements, it is thought that the raised Tm of the double mutant may 
allow NMR experiments to observe the Einact/Eact transition. If fitted  ∆Ginact
‡  
parameters from the original EM are incorrect (see Section 5.2.2), then 
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there may be a much larger Einact population present than what is shown in 
the simulations. 15N-labelled DM barnase, prepared for this purpose, has 
been sent to The University of Sheffield, UK, for protein dynamics 
measurements. 
It would also be useful to investigate if a highly-stable mutant of barnase 
could be prepared. The obvious choice for this is in combining multiple 
disulfide bonds to raise the Tm as high as possible. The mutations would 
have to be carefully selected, as the only other stabilising cross-link made 
to date incorporates an active-site residue which is no use for activity 
assays and would also perturb the active-site dynamics (Clarke et al., 
1995a). If a similar stabilising mutation raised  ∆Ginact
‡  to a level 
approaching that of the theoretical “ideal enzyme” (Section 4.3.2), then the 
Einact species would be well protected from denaturation and, therefore, 
available for dynamics measurements. 
5.3.2 Modelling and Mathematics 
There is always the possibility that a better model could be derived for the 
EM. Based on the remarkably good statistical fit of model O to the data 
sets, a reversibly denaturing counterpart could be easily derived, for 
example. This would be of little utility, however, as models EM, P and M 
all point towards model O being an exception (see Section 4.2.1.3). 
Although not attempted in this thesis, if the denaturation process under 
assay conditions could be measured directly, and then accounted for 
separately from activity, that would leave the fitting procedures free to fit 
the Keq equilibrium parameters (∆Heq & Teq) and  ∆Gcat
‡  more accurately. 
Essentially, the concentration of X could be input alongside the time, 
temperature and rate data as another independent variable. This would 
simplify the mathematics greatly, as equation (8) in Appendix B could be 
directly fitted to activity. The largest benefit would be that the actual 
model (e.g., models EM & M-R) fitted to the data becomes irrelevant 
(because all the models presented in this thesis have the Eact/Einact 
equilibrium at their core, yet differentiate from each other by describing 
different denaturation pathways). If [X] is input directly, then the 
renaturation properties of the enzyme are already accounted for in the fit. 
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Expanding the idea for the purposes of barnase assays, the denaturation 
could be followed using fluorescence spectroscopy at all the temperature 
points assayed. Stopped-flow apparatus may be required. It is well known 
that barnase folding and unfolding can be followed with intrinsic 
fluorescence at excitation of 293 nm and emission at 338 nm (Horovitz & 
Fersht, 1992). This data set could be collected using a modified procedure 
(including substrate) as described in Section 2.6.2.6, then added to existing 
data sets, as described above. Interactions between substrate and barnase 
fluorescence would have to be explored, as well as fluorometer settings 
and sensitivity. The experiment could also give information on the 
stabilising influence of substrate on enzyme stability, which is important if 
DSC and CD measurements are to be used analytically (see Section 5.1.2). 
An approach such as this would confirm if the original EM as it stands 
outputs reasonable  ∆Ginact
‡  values or not (as discussed in Section 5.1.1). 
Although this idea is ambitious, the benefits in terms of understanding 
how the current parameters are fitted to and relate to each model could be 
very large indeed. 
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Appendix A Reagents and Extra Methods 
All percent values are in weight/volume unless noted otherwise. If noted, 
ingredients were filtered through a MiniSart 0.22 µm filter (Satorius AG, 
Germany) and solutions were filtered through Supor® 200 47 mm 0.2 µm 
filters (Pall Corporation, USA). 
A.1 Buffers and Solutions 
All buffers and solutions were made up using RO water and autoclaved, if 
noted, for at least 15 minutes at 121 °C. 
Acetate buffer 5% (v/v) 0.1 M acetic acid, 95% 0.1 M sodium acetate, pH 
to 5.8 with 0.1 M acetic acid, all with DEPC water 
Assay buffer Mix together Pho buffers A:B in 932:68 ratio, check pH 8.0 
Buffer A 20 mM tri-sodium citrate, pH 5.5 with 10 M HCl, 0.2 µm 
filtered 
Buffer B 200 mM NaCl, 1.2 mL of 0.5 M KH2PO4, 18.8 mL of 0.5 M 
K2HPO4, pH 8.0 if needed, 0.2 µm filtered 
Coomassie stain 0.05% coomassie blue R-250, 25% (v/v) isopropanol, 10% 
(v/v) acetic acid  
DEPC water 0.1% (v/v) diethylpyrocarbonate is made up in 0.2 µm-
filtered MQ water and incubated at 37 °C overnight, then 
autoclaved 
Destain 10% acetic acid 
FLD (2x) 80% (v/v) formamide, 5 mM EDTA, 0.1% bromophenol 
blue, 0.1% xylene cyanol FF made up with MQ water 
GTE 50 mM glucose, 25 mM Tris-HCl pH 8.0, 10 mM EDTA pH 
8.0 
M9 salts 1.5% KH2PO4, 6.4% Na2HPO4·7H2O, 0.25% NaCl, 0.5% 
NH4Cl, pH 7.2 and autoclaved (Note: 15NH4Cl used for 
NMR labelling) 
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Pho buffer A 0.355% Na2HPO4 (0.1 M) in DEPC water 
Pho buffer B 0.390% NaH2PO4·2H2O (0.1 M) in DEPC water 
QX4 200 mM Tris-HCl pH 6.8, 8% SDS, 40% (v/v) glycerol, 
0.4% bromophenol blue, 400 mM ß-mercaptoethanol 
Resolving buffer 1.5 M Tris-HCl pH 8.8 
Running buffer 25 mM Tris-HCl pH 6.8, 0.1% SDS, 190 mM glycine 
Stacking buffer 0.5 M Tris-HCl pH 6.8 
TBE (10x) 10.78% Tris base, 5.50% boric acid, 20 mM EDTA, made 
up with MQ water at pH 8.3 
Tris 10 mM Tris-HCl, pH 8.0 
100 mM Tris 100 mM Tris-HCl, pH 8.0 
A.2 Growth Media 
All media were made up with MQ water and sterilised via autoclaving at 
121 °C for at least 15 minutes. 
A.2.1 Solid Media 
Agar was stored after autoclaving in a 55°C oven to preserve liquidity. 
Antibiotics were added at the desired concentration before pouring plates. 
LB Agar 1% bactotryptone, 0.5% yeast extract, 0.5% NaCl, 1.2% 
agar 
A.2.2 Liquid Media 
LB 1% bactotryptone, 0.5% yeast extract, 1% NaCl, pH 7.0 
M9 All v/v with no autoclaving: 20% M9 salts, 2% of 20% 0.22 
µm-filtered D-glucose stock, 1% basal vitamins eagle 
media (Sigma-Adrich, USA), 0.2% pre-autoclaved 1 M 
MgSO4, 0.01% pre-autoclaved 1 M CaCl2 
SOC 2% peptone from casein, 0.55% yeast extract, 10 mM NaCl, 
2.5 mM KCl, the following ingredients were 0.22 µm-
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filtered and added after autoclaving: 10 mM MgCl2, 10 
mM MgSO4, 20 mM glucose 
TB Made up to 90% of volume and autoclaved: 1.2% 
bactotryptone, 2.4% yeast extract, 0.4% (v/v) glycerol. 
Made up to 10% of volume and autoclaved: 0.231% 
KH2PO4, 1.254% K2HPO4. The two solutions are combined 
using sterile techniques before use. 
A.3 Antibiotics 
The following antibiotics were made up as stocks, filtered through a 
MiniSart 0.22 µm filter (Satorius AG, Germany), and then used at one 
thousand-fold dilutions in all liquid media and agar plates: 
Ampicillin 100 mg/mL 
Tetracycline 25 mg/mL dissolved in 100% EtOH 
A.4 PAGE Gels 
A.4.1 15% SDS-PAGE Gels 
Gels were made according to the following recipe and method, based on 
Sambrook et al. (Sambrook & Russell, 2001) which provides for 5 gels in a 
small multiple gel casting apparatus (Hoefer, USA). Note: 10% APS 
(ammonium persulphate) needs to be less than 1 week old. 
Prepare the gel casting apparatus with 5 casts, then make up the 
following: 
Resolving gel 7.05 mL RO water, 15 mL 30% acrylamide, 7.5 mL 
resolving buffer, 300 µL 10% SDS 
(sodium dodecyl sulphate), 150 µL 10% APS, 15 µL 
TEMED (tetramethyl ethylene diamine) 
This is gently mixed (inverted), added to the casts, then each individual 
gel is overlaid gently with 2 mL of isopropanol. Time to set is 
approximately 40 minutes. When set, the isolpropanol is drained away 
and the casts set upside down whilst the following is made up: 
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5% Stacking gel 8.5 mL RO water, 2.125 mL 30% acrylamide, 1.6 mL 
stacking buffer, 125 µL 10% SDS, 63 µL 10% APS, 6.3 µL 
TEMED 
This is then added to each cast after gentle mixing, the combs inserted, 
and the whole apparatus is covered with a moist kitchen towel. 
Polymerisation takes approximately 30 minutes. Gels can be stored at 4 °C 
in a moist wrapping for up to two weeks. 
A.4.2 5% Urea Denaturing PAGE Gels 
As above, the following makes 5 gels in similar apparatus. 
Gel mixture 12.6 g urea (final conc. 7 M), 20.6 mL RO water, 5 mL 30% 
acrylamide, 4.4 mL 10x TBE buffer and mix together at 55 
°C until all is dissolved 
130 µL 10% APS and 30 µL TEMED are added and gently mixed in before 
adding to the casting apparatus and inserting combs. At least an hour is 
needed to set and gels are very fragile. 
A.5 Bacterial Strains and Preparations 
A.5.1 Escherichia Coli DH5-! cells 
Geneotype: F- "80lacZ∆M15 ∆(lacZYA-argF) U169 recA1 endA1 hsdR17 (rk-, 
mk+) phoA supE44 #- thi-1 gyrA96 relA1 
DH5-$ cells were from Invitrogen (USA) (Catalogue #18258-012) and used 
for transformations of WT Barnase plasmids, expression and mini-preps. 
A.5.2 Escherichia Coli XL1-blue cells 
Geneotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ proAB 
lacIqZ∆M15 Tn10 (Tetr)] 
XL1-blue cells were from Stratagene (USA) (Catalogue #200249) and used 
for transformations of mutant Barnase plasmids, expression and mini-
preps. 
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A.5.3 Preparation of Electrocompetent XL1-blue Cells 
Electrocompetent XL1-blue E. coli cells were prepared using a modified 
method based on the Gene Pulser™ operating manual (Bio-Rad 
Laboratories, USA, Catalogue #165-2098). 10 µL of XL1-blue cells (Section 
A.5.2) from the provided stock in the Stratagene QuikChange™ II-E kit 
(Section 2.3) was resuspended in 250 µL SOC media and incubated at 37 
°C for 1 hour, then streaked on LB-agar plates with tetracycline at 25 
µg/mL. The plate was incubated overnight at 37 °C. A single colony was 
used to inoculate an overnight 10 mL culture in LB media, shaken at 200 
rpm at 37 °C. This starter culture was used to inoculate a 1 L culture of LB 
media incubated at 37 °C with 200 rpm shaking until at OD600 of 0.6. 
This flask was chilled on ice for 30 minutes, then cells were pelleted at 
4000 x g and 4 °C for 15 minutes in 750 mL centrifuge bottles. The 
supernatant was poured off and cells gently resuspended in 1 L of ice-
cold, sterile, 10% glycerol. Cells were similarly centrifuged and 
resuspended in 500 mL then 20 mL of the 10% glycerol, decreasing the 
volume whilst increasing the concentration of cells. Pelleting and 
resuspension in 2 mL of the 10% glycerol gives a stock that can be 
aliquotted and snap-frozen at -80 °C using an EtOH slurry. The 
transformation efficiency of the cells was found to be 6x108 cfu/µg of 
DNA for a pUC18 plasmid. 
A.6 DNA Mini-prep Method (Alkaline Lysis) 
The following is based on established methods (Sambrook & Russell, 
2001): For plasmid sequencing, a 4 mL culture of TB media was inoculated 
with a single colony from an agar plate prepared as in Section 2.2.3.1. 3 µL 
ampicillin stock was added and the culture shaken at 200 rpm overnight 
in a 13 mL tube at 30 °C. Overnight culture was divided into two 1.5 mL 
centrifuge tubes and spun down at 13000 rpm in a MiniSpin™ Plus 
centrifuge (Eppendorf, Germany) for 2 minutes at room temperature. The 
remaining 1 mL was used for glycerol cell stocks (Section 0). Each cell 
pellet was then treated as follows: 200 µL GTE buffer kept at 4 °C was 
added for resuspension. 300 µL room temperature 0.2 M NaOH/1% SDS 
was mixed in gently with a pipette and left for 5 minutes. 300 µL 3.0 M 
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potassium acetate solution (pH 4.8) was added and the resulting solution 
left on ice for 10 minutes. 
This solution was spun down similarly for 10 minutes, the supernatant 
transferred to a new tube with 1 µL 20 mg/mL RNAse A (Invitrogen, 
USA), and incubated at 37 °C for 20 minutes. 500 µL chloroform was 
mixed in and spun down for 1 minute to separate the phases. After 
transferring the aqueous layer to another 1.5 mL tube, the chloroform 
extraction was repeated. Removing the aqueous layer to another 1.5 mL 
tube, DNA was precipitated by addition of an equal volume of 
isopropanol, and spun down for 10 minutes. 
The pellet of DNA was washed with 500 µL 70% EtOH and left to air dry. 
The dry pellet was dissolved in 64 µL MQ water and transferred to a new 
1.5 mL tube, the old tube being washed out with 32 µL MQ water and 
pooled with the main volume. 24 µL 4 M NaCl and 120 µL autoclaved 
polyethylene glycol (PEG 8000) were mixed in thoroughly, then incubated 
on ice for 20 minutes. The mixture was spun similarly, but at 4 °C for 25 
minutes, and the supernatant carefully removed. 400 µL 70% EtOH was 
used to wash the pellet, then it was air dried and resuspended in Tris 
buffer for storage at -20 °C. 
A.7 Rotavirus RNA Synthesis 
All reagents not listed in Appendix A.1 were from Joanna McKenzie (The 
University of Waikato). 
A ~3-cm square portion of 14.6 mm diameter Spectra/Por® 6-8 kDa cut-
off dialysis membrane tube (Spectrum Laboratories, USA) was pre-wet in 
100 mM Tris buffer. 21 µL Rotavirus DLPs were placed into a 20 µL 
dialysis button covered with the membrane. In 50 mL of 100 mM Tris, the 
button was shaken gently on an orbital mixer for 2 hours, then in fresh 
buffer overnight. A small hole was made in the membrane with a sterile 
scalpel and 15 µL of the solution added to a 1.5 mL centrifuge tube (~ 0.1 
µg/mL). 20 µL 1 M Tris (pH 8.0), 20 µL 10 mM rNTPs, 12 µL 100 mM 
MgCl2 and 133 µL 0.22 µm-filtered MQ water were added and incubated 
at 37 °C for 1 hour, shaken at 300 rpm. 
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100 µL 7.5 M ammonium acetate and 500 µL 100 % EtOH were mixed in 
well and the solution incubated at -80 °C for 1-24 hours depending on 
available time. The slurry was then spun down at 13000 rpm at 4 °C for 25 
minutes on a Biofuge Fresco™ centrifuge (Thermofisher Scientific, USA). 
The supernatant was carefully removed and the pellet air-dried for 30 
minutes then resuspended in 20 µL 0.22 µm-filtered DEPC water. The 
concentration of RNA was determined as in Section 2.2.2, usually 1-5 
µg/µL, and the solution stored at 4 °C. 
A.8 Thermocouple Calibration 
Thermocouples A and B, both H1 93530 thermocouple probes (Hanna 
Instruments, USA), were equilibrated in a water bath along with a NIST-
traceable high resolution glass thermometer (Cole-Parmer, USA), the 
temperature increased in 5 °C increments and the readings from the 
thermometer plotted against those from the thermocouples. A linear 
relationship (R2 >0.9999) was then used to convert thermocouple readings 
to accurate temperatures in assays. 
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Appendix B Derivations of Model Equations 
B.1 Original Equilibrium Model 
See section 1.2.2 for the reasoning behind derivations and explanations of 
terms. Bold equation numbers represent a final equation. 
B.1.1 Original Model Species 
 Eact  
Keq! "!# !!  Einact  
kinact! "!!  X  
B.1.2 General Definitions 
  
 
Vmax = kcat ![Eact ] (1.) 
  
 
[E0 ] = [Eact ] + [Einact ] + [X] (2.) 
  
 
Keq = exp
!Heq
R "
1
Teq
# 1T
$ 
% 
& 
' 
( 
) 
$ 
% 
& 
' 
( 
)      and     
  
 
Keq =
[Einact ]
[Eact ]
 (3. a&b) 
  
 
kcat =
kB !T
hP
!exp "#Gcat
‡
R !T
$ 
% & 
' 
( ) 
 (4.) 
  
 
kinact =
kB !T
hP
!exp "#Ginact
‡
R !T
$ 
% & 
' 
( )  (5.) 
B.1.3 Derivations from General Definitions 
  
 
[Eact ] =
[E0 ]! [X]
1 + Keq
     via (2) and (3b) (6.) 
  
 
[Einact ] =
[E0 ]! [X]
1 + 1 Keq
     via (2) and (3b) (7.) 
  
 
Vmax = kcat !
[E0 ]" [X]
1 + Keq
     via (1) and (6) (8.)
 
B.1.4 Original Model Manipulations 
  
 
d[X]
dt = kinact ![Einact ] (9.) 
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d[X]
dt =
kinact
1 + 1 Keq
! [E0 ]" [X]( )      via (7) (10.)
 
  
 
d[X]
[E0 ]! [X]
= kinact1 + 1 Keq
 dt  (11.)
 
  
 
! ln [E0 ]! [X]( ) = kinact1 + 1 Keq
"t + c (12.)
 
  
 
[E0 ]! [X] = exp
!kinact "Keq "t
1 + Keq
# 
$ 
% 
& 
' 
( "exp c( )     (by multiplying through Keq) (13.)
 
  
 
at t = 0,  [E0 ]! [X] = exp c( )
"  if [X]0 = 0,  [E0 ] = exp c( )
 (14.)
 
  
 
!  [E0 ]" [X] = [E0 ] #exp
"kinact #Keq #t
1 + Keq
$ 
% 
& 
' 
( 
)      via (14) (15.) 
B.1.5 Original Model Rate Equation 
  
 
Vmax =
kcat ![E0 ]
1 + Keq
!exp "kinact !Keq !t1 + Keq
# 
$ 
% 
& 
' 
(      via (8) and (15) (16.) 
The above can be expanded to include
 
∆G‡ terms via (4) & (5) and 
expanded to include ∆Heq and Teq terms via (3a). 
B.1.6 Original Model Product Equation 
The product equation is the integration of the rate equation with respect to 
time: 
  
 
d[P]
dt = Vmax !  [P] =
kcat "[E0 ]
1 + Keq
"exp #kinact "Keq "t1 + Keq
$ 
% 
& 
' 
( 
) *  dt      via (16) (17.) 
  
 
!  [P] = kcat "[E0 ]kinact "Keq
" 1# exp #kinact "Keq "t1 + Keq
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) 
$ 
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' 
( 
)  (18.) 
The product equation can be expanded to include
 
∆G‡, ∆Heq and Teq terms 
also. 
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B.1.7 Original Model Species Concentration Equations 
  
 
[Eact ] =
[E0 ]
1 + Keq
!exp "kinact !Keq !t1 + Keq
# 
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& 
' 
(      via (6) and (15) (19.) 
  
 
[Einact ] =
[E0 ]
1 + 1 Keq
!exp "kinact !Keq !t1 + Keq
# 
$ 
% 
& 
' 
(      via (7) and (15) (20.) 
  
 
[X] = [E0 ]! [E0 ] "exp
!kinact "Keq "t
1 + Keq
# 
$ 
% 
& 
' 
(      via (15) (21.) 
  
 
[X] = [E0 ] ! 1" exp
"kinact !Keq !t
1 + Keq
# 
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(  (22.) 
B.2 Model “M” 
B.2.1 Model “M” Species 
 
Eact  
Keq! "!# !!  Einact$%&
'
()
 kinact! "!!  X
 
B.2.2 New Manipulations for Model “M” 
  
 
d[X]
dt = kinact ! [Eact ] + [Einact ]( )  (23.) 
  
 
d[X]
dt = kinact ! [E0 ]" [X]( )     via (2) (24.) 
  
 
d[X]
[E0 ]! [X]
= kinact  dt  (25.)
 
  
 
! ln [E0 ]! [X]( ) = kinact "t + c  (26.)
 
  
 
[E0 ]! [X] = exp !kinact "t( ) "exp c( ) (27.)
 
  
 
!  [E0 ]" [X] = [E0 ] #exp "kinact #t( )     via (14) (28.) 
B.2.3 Model “M” Rate Equation 
  
 
Vmax =
kcat ![E0 ]
1 + Keq
!exp "kinact !t( )     via (8) and (28) (29.) 
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The above equation can be expanded as in Section B.1.5. 
B.2.4 Model “M” Product Equation 
The product equation is the integration of the rate equation with respect to 
time: 
  
 
d[P]
dt = Vmax !  [P] =
kcat "[E0 ]
1 + Keq
"exp #kinact "t( )$  dt      via (29) (30.) 
  
 
!  [P] = kcat "[E0 ]
kinact " 1 + Keq( ) " 1# exp #kinact "t( )( )  (31.) 
The above equation can be expanded as in Section B.1.5. 
B.2.5 Model “M” Species Concentration Equations 
 
[Eact] =
[E0]
1+ Keq
!exp "kinact ! t( )      via (6) and (28) (32.) 
 
[Einact] =
[E0]
1+1 Keq
!exp "kinact ! t( )      via (7) and (28) (33.) 
 [X] = [E0]! [E0] "exp !kinact " t( )      via (28) (34.) 
 [X] = [E0] ! 1" exp "kinact ! t( )( )  (35.) 
B.3 Reversible Denaturation Models (N & Q) 
For these models, it is not possible to separate ([E0] – [X]) from the time-
independent rate variables (as in (25.)) and then directly integrate both 
sides with respect to X and t independently. Hence, a general method for 
solving linear differential equations is required: 
For equations of the form:     
 
d[X]
dt + A ![X](t) = B  (36.) 
it can be shown that:     
 
[X](t) =
B !exp A ! t( )dt"
exp A ! t( ) +
C
exp A ! t( )  (37.) 
where C is a constant. That simplifies to: 
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[X](t) = BA +C !exp "A ! t( )  (38.) 
if we let:      [X](0) = 0      then      
0 = BA +C !exp "A !0( ) =
B
A +C  (39. a&b) 
 
!  C = " BA      and      
[X](t) = BA !
B
A "exp !A " t( )      simplifying to: (40.) 
 
[X](t) = BA 1! exp !A " t( )( )  (41.) 
which can be substituted into (8) instead of the usual ([E0] – [X]) term. 
B.4 Model “N” 
B.4.1 Model “N” Species 
 
Eact  
Keq! "!# !!  Einact$%&
'
()
 kinact
kreact
! "!!# !!!  X  
B.4.2 New Definitions for Model “N” 
  
 
kreact =
kB !T
hP
!exp "#Greact
‡
R !T
$ 
% & 
' 
( ) 
      (kreact is the renaturation constant) (42.) 
B.4.3 New Manipulations for Model “N” 
 
d[X]
dt = kinact ! [E0]" [X]( )" kreact ![X]      modifying (24) (43.) 
 
d[X]
dt + kinact + kreact( ) ![X] = kinact ![E0]  (44.) 
Model N must be solved as in Appendix Section B.3. We let: 
 A = kinact + kreact      and      B = kinact ![E0]  (45. a&b) 
 
!  [X] = kinact "[E0]kinact + kreact
" 1# exp # kinact + kreact( ) " t( )( )      via (41) (46.) 
This can be simplified using A (45 a): 
 
[X] = kinact ![E0]A ! 1" exp "A ! t( )( )  (47.) 
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B.4.4 Model “N” Rate Equation 
 
Vmax =
kcat
1+ Keq
! [E0]"
kinact ![E0]
A ! 1" exp "A ! t( )( )
#
$%
&
'(
     via (8) and (47) (48.) 
 
Vmax =
kcat ![E0]
1+ Keq
! 1" kinactA ! 1" exp "A ! t( )( )
#
$%
&
'(  
(49.) 
The above equation can be expanded as in Section B.1.5. 
B.4.5 Model “N” Product Equation 
The product equation is the integration of the rate equation with respect to 
time: 
 
d[P]
dt =Vmax  !  [P] =
kcat "[E0]
1+ Keq
" 1# kinactA " 1# exp #A " t( )( )
$
%&
'
()
dt*
     
via (49) (50.) 
 
!  [P] = kcat "[E0]1+ Keq
" t #
kinact " A " t + exp #A " t( )( )
A2
$
%
&
'
(
)
 
(51.) 
The above equation can be expanded as in Section B.1.5. 
B.4.6 Model “N” Species Concentration Equations 
 
[Eact] =
[E0]
1+ Keq
! 1" kinactA ! 1" exp "A ! t( )( )
#
$%
&
'(      
via (6) and (47) (52.) 
 
[Einact] =
[E0]
1+1 Keq
! 1" kinactA ! 1" exp "A ! t( )( )
#
$%
&
'(
     via (7) and (47) (53.) 
[X] is defined above (47). 
B.5 Model “O” 
B.5.1 Model “O” Species 
 X  
kdeact! """  Eact  
Keq" #"! ""  Einact  
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B.5.2 New Definitions for Model “O” 
  
 
kdeact =
kB !T
hP
!exp "#Gdeact
‡
R !T
$ 
% & 
' 
( ) 
     (kdeact is the Eact denaturation constant) (54.) 
B.5.3 New Manipulations for Model “O” 
  
 
d[X]
dt = kdeact ![Eact ] (55.) 
  
 
d[X]
dt =
kdeact
1 + Keq
! [E0 ]" [X]( )      via (6) (56.) 
  
 
d[X]
[E0 ]! [X]
= kdeact1 + Keq
 dt  (57.)
 
  
 
! ln [E0 ]! [X]( ) = kdeact1 + Keq
"t + c  (58.)
 
  
 
[E0 ]! [X] = exp
!kdeact "t
1 + Keq
# 
$ 
% 
& 
' 
( "exp c( )  (59.)
 
  
 
!  [E0 ]" [X] = [E0 ] #exp
"kdeact #t
1 + Keq
$ 
% 
& 
' 
( 
)      via (14) (60.) 
B.5.4 Model “O” Rate Equation 
  
 
Vmax =
kcat ![E0 ]
1 + Keq
!exp "kdeact !t1 + Keq
# 
$ 
% 
& 
' 
(      via (8) and (60) (61.) 
The above equation can be expanded as in Section B.1.5. 
B.5.5 Model “O” Product Equation 
The product equation is the integration of the rate equation with respect to 
time: 
  
 
d[P]
dt = Vmax !  [P] =
kcat "[E0 ]
1 + Keq
"exp #kdeact "t1 + Keq
$ 
% 
& 
' 
( 
) *  dt      via (61) (62.) 
  
 
!  [P] = kcat "[E0 ]kinact
" 1# exp #kdeact "t1 + Keq
$ 
% 
& 
' 
( 
) 
$ 
% 
& 
' 
( 
)  (63.) 
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The above equation can be expanded as in Section B.1.5. 
B.5.6 Model “O” Species Concentration Equations 
 
[Eact] =
[E0]
1+ Keq
!exp "kdeact ! t1+ Keq
#
$
%
&
'
(      via (6) and (60) (64.) 
 
[Einact] =
[E0]
1+1 Keq
!exp "kdeact ! t1+ Keq
#
$
%
&
'
(      via (7) and (60) (65.) 
 
[X] = [E0]! [E0] "exp
!kdeact " t
1+ Keq
#
$
%
&
'
(      via (60) (66.) 
 
[X] = [E0] ! 1" exp
"kdeact ! t
1+ Keq
#
$
%
&
'
(
#
$
%%
&
'
((
 (67.) 
B.6 Model “P” 
B.6.1 Model “P” Species 
 X  
kdeact! """  Eact  
Keq" #"! ""  Einact  
kinact" #""  X  
B.6.2 New Manipulations for Model “P” 
  
 
d[X]
dt = kinact ![Einact ] + kdeact ![Eact ]  (68.) 
  
 
d[X]
dt = kinact !
[E0 ]" [X]
1 + 1 Keq
+ kdeact !
[E0 ]" [X]
1 + Keq
     via (6) and (7) (69.) 
  
 
d[X]
dt = [E0 ]! [X]( ) "
kinact "Keq + kdeact
1 + Keq
# 
$ 
% 
& 
' 
(      (by multiplying through Keq) (70.) 
 
  
 
d[X]
[E0 ]! [X]
=
kinact "Keq + kdeact
1 + Keq
 dt  (71.)
 
  
 
! ln [E0 ]! [X]( ) =
kinact "Keq + kdeact
1 + Keq
"t + c  (72.)
 
  
 
[E0 ]! [X] = exp
! kinact "Keq + kdeact( ) "t
1 + Keq
# 
$ 
% % 
& 
' 
( ( 
"exp c( )  (73.)
 
Derivations of Model Equations – Model “P” 120 
  
  
 
!  [E0 ]" [X] = [E0 ] #exp
" kinact #Keq + kdeact( ) #t
1 + Keq
$ 
% 
& & 
' 
( 
) ) 
     via (14) (74.) 
B.6.3 Model “P” Rate Equation 
  
 
Vmax =
kcat ![E0 ]
1 + Keq
!exp
" kinact !Keq + kdeact( ) !t
1 + Keq
# 
$ 
% % 
& 
' 
( ( 
     via (8) and (74) (75.) 
The above equation can be expanded as in Section B.1.5. 
B.6.4 Model “P” Product Equation 
The product equation is the integration of the rate equation with respect to 
time: 
  
 
d[P]
dt = Vmax !  [P] =
kcat "[E0 ]
1 + Keq
"exp
# kinact "Keq + kdeact( ) "t
1 + Keq
$ 
% 
& & 
' 
( 
) ) * dt      via (75) (76.) 
  
 
!  [P] = kcat "[E0 ]kinact "Keq + kdeact
" 1# exp
# kinact "Keq + kdeact( ) "t
1 + Keq
$ 
% 
& & 
' 
( 
) ) 
$ 
% 
& 
& 
' 
( 
) 
) 
 (77.) 
The above equation can be expanded as in Section B.1.5. 
B.6.5 Model “P” Species Concentration Equations 
 
[Eact] =
[E0]
1+ Keq
!exp
" kinact !Keq + kdeact( ) ! t
1+ Keq
#
$
%
%
&
'
(
(
     via (6) and (74) (78.) 
 
[Einact] =
[E0]
1+1 Keq
!exp
" kinact !Keq + kdeact( ) ! t
1+ Keq
#
$
%
%
&
'
(
(
     via (7) and (74) (79.) 
 
[X] = [E0]! [E0] "exp
! kinact "Keq + kdeact( ) " t
1+ Keq
#
$
%
%
&
'
(
(
     via (74) (80.) 
 
[X] = [E0] ! 1" exp
" kinact !Keq + kdeact( ) ! t
1+ Keq
#
$
%
%
&
'
(
(
#
$
%
%
&
'
(
(
 (81.) 
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B.7 Model “Q” 
B.7.1 Model “Q” Species 
 
X  k! a
ka
" #""$ ""  Eact  
Keq" #"$ ""  Einact  
ki
k! i
" #""$ ""  X  
B.7.2 New Definitions for Model “Q” 
 ki = kinact      as previously (5) 
 ka = kdeact      as previously (51) 
With associated ∆G‡ values as output parameters, named appropriately. 
 
k! i =
kb "T
hp
"exp !∆G! i
‡
R "T
#
$%
&
'(
     (k–i is the Einact renaturation constant) (82.) 
 
k! a =
kb "T
hp
"exp !∆G! a
‡
R "T
#
$%
&
'(
     (k–a is the Eact renaturation constant) (83.) 
B.7.3 New Manipulations for Model “Q” 
 
d[X]
dt = ka ![Eact]" k– a ![X]+ ki ![Einact]" k– i ![X]  (84.) 
 
d[X]
dt = ka ![Eact]+ ki ![Einact]" [X] ! k– a + k– i( )  (85.) 
 
d[X]
dt = [E0]! [X]( ) "
ka + ki "Keq
1+ Keq
#
$
%
&
'
( ! [X] " k– a + k– i( )      via (6) and (7) (86.) 
 
d[X]
dt +
ka + ki !Keq
1+ Keq
+ k" a + k" i
#
$
%
&
'
( ![X] =
ka + ki !Keq
1+ Keq
#
$
%
&
'
( ![E0]  (87.) 
Model Q must be solved as in Appendix Section B.3. We let: 
 
A =
ka + ki !Keq
1+ Keq
+ k– a + k– i      and     
 
B =
ka + ki !Keq
1+ Keq
"
#
$
%
&
' ![E0]  (88. a&b) 
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!  [X] =
ka + ki "Keq
1+ Keq
#
$
%
&
'
( "[E0]
ka + ki "Keq
1+ Keq
+ k) a + k) i
" 1) exp )
ka + ki "Keq
1+ Keq
+ k) a + k) i
#
$
%
&
'
( " t
#
$
%%
&
'
((
#
$
%
%
&
'
(
(
via (41) (89.) 
This can be simplified into compound terms D (where D = B/[E0]) and A: 
 
D =
ka + ki !Keq
1+ Keq  
(90.)
 
 
[X] = D ![E0]A ! 1" exp "A ! t( )( )  (91.) 
This holds for all reversible models; N,Q and R. 
B.7.4 Model “Q” Rate Equation 
 
Vmax =
kcat
1+ Keq
! [E0]"
D ![E0]
A ! 1" exp "A ! t( )( )
#
$%
&
'(
     via (8) and (91) (92.) 
 
Vmax =
kcat ![E0]
1+ Keq
! 1" DA ! 1" exp "A ! t( )( )
#
$%
&
'(  
(93.) 
The above equation can be expanded as in Section B.1.5. 
B.7.5 Model “Q” Product Equation 
The product equation is the integration of the rate equation with respect to 
time: 
 
d[P]
dt =Vmax  !  [P] =
kcat "[E0]
1+ Keq
" 1# DA " 1# exp #A " t( )( )
$
%&
'
()
dt*
     
via (93.) (94.) 
 
!  [P] = kcat "[E0]1+ Keq
" t #
D " A " t + exp #A " t( )( )
A2
$
%
&
'
(
)
 
(95.)
 
The above equation can be expanded as in Section B.1.5. 
B.7.6 Model “Q” Species Concentration Equations 
 
[Eact] =
[E0]
1+ Keq
! 1" DA ! 1" exp "A ! t( )( )
#
$%
&
'(
      via (6) and (91) (96.) 
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[Einact] =
[E0]
1+1 Keq
! 1" DA ! 1" exp "A ! t( )( )
#
$%
&
'(
     via (7) and (91) (97.) 
[X] is defined above (91). 
B.8 Model “R” 
B.8.1 Model “R” Species 
 
Eact  
Keq! "!# !!  Einact  
kinact
kreact
! "!!# !!!  X  
B.8.2 New Manipulations for Model “R” 
 
d[X]
dt = kinact ![Einact]" kreact ![X]  (98.) 
 
d[X]
dt =
kinact
1+1 Keq
! [E0]" [X]( )" kreact ![X]      via (6) and (7) (99.) 
 
d[X]
dt +
kinact !Keq
1+ Keq
+ kreact
"
#
$
%
&
' ![X] =
kinact !Keq ![E0]
1+ Keq
 (100.) 
Model R must be solved as in Appendix Section B.3. We let: 
 
A =
kinact !Keq
1+ Keq
+ kreact      and     
 
B =
kinact !Keq ![E0]
1+ Keq
 (101. a&b) 
 
!  [X] =
kinact "Keq "[E0]
1+ Keq
#
$
%
&
'
(
A " 1) exp )A " t( )( )      via (41) (102.) 
This can be simplified via the compound term D (where D = B/[E0]): 
 
D =
kinact !Keq
1+ Keq  
(103.)
 
 
[X] = D ![E0]A ! 1" exp "A ! t( )( )  (104.) 
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B.8.3 Model “R” Rate Equation 
 
Vmax =
kcat
1+ Keq
! [E0]"
D ![E0]
A ! 1" exp "A ! t( )( )
#
$%
&
'(
     via (8) and (104) (105.) 
 
Vmax =
kcat ![E0]
1+ Keq
! 1" DA ! 1" exp "A ! t( )( )
#
$%
&
'(  
(106.) 
The above equation can be expanded as in Section B.1.5. 
B.8.4 Model “R” Product Equation 
The product equation is the integration of the rate equation with respect to 
time: 
 
d[P]
dt =Vmax  !  [P] =
kcat "[E0]
1+ Keq
" 1# DA " 1# exp #A " t( )( )
$
%&
'
()
dt*
     
via (93.) (107.) 
 
!  [P] = kcat "[E0]1+ Keq
" t #
D " A " t + exp #A " t( )( )
A2
$
%
&
'
(
)
 
(108.) 
The above equation can be expanded as in Section B.1.5. 
B.8.5 Model “R” Species Concentration Equations 
 
[Eact] =
[E0]
1+ Keq
! 1" DA ! 1" exp "A ! t( )( )
#
$%
&
'(      
via (6) and (104) (109.) 
 
[Einact] =
[E0]
1+1 Keq
! 1" DA ! 1" exp "A ! t( )( )
#
$%
&
'(      via (7) and (104) (110.) 
[X] is defined above (104). 
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Appendix C Contents of Compact Disc 
The contents of the supplementary compact disc included at the back of 
this thesis are listed below. Bold headings represent folder names. 
C.1 Ashley Davys Easter MSc Thesis Waikato 2010 
C.1.1 PyMol Session Files and Structures 
PyMol (DeLano, 2002) .pse session files are given for the WT and mutant 
overlays from Section 1.3.3.2. High-resolution renderings of these files, as 
well as the overall barnase structures from Section 1.3.1 and Section 1.3.2, 
are also included. 
C.1.2 MALDI-TOF MS Data and Settings 
Raw data for the MS in this thesis (Section 3.2.1) is included, alongside the 
Bruker Daltonics Autoflex™ II settings files used for the work. 
C.1.3 CD and DSC Raw Data and Fitting 
The raw, worked-up and fitted data for the thermostability measurements 
summarised in Section 3.2.6 is given. 
C.1.4 GpUp Worked-up Data and Fitting 
The raw, worked-up and fitted data for the GpUp substrate is included 
alongside output statistics from fitting.exe. 
C.1.5 FrG Worked-up Data and Fitting 
As above, for the FrG substrate. Also has FittingTool files for the EM. 
C.1.6 Alternative Models Data and Fitting 
The data sets used in the fitting experiments are given, alongside 
MATLAB files used to perform the fitting. Results are also included. 
C.1.7 Simulations of Alternative Models and Species 
Interactive files used to simulate rate, product and species curves are 
included. Parameters may be changed to observe changes in plots. Files 
ending with “.gcx” require the program Grapher and may need the 
version included in Mac OS X 10.6.2 (Grapher version 2.1 (43), Apple Inc., 
USA). 
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Appendix D Sequencing Results 
D.1 Sequence of pMT1002 
The sequence of pMT1002 is shown below annotated. See Section 2.2.4.1. 
 
CCC TTG CCG GTT ATC CCC TGA TTC TGT GAT AAC GTT ATT ACG GCC TTG AGT GAA GCT GGA TTA CCG GCT CGG
CGG CAA GCC GAA CCG AAC CGA AGC GCA GCC GAG TTC AGT GAG CGA GGA AGC GGA AAG AGA AAT CTC CAT GTT
TTG ACA GCT TAT CAT CGA TGA AGA TTT CTT GCT CAA TTG TTA TCA GCT ATG CGC CGA CCA GAA CAC CTT GCC
GAT CAG CCA AAC GTC TCT TCA GGC CAC TGA CTA GCG ATA ACT TTC CCC ACA ACG GAA CAA CTC TCA TTG CAT
GGG ATC ATT GGG TAC TGT GGG TTT AGT GGT TGT AAA AAC ACC TGA CCG CTA TCC CTG ATC AGT TTC TTG AAG
GTA AAC TCA TCA CCC CCA AGT CTG GCT ATG CAG AAA TCA CCT GGC TCA ACA GCC TGC TCA GGG TCA ACG AGA
ATT AAC ATT CCG TCA GGA AAA CTT GGC TTG GAG CCT GTT GGT GCG GTC ATG GAA TTA CCT TCA ACC TCA AGC
CAG AAT GCA GAA TCA CTG GCT TTT TTG GTT GTG CTT ACC CAT CTC TCC GCA TCA CCT TTG GTA AAG GTT CTC
AGC TTA GGT GAG AAC ATC CCT GCC TGA ACA TGA GAA AAA ACA GGG TAC TCA TAC TCA CTT CTA AGT GAC GGC
TGC ATA CTA ACC GCT TCA TAC ATC TCG TAG ATT TCT CTG GCG ATT GAA GGG CTA AAT TCT TCA ACG CTA ACT
TTG AGA ATT TTT GTA AGC AAT GCG GCG TTA TAA GCA TTT AAT GCA TTG ATG CCA TTA AAT AAA GCA CCA ACG
New Sequencing
New Sequencing
New Sequencing
New Sequencing
New Sequencing
New Sequencing
New Sequencing
New Sequencing
New Sequencing
New Sequencing
New Sequencing
1 10 20 30 40 50 60 70
80 90 100 110 120 130 140
150 160 170 180 190 200 210
220 230 240 250 260 270 280
290 300 310 320 330 340 350 360
370 380 390 400 410 420 430
440 450 460 470 480 490 500
510 520 530 540 550 560 570
580 590 600 610 620 630 640
650 660 670 680 690 700 710 720
730 740 750 760 770 780 790
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CCT GAC TGC CCC ATC CCC ATC TTG TCT GCG ACA GAT TCC TGG GAT AAG CCA AGT TCA TTT TTC TTT TTT TCA
TAA ATT GCT TTA AGG CGA CGT GCG TCC TCA AGC TGC TCT TGT GTT AAT GGT TTC TTT TTT GTG CTC ATA CGT
TAA ATC TAT CAC CGC AAG GGA TAA ATA TCT AAC ACC GTG CGT GTT GAC TAT TTT ACC TCT GGC GGT GAT AAT
GGT TGC ATG TAC TAA GGA GGT TGT ATG GAT CCG TGG AGA AAA TAA AGT GAA ACA AAG CAC TAT TGC ACT GGC
ACT CTT ACC GTT ACT GTT TAC CCC TGT GAC AAA AGC CGC ACA GGT TAT CAA CAC GTT TGA CGG GGT TGC GGA
TTA TCT TCA GAC ATA TCA TAA GCT ACC TGA TAA TTA CAT TAC AAA ATC AGA AGC ACA AGC CCT CGG CTG GGT
GGC ATC AAA AGG GAA CCT TGC AGA CGT CGC TCC GGG GAA AAG CAT CGG CGG AGA CAT CTT CTC AAA CAG GGA
AGG CAA ACT CCC GGG CAA AAG CGG ACG AAC ATG GCG TGA AGC GGA TAT TAA CTA TAC ATC AGG CTT CAG AAA
TTC AGA CCG GAT TCT TTA CTC AAG CGA CTG GCT GAT TTA CAA AAC AAC GGA CCA TTA TCA GAC CTT TAC AAA
AAT CAG ATA ACG AAA AAA ACG GCT TCC CTG CGG GAG GCC GTT TTT TTC AGC TTT ACA TAA AGT GTG TAA TAA
ATT TTT CTT CAA ACT CTG ATC GGT CAA TTT CAC TTT CCG GCT CTA GAG CTC TAG AGT CCG GTC CAA TCT GCA
New Sequencing
New Sequencing
PR Promoter from Lambda PhageNew Sequencing RNA Polymerase Binding Site
Forward Start PrimerPR Promoter from Lambda Phage
Modified Addgene Sequence of pMT1002
New SequencingRNA Polymerase Binding Site
Barnase
Reverse Start PrimerForward Start Primer Modified Addgene Sequence of pMT1002
Barnase
Reverse Start Primer Modified Addgene Sequence of pMT1002
Barnase
Modified Addgene Sequence of pMT1002
Barnase
Modified Addgene Sequence of pMT1002
Barnase
Modified Addgene Sequence of pMT1002
Barnase
Modified Addgene Sequence of pMT1002
Modified Addgene Sequence of pMT1002
800 810 820 830 840 850 860
870 880 890 900 910 920 930
940 950 960 970 980 990 1,000
1,010 1,020 1,030 1,040 1,050 1,060 1,070 1,080
1,090 1,100 1,110 1,120 1,130 1,140 1,150
1,160 1,170 1,180 1,190 1,200 1,210 1,220
1,230 1,240 1,250 1,260 1,270 1,280 1,290
1,300 1,310 1,320 1,330 1,340 1,350 1,360
1,370 1,380 1,390 1,400 1,410 1,420 1,430 1,440
1,450 1,460 1,470 1,480 1,490 1,500 1,510
1,520 1,530 1,540 1,550 1,560 1,570 1,580
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GCC GTC CGA GAC AGG AGG ACA TCG TCC AGC TGA AAC CGG GGC AGA ATC CGG CCA TTT CTG AAG AGA AAA ATG
GTA AAC TGA TAG AAT AAA ATC ATA AGA AAG GAG CCG CAC ATG AAA AAA GCA GTC ATT AAC GGG GAA CAA ATC
AGA AGT ATC AGC GAC CTC CAC CAG ACA TTG AAA AAG GAG CTT GCC CTT CCG GAA TAC TAC GGT GAA AAC CTG
GAC GCT TTA TGG GAT TGT CTG ACC GGA TGG GTG GAG TAC CCG CTC GTT TTG GAA TGG AGG CAG TTT GAA CAA
AGC AAG CAG CTG ACT GAA AAT GGC GCC GAG AGT GTG CTT CAG GTT TTC CGT GAA GCG AAA GCG GAA GGC TGC
GAC ATC ACC ATC ATA CTT TCT TAA TAC GAT CAA TGG GAG ATG AAC AAT ATG GAA ACA CAA ACC CGC AAG CTT
GCA TTG AAA AAG GAA GAG TAT GAG TAT TCA ACA TTT CCG TGT CGC CCT TAT TCC CTT TTT TGC GGC ATT TTG
CCT TCC TGT TTT TGC TCA CCC AGA AAC GCT GGT GAA AGT AAA AGA TGC TGA AGA TCA GTT GGG TGC ACG AGT
GGG TTA CAT CGA ACT GGA TCT CAA CAG CGG TAA GAT CCT TGA GAG TTT TCG CCC CAA AGA ACG TTT TCC AAT
GAT GAG CAC TTT TAA AGT TCT GCT ATG TGG CGC GGT ATT ATC CCG TAT TGA CGC CGG GCA AGA GCA ACT CGG
TCG CCG CAT ACA CTA TTC TCA GAA TGA CTT GGT TGA GTA CTC ACC AGT CAC AGA AAA GCA TCT TAC GGA TGG
Modified Addgene Sequence of pMT1002
Barstar
Modified Addgene Sequence of pMT1002
Barstar
Modified Addgene Sequence of pMT1002
Barstar
Modified Addgene Sequence of pMT1002
Barstar
Forward End Primer Modified Addgene Sequence of pMT1002
Barstar
Reverse End Primer New SequencingModified Addgene Sequence of pMT1002
ß-lactamase GeneNew Sequencing
ß-lactamase Gene New Sequencing
ß-lactamase Gene New Sequencing
ß-lactamase Gene New Sequencing
ß-lactamase Gene New Sequencing
1,590 1,600 1,610 1,620 1,630 1,640 1,650
1,660 1,670 1,680 1,690 1,700 1,710 1,720
1,730 1,740 1,750 1,760 1,770 1,780 1,790 1,800
1,810 1,820 1,830 1,840 1,850 1,860 1,870
1,880 1,890 1,900 1,910 1,920 1,930 1,940
1,950 1,960 1,970 1,980 1,990 2,000 2,010
2,020 2,030 2,040 2,050 2,060 2,070 2,080
2,090 2,100 2,110 2,120 2,130 2,140 2,150 2,160
2,170 2,180 2,190 2,200 2,210 2,220 2,230
2,240 2,250 2,260 2,270 2,280 2,290 2,300
2,310 2,320 2,330 2,340 2,350 2,360 2,370
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Figure D.1 – Sequence of pMT1002: Alignment of the modified Addgene sequencing 
(blue), additional new outward sequencing (grey), sequencing primers (brown) and 
other regions of interest (various) 
Pr promoter is from # phage (Okorokov et al., 1994) and is coloured in 
light green above. ß-lactamase is from Citrobacter sp. CI157 and coloured in 
medium green. 
 
CAT GAC AGT AAG AGA ATT ATG CAG TGC TGC CAT AAC CAT GAG TGA TAA CAC TGC GGC CAA CTT ACT TCT GAC
AAC GAT CGG AGG ACC GAA GGA GCT AAC CGC TTT TTT GCA CAA CAT GGG GGA TCA TGT AAC TCG CCT TGA TCG
TTG GGA ACC GGA GCT GAA TGA AGC CAT ACC AAA CGA CGA GCG TGA CAC CAC GAT GCC TGT AGC AAT GGC AAC
AAC GTT GCG CAA ACT ATT AAC TGG CGA ACT ACT TAC TCT AGC TTC CCG GCA ACA ATT AAT AGA CTG GAT GGA
GGC GGA TAA AGT TGC AGG ACC ACT TCT GCG CTC GGC CCT TCC GGC TGG CTG GTT TAT TGC TGA TAA AAT CTG
GAG CCG GTG AGC GTG GGT CTC GCG GTA TCA TTG CAG CAC TGG GGG CCA GAT GGT AAG CCC TCC CGT ATC GTA
GTT ATC TAC ACG ACG GGG AGT CAG GCA AAC TAT GGG ATG AAC CGA AAT AAA CAG AAT CGC TGA AAT AAG GTG
GCC CTC CAC TGA TTT AAG CAA TTG GTA ACC TGT CCA GAC CAA GTT TAC TCA TAT AAT AAC TTT AAG ATT GGA
TTT AAA ACT TCT TTT TTT AAT TTA AAA GGG ATC TAG GGT GAA GAT CCT TTT TGA ATA AAA TCC TCA ATG GAC
CAC AAA TCT CCT TAA CGG TGG GAA TTT CTC GTC TCA CAC ACT GTG AAC GCG GTC G
ß-lactamase Gene New Sequencing
ß-lactamase Gene New Sequencing
ß-lactamase Gene New Sequencing
ß-lactamase Gene New Sequencing
ß-lactamase Gene New Sequencing
ß-lactamase Gene New Sequencing
ß-lactamase Gene New Sequencing
ß-lactamase Gene New Sequencing
New Sequencing
New Sequencing
2,380 2,390 2,400 2,410 2,420 2,430 2,440
2,450 2,460 2,470 2,480 2,490 2,500 2,510 2,520
2,530 2,540 2,550 2,560 2,570 2,580 2,590
2,600 2,610 2,620 2,630 2,640 2,650 2,660
2,670 2,680 2,690 2,700 2,710 2,720 2,730
2,740 2,750 2,760 2,770 2,780 2,790 2,800
2,810 2,820 2,830 2,840 2,850 2,860 2,870 2,880
2,890 2,900 2,910 2,920 2,930 2,940 2,950
2,960 2,970 2,980 2,990 3,000 3,010 3,020
3,030 3,040 3,050 3,060 3,070 3,079
